{"meta":{"query_hash":"cef24c963283","filters":{"venue":"Journal of the National Comprehensive Cancer Network"},"cohort_total":168,"direct_labels_cover":0,"predictions_cover":168,"exported":168,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/cef24c963283","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+the+National+Comprehensive+Cancer+Network"},"results":[{"id":"W1784289554","doi":"10.6004/jnccn.2010.0069","title":"Exercise Programs for Cancer-Related Fatigue: Evidence and Clinical Guidelines","year":2010,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Aerobic exercise; Cancer-related fatigue; Survivorship curve; Physical therapy; Physical activity; Clinical trial; Resistance training; Prostate cancer; Physical fitness; Cancer; Exercise therapy; Physical exercise; Physical medicine and rehabilitation; Randomized controlled trial; Oncology; Internal medicine","score_opus":0.3671629895005242,"score_gpt":0.5143988378637816,"score_spread":0.14723584836325743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1784289554","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015421216,0.99731857,0.00014273098,0.0008919419,0.00022337645,0.000071560375,0.000067928624,0.000009941044,0.0011197192],"genre_scores_gemma":[0.0012865387,0.99664116,0.00096488144,0.00043113995,0.00011336703,0.00010134002,0.00007965861,0.000003557069,0.0003783611],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9991416,0.00022050366,0.0002650815,0.00007465346,0.0002603625,0.000037805592],"domain_scores_gemma":[0.9975587,0.0016843935,0.00033351293,0.000036843237,0.00032081243,0.000065674896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019172006,0.001139579,0.002716658,0.00271544,0.00043492415,0.0011479722,0.0021241766,0.0025742622,0.0069571673],"category_scores_gemma":[0.004589348,0.00039156218,0.0016706127,0.0022419218,0.0004483923,0.0009922982,0.00061632745,0.0018439218,0.001973577],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002096097,0.00018387607,0.0002968112,0.0839878,0.00037977824,0.00011928528,0.000080670216,0.00022965642,0.0002671432,0.001649964,0.03089163,0.88170385],"study_design_scores_gemma":[0.0005079182,0.00031666408,0.0058747996,0.39164582,0.002636884,0.0010176486,0.00028462367,0.00038700821,0.0005595675,0.0045624445,0.59215885,0.000047682952],"about_ca_topic_score_codex":0.0033778516,"about_ca_topic_score_gemma":0.0068162675,"teacher_disagreement_score":0.0069571673,"about_ca_system_score_codex":0.0008838169,"about_ca_system_score_gemma":0.001967297,"threshold_uncertainty_score":0.023274064},"labels":[],"label_agreement":null},{"id":"W1808718376","doi":"10.6004/jnccn.2013.0217","title":"Emerging Treatments in Recurrent and Metastatic Colorectal Cancer","year":2013,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Sanofi; Bayer HealthCare; Regeneron Pharmaceuticals; Amgen; Pfizer; Oncolytics Biotech; Eli Lilly and Company; Bristol-Myers Squibb; Genentech; Bayer","keywords":"Medicine; Bevacizumab; Cetuximab; Regorafenib; Panitumumab; Colorectal cancer; Aflibercept; Oncology; Chemotherapy; Targeted therapy; Epidermal growth factor receptor; Internal medicine; Cancer","score_opus":0.10690245731208563,"score_gpt":0.4167122480531281,"score_spread":0.3098097907410425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1808718376","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000066611894,0.9991615,0.000035829537,0.00012792769,0.00008908175,0.000003967801,0.000008376181,0.0000025145875,0.0005042831],"genre_scores_gemma":[0.00042330453,0.999027,0.00009603837,0.000130206,0.000076681,0.0000048647344,0.000017121187,6.003357e-7,0.00022425131],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976724,0.00005366403,0.000041577518,0.000030017476,0.00008873949,0.000018740153],"domain_scores_gemma":[0.99966705,0.0001592038,0.000054866,0.0000087901535,0.00008775525,0.000022445523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006492813,0.00072198827,0.0014650592,0.0028900977,0.00028672093,0.0007992919,0.00087264396,0.000882104,0.003502242],"category_scores_gemma":[0.0008640288,0.00024619646,0.00062724785,0.0025013362,0.00039058208,0.0010859708,0.00066491327,0.0015965801,0.0013648019],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006679343,0.000063029875,0.00016289753,0.02556713,0.00010922435,0.00018471193,0.000055069144,0.00022261396,0.0006419324,0.002227948,0.020406887,0.9502918],"study_design_scores_gemma":[0.000042760803,0.00011620222,0.0011109492,0.011365859,0.00021823478,0.0016796216,0.00009510986,0.00009241127,0.0002984529,0.0017853751,0.98317844,0.000016682234],"about_ca_topic_score_codex":0.0014548843,"about_ca_topic_score_gemma":0.003472604,"teacher_disagreement_score":0.003502242,"about_ca_system_score_codex":0.0006698964,"about_ca_system_score_gemma":0.0010349809,"threshold_uncertainty_score":0.011716187},"labels":[],"label_agreement":null},{"id":"W1880033105","doi":"10.6004/jnccn.2014.0007","title":"The Prostate Cancer Risk Stratification Project: Database Construction and Risk Stratification Outcome Analysis","year":2014,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôtel-Dieu de Québec; Montreal General Hospital; Juravinski Cancer Centre; Kingston Health Sciences Centre; Cancer Care South East; BC Cancer Agency; Kelowna General Hospital; Princess Margaret Cancer Centre; London Health Sciences Centre","funders":"Ontario Institute for Cancer Research; Association of Canadian Universities for Research in Astronomy; Canadian Association of Radiation Oncology; National Comprehensive Cancer Network; American Society for Radiation Oncology","keywords":"Medicine; Prostate cancer; Brachytherapy; Radiation therapy; Oncology; Proportional hazards model; Risk stratification; Database; Internal medicine; Prostate; Survival analysis; Gynecology; Cancer","score_opus":0.05022082447700471,"score_gpt":0.3718909252158641,"score_spread":0.3216701007388594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1880033105","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29860997,0.0014892635,0.05753594,0.0020752938,0.00014356492,0.022488229,0.6032882,0.0020380234,0.012331639],"genre_scores_gemma":[0.2444312,0.00094679435,0.12898771,0.00029199358,0.00008112589,0.011584944,0.6113982,0.0002977315,0.0019802998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9864531,0.0028656214,0.0019336739,0.0013063774,0.0065219277,0.0009192223],"domain_scores_gemma":[0.97240645,0.0028570446,0.0031115678,0.0046642637,0.014821035,0.0021396969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014811179,0.00089273043,0.00087462977,0.009794008,0.001510159,0.0020834673,0.0023822405,0.0002943686,0.0021160196],"category_scores_gemma":[0.038203083,0.0005852367,0.0011575503,0.014790374,0.0004408947,0.00069356774,0.002526018,0.000794983,0.00072069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017016067,0.00042832416,0.68024826,0.0010511893,0.0009727058,0.00023949803,0.0012803163,0.0049476153,0.0015248305,0.006840578,0.0766161,0.22414894],"study_design_scores_gemma":[0.000586696,0.00035907642,0.8476008,0.0003818219,0.00084472145,0.00053882407,0.0008517199,0.012330829,0.003508332,0.0015210141,0.13129163,0.00018460337],"about_ca_topic_score_codex":0.6843495,"about_ca_topic_score_gemma":0.6552571,"teacher_disagreement_score":0.6843495,"about_ca_system_score_codex":0.01552772,"about_ca_system_score_gemma":0.06491377,"threshold_uncertainty_score":0.6350189},"labels":[],"label_agreement":null},{"id":"W1897199628","doi":"10.6004/jnccn.2004.0034","title":"Point: Fluoroquinolone-Based Antibacterial Chemoprophylaxis in Neutropenic Cancer Patients Works for Defined Outcomes in Defined Populations, but Must Be Used Wisely","year":2004,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Chemoprophylaxis; Intensive care medicine; Cancer; Oncology; Internal medicine","score_opus":0.10731921514213227,"score_gpt":0.37975980239786516,"score_spread":0.2724405872557329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1897199628","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017417574,0.9897508,0.00033754788,0.0057069934,0.0010040468,0.00005579716,0.000044008004,0.000034109875,0.0028925303],"genre_scores_gemma":[0.0023518512,0.98895466,0.0011131469,0.004322852,0.0009820526,0.000065745444,0.00006420004,0.000007917836,0.0021374836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99858284,0.00046147886,0.00023916608,0.00012478461,0.00054594985,0.00004580918],"domain_scores_gemma":[0.9953949,0.00237693,0.00063840585,0.00016417482,0.0012917304,0.00013386531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027623144,0.00090510404,0.0021884555,0.0023877136,0.00033249997,0.0014455052,0.0011699303,0.0022124283,0.006252507],"category_scores_gemma":[0.006090879,0.00028774154,0.0014050076,0.0031702814,0.0008929099,0.002312108,0.0006262793,0.002392415,0.0039556534],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012749116,0.00006331243,0.00092105026,0.048626922,0.00050672016,0.00021372,0.000079569094,0.00022642412,0.00091727567,0.0034777212,0.08918425,0.85565543],"study_design_scores_gemma":[0.00020484948,0.00025435793,0.0073624705,0.083434306,0.0012149526,0.002897564,0.00021975131,0.00022105515,0.0005974013,0.0076261917,0.895923,0.000044050506],"about_ca_topic_score_codex":0.0014166867,"about_ca_topic_score_gemma":0.0029012384,"teacher_disagreement_score":0.006252507,"about_ca_system_score_codex":0.0010091729,"about_ca_system_score_gemma":0.0027662208,"threshold_uncertainty_score":0.0209167},"labels":[],"label_agreement":null},{"id":"W1897407769","doi":"10.6004/jnccn.2014.0074","title":"Intermittent Versus Continuous Androgen Deprivation Therapy","year":2014,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Prostatectomy; Clinical endpoint; Oncology; Internal medicine; Randomized controlled trial; Quality of life (healthcare); Prostate-specific antigen; Cancer","score_opus":0.15959646740038702,"score_gpt":0.43107974396040766,"score_spread":0.27148327656002064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1897407769","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62359685,0.25039053,0.014297723,0.0076605454,0.008630588,0.0044548474,0.0073390882,0.0006835067,0.08294634],"genre_scores_gemma":[0.94548506,0.025053758,0.0056575495,0.0056866566,0.0023989405,0.002359656,0.001671473,0.000066216824,0.0116206445],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9988631,0.0004662426,0.0001476984,0.00019621124,0.00022352641,0.00010336037],"domain_scores_gemma":[0.9980557,0.0009933925,0.000307467,0.00014390926,0.00012852762,0.00037107678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015333396,0.00032316925,0.001253119,0.00040541956,0.00028379136,0.00083085307,0.0006584407,0.0007869097,0.025298754],"category_scores_gemma":[0.0034177061,0.00013261523,0.0013743751,0.00045742645,0.00035948603,0.00085507164,0.00046053083,0.0016286093,0.0018077166],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21459849,0.0036471714,0.003017982,0.0072872643,0.0022814297,0.00010417346,0.0001365826,0.0013867017,0.0019689824,0.003331566,0.009485107,0.75275457],"study_design_scores_gemma":[0.35829654,0.31025085,0.05680183,0.009507716,0.01214386,0.0026193438,0.0006050441,0.0067886566,0.0049362606,0.022837792,0.21495418,0.00025791247],"about_ca_topic_score_codex":0.00059108186,"about_ca_topic_score_gemma":0.0013275936,"teacher_disagreement_score":0.025298754,"about_ca_system_score_codex":0.00058794295,"about_ca_system_score_gemma":0.0005962043,"threshold_uncertainty_score":0.084632754},"labels":[],"label_agreement":null},{"id":"W1920790082","doi":"10.6004/jnccn.2013.0019","title":"Defining Cancer Care Quality or Delivering Quality Cancer Care?","year":2013,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality (philosophy); Context (archaeology); Psychological intervention; Gynecologic oncology; Quality management; Specialty; Oncology; Nursing; Family medicine; Operations management","score_opus":0.3197738329737732,"score_gpt":0.5453922862579675,"score_spread":0.22561845328419433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1920790082","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004083977,0.0742284,0.02129376,0.8707913,0.005795188,0.0002687172,0.00016406503,0.000098362005,0.023276184],"genre_scores_gemma":[0.5008206,0.12271233,0.11677092,0.24045621,0.011552795,0.0022090925,0.0006865407,0.00041229287,0.004379313],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8697563,0.08896901,0.01078242,0.00479793,0.021743692,0.0039506797],"domain_scores_gemma":[0.84865737,0.075195745,0.023671553,0.006676512,0.036610533,0.009188353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10544015,0.0012676603,0.0026681584,0.006272104,0.0040931203,0.017772198,0.0047331396,0.0072994223,0.003636341],"category_scores_gemma":[0.22728866,0.0006279411,0.0014097053,0.009297803,0.035453804,0.033943754,0.007858755,0.016901456,0.0008988399],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007662432,0.00022423992,0.014940868,0.004169599,0.0001542009,0.0000838754,0.015001896,0.0009976631,0.00024682816,0.6355665,0.113497116,0.21504065],"study_design_scores_gemma":[0.000137207,0.00033912683,0.015688514,0.02592286,0.0001776234,0.00036317616,0.03837041,0.0017337819,0.0006783614,0.5830715,0.3332515,0.00026591893],"about_ca_topic_score_codex":0.036570106,"about_ca_topic_score_gemma":0.021535877,"teacher_disagreement_score":0.10544015,"about_ca_system_score_codex":0.025557652,"about_ca_system_score_gemma":0.053068917,"threshold_uncertainty_score":0.55762744},"labels":[],"label_agreement":null},{"id":"W1932364922","doi":"10.6004/jnccn.2012.0115","title":"Androgen Deprivation Therapy: Minimizing Exposure and Mitigating Side Effects","year":2012,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Radiation therapy; Brachytherapy; Intensive care medicine; Quality of life (healthcare); Disease; Side effect (computer science); Management of prostate cancer; Oncology; Cancer; Internal medicine","score_opus":0.11714701237884668,"score_gpt":0.39061392929566496,"score_spread":0.2734669169168183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1932364922","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023489782,0.99886537,0.00007511674,0.00014701099,0.0000430192,0.000010624426,0.000018901615,0.000004006495,0.00060117093],"genre_scores_gemma":[0.0021190317,0.99713314,0.0002556824,0.000100360885,0.000055926084,0.000010982451,0.0000276841,0.0000010903789,0.00029623718],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967945,0.000082448096,0.000062473075,0.00003131419,0.00012407334,0.000020351887],"domain_scores_gemma":[0.9996861,0.00018323287,0.00006046477,0.0000070170363,0.000049346658,0.000013896688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005880702,0.0006737351,0.0015424247,0.0018804632,0.00019678383,0.0007703225,0.00073911215,0.0006884404,0.0033581164],"category_scores_gemma":[0.0010607435,0.00021488874,0.00091515115,0.0015087576,0.00027096493,0.0006219827,0.0003687703,0.0009265327,0.00069831056],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001211631,0.000089306086,0.0003156758,0.0547084,0.000391248,0.00017903213,0.00006074171,0.00034949396,0.0010215878,0.0018518042,0.0133813,0.92753017],"study_design_scores_gemma":[0.00016979488,0.00030912526,0.0045295134,0.03050657,0.0010325608,0.0041273106,0.00019245474,0.00022708694,0.0011009561,0.0032498364,0.9545227,0.000032138007],"about_ca_topic_score_codex":0.0012170647,"about_ca_topic_score_gemma":0.002717786,"teacher_disagreement_score":0.0033581164,"about_ca_system_score_codex":0.0004474858,"about_ca_system_score_gemma":0.00076457317,"threshold_uncertainty_score":0.011234045},"labels":[],"label_agreement":null},{"id":"W1952404000","doi":"10.6004/jnccn.2015.0091","title":"Discharge to Primary Care for Survivorship Follow-Up: How Are Patients With Early-Stage Breast Cancer Faring?","year":2015,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Alberta Cancer Foundation; University of Calgary","funders":"Alberta Health Services","keywords":"Medicine; Psychosocial; Survivorship curve; Family medicine; Breast cancer; Mammography; Health care; Public health; Cancer; Physical therapy; Nursing; Psychiatry; Internal medicine","score_opus":0.041595737801169534,"score_gpt":0.2896324071374085,"score_spread":0.24803666933623897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1952404000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984861,0.0032104847,0.000082107435,0.009274655,0.000073349074,0.000029427183,0.0002598908,0.000012247413,0.002196766],"genre_scores_gemma":[0.9981427,0.0006997916,0.000061646446,0.00066462957,0.00002651914,0.0000095904,0.00014621251,0.0000018130426,0.0002469856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983028,0.000551031,0.00012986119,0.00012737713,0.00047830702,0.00041066078],"domain_scores_gemma":[0.9944003,0.0009504758,0.0019222546,0.00015359897,0.00082712603,0.0017461457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017289815,0.00015167943,0.00038021477,0.00040668374,0.0013592299,0.0017278543,0.000647278,0.0012570214,0.0026329583],"category_scores_gemma":[0.01415391,0.0001640637,0.00033484283,0.0010767987,0.0007602996,0.0010362023,0.00085789006,0.0010944131,0.00029118927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017067266,0.00017637089,0.9526474,0.00012604803,0.00006620819,0.00016509286,0.0026104688,0.00007010219,0.00008392934,0.000071789465,0.0034813567,0.040330518],"study_design_scores_gemma":[0.000013519959,0.00013999699,0.9914351,0.00014612646,0.00003208338,0.000117558986,0.0069613648,0.000118176205,0.000026759515,0.00008895263,0.0009093533,0.000010935481],"about_ca_topic_score_codex":0.09013598,"about_ca_topic_score_gemma":0.14915928,"teacher_disagreement_score":0.09013598,"about_ca_system_score_codex":0.0021779672,"about_ca_system_score_gemma":0.0035564308,"threshold_uncertainty_score":0.1792227},"labels":[],"label_agreement":null},{"id":"W1958421425","doi":"10.6004/jnccn.2015.0094","title":"Follow-Up Management of Patients With Testicular Cancer: A Multidisciplinary Consensus-Based Approach","year":2015,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Testicular cancer; Multidisciplinary approach; Cancer; Family medicine; Gynecology; Intensive care medicine; Internal medicine","score_opus":0.08251844369733212,"score_gpt":0.3684153047695581,"score_spread":0.28589686107222595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1958421425","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003128895,0.9947418,0.00072962506,0.002075921,0.00040061027,0.00008352178,0.000052797535,0.000010805229,0.0015920359],"genre_scores_gemma":[0.005481973,0.9895244,0.0030041984,0.0011299779,0.00028708353,0.00009742054,0.00018387158,0.0000035723997,0.00028747914],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99726236,0.0011077647,0.0005672599,0.00020364994,0.0007465841,0.000112359194],"domain_scores_gemma":[0.9974589,0.0010900048,0.00045120082,0.000047034457,0.0008037167,0.00014920799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045435466,0.00080192235,0.0019645446,0.003029724,0.00062970637,0.0013432577,0.0017877902,0.001352011,0.002331574],"category_scores_gemma":[0.008767763,0.0002547248,0.0014835756,0.0022830737,0.00030557724,0.0012382452,0.0013955667,0.0017986421,0.00052711024],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007031491,0.0000952818,0.0011374787,0.05642202,0.0007224155,0.00021518354,0.00028831148,0.00049744855,0.00025004565,0.0017851256,0.028925866,0.90959054],"study_design_scores_gemma":[0.0002495715,0.00035249876,0.013133997,0.3517168,0.004204091,0.003910582,0.0015749278,0.0008137204,0.0003927468,0.0070256647,0.61653167,0.000093714436],"about_ca_topic_score_codex":0.0029884398,"about_ca_topic_score_gemma":0.008401271,"teacher_disagreement_score":0.0045435466,"about_ca_system_score_codex":0.0013573373,"about_ca_system_score_gemma":0.0041813683,"threshold_uncertainty_score":0.024028838},"labels":[],"label_agreement":null},{"id":"W2116694967","doi":"10.6004/jnccn.2013.0147","title":"Implementing Routine Screening for Distress, the Sixth Vital Sign, for Patients With Head and Neck and Neurologic Cancers","year":2013,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; University of Calgary; University of Alberta; Alberta Health Services","funders":"Fondation pour la Recherche Médicale; Alberta Cancer Foundation; National Comprehensive Cancer Network","keywords":"Medicine; Cohort; Head and neck cancer; Quality of life (healthcare); Distress; Cohort study; Worry; Physical therapy; Cancer; Anxiety; Pediatrics; Internal medicine; Psychiatry; Clinical psychology","score_opus":0.028817385652889813,"score_gpt":0.297342806311295,"score_spread":0.2685254206584052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116694967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825734,0.0002605845,0.00007910642,0.00036879306,0.00002716277,0.00030423052,0.00008295993,0.000012109945,0.0006077416],"genre_scores_gemma":[0.99841905,0.00021810926,0.00057172094,0.00028713729,0.000049960447,0.0001530133,0.00017298512,0.000001767342,0.00012624025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975503,0.0009972387,0.00017735542,0.00026861054,0.00041334567,0.0005931953],"domain_scores_gemma":[0.9960621,0.0007285621,0.0012550646,0.00020679507,0.00043189205,0.001315589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023473864,0.00037006685,0.00039923744,0.0004413941,0.001055004,0.00070594996,0.00084843923,0.0005857409,0.0010046479],"category_scores_gemma":[0.010383835,0.00027969823,0.0004903897,0.00047085018,0.00033257666,0.0008479301,0.0013412035,0.00079310726,0.00012153806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001617233,0.007667694,0.873251,0.00023849808,0.00010312623,0.00016598325,0.0011102023,0.00033705917,0.0010592998,0.00006455266,0.001474666,0.11291064],"study_design_scores_gemma":[0.0003605434,0.012477907,0.9841756,0.00007009425,0.0001037028,0.00012127565,0.0010393974,0.0003900378,0.00032072348,0.00003093303,0.00089134724,0.000018512857],"about_ca_topic_score_codex":0.019822396,"about_ca_topic_score_gemma":0.059173755,"teacher_disagreement_score":0.019822396,"about_ca_system_score_codex":0.0019793448,"about_ca_system_score_gemma":0.0064035906,"threshold_uncertainty_score":0.03941405},"labels":[],"label_agreement":null},{"id":"W2120154982","doi":"10.6004/jnccn.2013.0158","title":"Translating Genomics in Cancer Care","year":2013,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Personalized medicine; Precision medicine; Genetic testing; Disease; Health care; Genomics; Breast cancer; Oncology; Bioinformatics; Intensive care medicine; Internal medicine; Cancer; Pathology; Genome; Gene; Genetics","score_opus":0.06627838341564117,"score_gpt":0.3611535352735258,"score_spread":0.2948751518578846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120154982","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001935657,0.078445114,0.016893186,0.8102243,0.012487748,0.00022040227,0.0007722282,0.000298968,0.078722365],"genre_scores_gemma":[0.19377585,0.2780453,0.043911576,0.43261236,0.036455575,0.001094957,0.0015332385,0.00065549876,0.0119156195],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9688028,0.01965824,0.0017438274,0.0024023107,0.005971774,0.0014210772],"domain_scores_gemma":[0.9310407,0.052708082,0.0021999762,0.0034104167,0.0072948,0.0033458602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.040582016,0.0010154422,0.0013321686,0.0036154634,0.0025080529,0.012565036,0.0027857055,0.0071131494,0.020318205],"category_scores_gemma":[0.12182062,0.00057750713,0.0013143872,0.0034804875,0.011037405,0.009282754,0.013581327,0.01233818,0.004995101],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008955262,0.00012455734,0.0033711612,0.0027621817,0.00020892736,0.0005089554,0.0034498144,0.0019010403,0.0003026283,0.43059668,0.22467142,0.332013],"study_design_scores_gemma":[0.00007094506,0.0001305407,0.0021500934,0.0068963533,0.00008993666,0.00026424867,0.0029510742,0.00062143995,0.00035238298,0.37358552,0.61282486,0.000062596555],"about_ca_topic_score_codex":0.012196263,"about_ca_topic_score_gemma":0.0072246366,"teacher_disagreement_score":0.040582016,"about_ca_system_score_codex":0.016841944,"about_ca_system_score_gemma":0.028289448,"threshold_uncertainty_score":0.21462077},"labels":[],"label_agreement":null},{"id":"W2163914042","doi":"10.6004/jnccn.2015.0029","title":"Multimodality Approaches for the Curative Treatment of Esophageal Cancer","year":2015,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Esophageal cancer; Chemoradiotherapy; Esophagus; Gastroesophageal Junction; Modality (human–computer interaction); Treatment modality; General surgery; Surgery; Cancer; Radiation therapy; Radiology; Internal medicine; Adenocarcinoma","score_opus":0.39219700837940275,"score_gpt":0.48296294181661337,"score_spread":0.09076593343721062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163914042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000075486256,0.9995701,0.000021722653,0.00007406089,0.000028558763,0.000008771975,0.000013253551,9.25213e-7,0.00020719234],"genre_scores_gemma":[0.0011207996,0.99854267,0.00010561546,0.00010291241,0.000030124469,0.000012961958,0.000019561787,3.69546e-7,0.00006498161],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99949443,0.00017564904,0.0001245657,0.000045300356,0.0001357923,0.000024233637],"domain_scores_gemma":[0.99931574,0.00043858253,0.0001407881,0.000012748735,0.000073376505,0.000018719868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010414445,0.0006146254,0.0012420736,0.0028735567,0.00023138354,0.00071545434,0.000612322,0.00062020385,0.003255422],"category_scores_gemma":[0.0022141985,0.00020837305,0.0018326079,0.0024118721,0.00030629066,0.0007641565,0.0005442994,0.0007908515,0.0003472326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001304939,0.000042604133,0.00034452806,0.25991842,0.0016248547,0.00011876744,0.000113226495,0.0003389884,0.0005132344,0.0018297809,0.0133492425,0.7216759],"study_design_scores_gemma":[0.0002511261,0.00033368007,0.0062851417,0.32815516,0.008457595,0.0019873916,0.00027756137,0.00020800669,0.00055087206,0.0022515084,0.65119255,0.00004941205],"about_ca_topic_score_codex":0.002766205,"about_ca_topic_score_gemma":0.0071317162,"teacher_disagreement_score":0.003255422,"about_ca_system_score_codex":0.00086913677,"about_ca_system_score_gemma":0.0017811692,"threshold_uncertainty_score":0.010890484},"labels":[],"label_agreement":null},{"id":"W2193279488","doi":"10.6004/jnccn.2014.0105","title":"Ipilimumab-Induced Hypophysitis and Uveitis in a Patient With Metastatic Melanoma and a History of Ipilimumab-Induced Skin Rash","year":2014,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"National Comprehensive Cancer Network; Pfizer","keywords":"Ipilimumab; Medicine; Rash; Hypophysitis; Uveitis; Adverse effect; Melanoma; Internal medicine; Immunology; Nivolumab; Immune system; Dermatology; Oncology; Immunotherapy; Pituitary gland; Cancer research","score_opus":0.02845236996536298,"score_gpt":0.26629667061326306,"score_spread":0.23784430064790008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2193279488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736989,0.004371629,0.001948251,0.0055330102,0.00028386625,0.00016219022,0.00019573298,0.00018403165,0.0136223715],"genre_scores_gemma":[0.9969848,0.00072184857,0.0005567234,0.0008360588,0.0002598629,0.000011026581,0.000042353782,0.000011589927,0.0005757714],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99954873,0.00005430576,0.000050138857,0.00011098308,0.00007311375,0.00016260147],"domain_scores_gemma":[0.9990584,0.00021154844,0.00015446323,0.000057225025,0.00006044219,0.0004577799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003549023,0.0011241902,0.00082263723,0.0021631885,0.002092191,0.0011091745,0.0008110451,0.0026589,0.0016273351],"category_scores_gemma":[0.0021611308,0.0009793941,0.0009793292,0.0011203021,0.0013827361,0.0014669899,0.0007610719,0.0027974078,0.0005333432],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006348982,0.000072048235,0.015555119,0.000023480326,0.000012192161,0.9813328,0.00019371511,0.00007570664,0.0010249446,0.00012247662,0.00032206066,0.0012020374],"study_design_scores_gemma":[0.000017379632,0.00011561955,0.015121238,0.00001829395,0.000018160224,0.9832909,0.00013463173,0.0003336043,0.00044781918,0.00010945846,0.00037838673,0.000014566582],"about_ca_topic_score_codex":0.0066670836,"about_ca_topic_score_gemma":0.008877197,"teacher_disagreement_score":0.0066670836,"about_ca_system_score_codex":0.00237321,"about_ca_system_score_gemma":0.0011414982,"threshold_uncertainty_score":0.017218888},"labels":[],"label_agreement":null},{"id":"W2214708991","doi":"10.6004/jnccn.2015.0149","title":"Making Sense of Variations in Prevalence Estimates of Depression in Cancer: A Co-Calibration of Commonly Used Depression Scales Using Rasch Analysis","year":2015,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Rasch model; Depression (economics); Hospital Anxiety and Depression Scale; Cutoff; Medicine; Receiver operating characteristic; Patient Health Questionnaire; Psychometrics; Beck Depression Inventory; Anxiety; Clinical psychology; Psychiatry; Psychology; Internal medicine; Depressive symptoms","score_opus":0.12668161096450306,"score_gpt":0.41028620193817766,"score_spread":0.28360459097367463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2214708991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8906724,0.0022345537,0.10219285,0.00044494998,0.00017099887,0.0005340897,0.00063535845,0.00025989904,0.002854841],"genre_scores_gemma":[0.98523235,0.00017015658,0.013990078,0.000047923055,0.000032528664,0.00015565084,0.0002676775,0.000024737135,0.00007892365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.92027503,0.057749853,0.0056172265,0.0059102206,0.009884872,0.00056270807],"domain_scores_gemma":[0.7767956,0.15517619,0.027334003,0.025859123,0.014249947,0.0005851215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.078458875,0.0006031274,0.0009408394,0.0038051486,0.0005311939,0.001830169,0.0009763318,0.000653576,0.00040430107],"category_scores_gemma":[0.17445464,0.00052149163,0.0013563444,0.0037937835,0.0012655671,0.0015534555,0.0018888885,0.001365117,0.00017523789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001562079,0.00004566078,0.9626666,0.00011084576,0.0014020671,0.000058539765,0.0016414487,0.0019371588,0.00043742458,0.00044514664,0.00046354544,0.030635532],"study_design_scores_gemma":[0.000021019056,0.00031375088,0.9752196,0.00012273884,0.00033160447,0.0003613498,0.0010588667,0.018677523,0.00062006956,0.0021988566,0.0010197056,0.000054982578],"about_ca_topic_score_codex":0.002234032,"about_ca_topic_score_gemma":0.0031086833,"teacher_disagreement_score":0.078458875,"about_ca_system_score_codex":0.0006573091,"about_ca_system_score_gemma":0.0006523389,"threshold_uncertainty_score":0.41493517},"labels":[],"label_agreement":null},{"id":"W2223162680","doi":"10.6004/jnccn.2010.0100","title":"The Changing Face of Cervical Cancer Screening in the United States","year":2010,"lang":"en","type":"editorial","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Face (sociological concept); Cervical cancer; Cervical cancer screening; Cancer; Internal medicine","score_opus":0.05118615593635917,"score_gpt":0.3877624335798247,"score_spread":0.33657627764346554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2223162680","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010469772,0.03722742,0.00027531965,0.9264835,0.007109158,0.000014505454,0.0004250975,0.000045544235,0.01794971],"genre_scores_gemma":[0.2599268,0.09238583,0.0017850852,0.62138593,0.017391227,0.00007526294,0.00095201225,0.00010249093,0.005995357],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950009,0.0013047251,0.00041298565,0.00043543254,0.0019453979,0.0009005552],"domain_scores_gemma":[0.9906997,0.0019557152,0.00088923745,0.00021063832,0.002068827,0.004176032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055147503,0.00036318888,0.0006836574,0.0018864099,0.0043971227,0.005841138,0.001535643,0.007831665,0.014234297],"category_scores_gemma":[0.015904743,0.0004069748,0.0006724451,0.0020802894,0.0033506083,0.0058782287,0.0046235565,0.009903982,0.001057214],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019608685,0.00026507903,0.0344158,0.0007156591,0.000071385846,0.0019002173,0.0031241272,0.0004054332,0.00057600543,0.048625313,0.63537574,0.27432913],"study_design_scores_gemma":[0.00006220252,0.0002887161,0.07099629,0.004314553,0.00007115405,0.002312537,0.013491334,0.0007125758,0.0003186626,0.032593522,0.8745992,0.0002393641],"about_ca_topic_score_codex":0.0678857,"about_ca_topic_score_gemma":0.10933859,"teacher_disagreement_score":0.0678857,"about_ca_system_score_codex":0.008524278,"about_ca_system_score_gemma":0.010315211,"threshold_uncertainty_score":0.1349811},"labels":[],"label_agreement":null},{"id":"W2255713821","doi":"10.6004/jnccn.2016.0006","title":"Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Medicine; Poisson regression; Internal medicine; Cancer registry; Colorectal cancer; Hazard ratio; Population; Cancer; Proportional hazards model; Propensity score matching; Stage (stratigraphy); Comorbidity; Oncology; Surgery; Confidence interval","score_opus":0.05853885366993404,"score_gpt":0.36204321669971923,"score_spread":0.3035043630297852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2255713821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982383,0.00038880162,0.000043656317,0.00007334194,0.0000032413843,0.000024494253,0.0006957347,0.0000025517147,0.0005299184],"genre_scores_gemma":[0.9992785,0.00015827843,0.000033923912,0.000034512897,0.0000075194866,0.000014154166,0.0004213931,0.0000013372471,0.000050496426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991819,0.00018658291,0.0000833279,0.00016853017,0.00026513948,0.00011443653],"domain_scores_gemma":[0.9973379,0.0003645094,0.0014603289,0.00016944442,0.0003004295,0.00036732346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097621966,0.00020175186,0.00033713708,0.0006342678,0.0004667662,0.0006791364,0.00047795792,0.00044274886,0.00096488354],"category_scores_gemma":[0.0030953693,0.00023462567,0.0005290502,0.0019865637,0.0004964974,0.00038674174,0.00041494143,0.00048348965,0.00014703655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006141181,0.000021903443,0.99919826,0.000009395055,0.000064759515,0.000020831103,0.00005263797,0.000018707353,0.000038320803,0.000005880184,0.00007906177,0.00042884206],"study_design_scores_gemma":[0.00000993883,0.00005851517,0.99957854,0.0000047749786,0.00003320443,0.000055837056,0.00006227939,0.000051039446,0.000006410954,0.0000054314237,0.00013194888,0.0000020996595],"about_ca_topic_score_codex":0.088582665,"about_ca_topic_score_gemma":0.1072068,"teacher_disagreement_score":0.088582665,"about_ca_system_score_codex":0.0017763848,"about_ca_system_score_gemma":0.0016001802,"threshold_uncertainty_score":0.17613411},"labels":[],"label_agreement":null},{"id":"W2289764068","doi":"10.6004/jnccn.2005.0049","title":"Benefits Associated with an Early Hemoglobin Response to Epoetin Alfa Therapy in the Treatment of Chemotherapy-Related Anemia","year":2005,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Epoetin alfa; Medicine; Anemia; Hemoglobin; Dosing; Chemotherapy; Internal medicine; Erythropoietin; Intensive care medicine","score_opus":0.03423551989230179,"score_gpt":0.314324781219764,"score_spread":0.2800892613274622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289764068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993105,0.0056315,0.00030678156,0.00017220048,0.000011268079,0.000044290122,0.000027515314,0.000006338241,0.0006950897],"genre_scores_gemma":[0.9992138,0.00036189,0.00024198815,0.00006636447,0.000017187183,0.00001279524,0.000028202368,8.009977e-7,0.000057044403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986539,0.001021932,0.00009207278,0.000044329274,0.00013201931,0.000055800036],"domain_scores_gemma":[0.9918522,0.004770998,0.0024113571,0.0002097067,0.0003044834,0.00045123842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025580078,0.00011051924,0.00028980392,0.00024588284,0.00012605582,0.000412581,0.00013092377,0.00024285793,0.00040465695],"category_scores_gemma":[0.006058708,0.00006184138,0.00036443718,0.00027914174,0.00023746496,0.00019938854,0.00019778004,0.00043987398,0.00003148263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044181887,0.0044228397,0.5881364,0.0008057437,0.0011756108,0.00085248845,0.00024536686,0.0027000078,0.017117267,0.00037494279,0.0006579779,0.33932945],"study_design_scores_gemma":[0.0015397742,0.039285343,0.9490333,0.00012476543,0.0007405185,0.0015958754,0.00013887284,0.001456847,0.0037972932,0.00027289844,0.001990889,0.00002354328],"about_ca_topic_score_codex":0.00026690302,"about_ca_topic_score_gemma":0.00054647354,"teacher_disagreement_score":0.0025580078,"about_ca_system_score_codex":0.00021946298,"about_ca_system_score_gemma":0.0003245197,"threshold_uncertainty_score":0.013528228},"labels":[],"label_agreement":null},{"id":"W2293043909","doi":"10.6004/jnccn.2016.0034","title":"Use of Palliative Chemotherapy for Advanced Bladder Cancer: Patterns of Care in Routine Clinical Practice","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Referral; Cancer; Medical record; Cancer registry; Population; Chemotherapy; Internal medicine; Poisson regression; Palliative care; Intensive care medicine; Oncology; Family medicine; Nursing","score_opus":0.0860858806100914,"score_gpt":0.42137763597446964,"score_spread":0.3352917553643783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293043909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939814,0.0016247713,0.00026977574,0.0020707133,0.000007833769,0.000036985988,0.00060895586,0.000011796318,0.0013877269],"genre_scores_gemma":[0.99898154,0.00045369024,0.00018831884,0.00009586471,0.000005530276,0.000008526387,0.00019280787,0.0000024454805,0.00007128499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976671,0.00061685353,0.00035497727,0.00034720293,0.0007457522,0.00026819733],"domain_scores_gemma":[0.98863447,0.0019239067,0.007184865,0.00031648306,0.0010199785,0.0009202026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013425421,0.00008144442,0.00019640013,0.0009253037,0.00039526736,0.0009154807,0.0006211098,0.00039608835,0.0012996813],"category_scores_gemma":[0.009189785,0.00017295704,0.00017194971,0.0025448932,0.00067506946,0.00055416394,0.0009055716,0.00040446702,0.00012040507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014620375,0.0000090916865,0.99446917,0.000038334783,0.000019768675,0.000045856752,0.00070194126,0.000038964357,0.00007845716,0.00005807904,0.00031115278,0.004214537],"study_design_scores_gemma":[0.0000022107088,0.0000144756705,0.9979845,0.000044500015,0.000005328553,0.00020553025,0.0009812854,0.00017697936,0.000020670837,0.00005066624,0.0005100346,0.0000038842763],"about_ca_topic_score_codex":0.10426508,"about_ca_topic_score_gemma":0.17412156,"teacher_disagreement_score":0.10426508,"about_ca_system_score_codex":0.0029433218,"about_ca_system_score_gemma":0.0036359904,"threshold_uncertainty_score":0.2073164},"labels":[],"label_agreement":null},{"id":"W2306826149","doi":"10.6004/jnccn.2016.0019","title":"Evaluating the Impact of Provincial Implementation of Screening for Distress on Quality of Life, Symptom Reports, and Psychosocial Well-Being in Patients With Cancer","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Psychosocial; Cohort; Quality of life (healthcare); Psychological intervention; Distress; Anxiety; Intervention (counseling); Family medicine; Physical therapy; Psychiatry; Nursing; Clinical psychology; Internal medicine","score_opus":0.06008552437312038,"score_gpt":0.4321481098150398,"score_spread":0.37206258544191945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2306826149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987031,0.00008088028,0.000089097375,0.00012708451,0.0000062753834,0.00038149036,0.00012918051,0.000011812543,0.0004710431],"genre_scores_gemma":[0.99826354,0.000080572434,0.0008920151,0.000054069173,0.000007409868,0.00028820685,0.00026950848,0.0000016419401,0.00014305081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798334,0.0008636927,0.00018026764,0.00011655482,0.00042737828,0.0004288747],"domain_scores_gemma":[0.9938899,0.0015957154,0.001637428,0.00037305735,0.0011381068,0.0013657288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034052748,0.00029165132,0.0003582667,0.00043192066,0.0007701398,0.00053773774,0.00052730646,0.00024537346,0.0017910515],"category_scores_gemma":[0.008110895,0.00025744812,0.00081968796,0.000671689,0.0003747754,0.00024890836,0.001095714,0.00074911054,0.0001307268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008179461,0.015728248,0.7933683,0.0006361249,0.00024257228,0.000109170855,0.0021380375,0.0017206168,0.0031155325,0.0000672989,0.0014051847,0.17328945],"study_design_scores_gemma":[0.0009194999,0.015243024,0.9807345,0.00004599806,0.000111867164,0.000032858945,0.0006580704,0.0006005489,0.0010199749,0.00001511064,0.0006052807,0.000013202642],"about_ca_topic_score_codex":0.06470837,"about_ca_topic_score_gemma":0.108406484,"teacher_disagreement_score":0.06470837,"about_ca_system_score_codex":0.00409134,"about_ca_system_score_gemma":0.007735022,"threshold_uncertainty_score":0.12866342},"labels":[],"label_agreement":null},{"id":"W2307758074","doi":"10.6004/jnccn.2014.0187","title":"New Developments in the Treatment of Castration-Resistant Prostate Cancer","year":2014,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Achieve Life Sciences (Canada)","funders":"","keywords":"Medicine; Prostate cancer; Clinical trial; Intensive care medicine; Hormonal therapy; Immunotherapy; Oncology; Cancer; Internal medicine","score_opus":0.13388232305812728,"score_gpt":0.4345753972711803,"score_spread":0.300693074213053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307758074","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036222937,0.99928373,0.000034546898,0.0001486882,0.0001241293,0.0000021451424,0.0000049551195,0.0000026251219,0.00036296833],"genre_scores_gemma":[0.00029512454,0.9992267,0.00006928361,0.00013043026,0.00011435928,0.0000018213351,0.000008792467,5.7956834e-7,0.00015297461],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968946,0.00006297389,0.000049887953,0.000043681688,0.0001319001,0.000022013393],"domain_scores_gemma":[0.99958915,0.00022192253,0.00005586934,0.000011031899,0.00009231146,0.000029626517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077112636,0.0006931964,0.0014205187,0.0032231705,0.00029587725,0.000948671,0.0008879386,0.000857586,0.003167031],"category_scores_gemma":[0.0009790722,0.0002719204,0.000713213,0.0027663892,0.0005485728,0.001443529,0.0005994399,0.002290428,0.0014175187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062529514,0.00007524717,0.00013478761,0.026470074,0.00011442167,0.00023251752,0.000064542284,0.00031093162,0.00085270155,0.0035425806,0.027574068,0.94056565],"study_design_scores_gemma":[0.000024885829,0.000084929896,0.0007017437,0.005675825,0.00012091261,0.0015272518,0.000058626247,0.000063148254,0.00018702593,0.0016959409,0.9898415,0.000018135068],"about_ca_topic_score_codex":0.0013239211,"about_ca_topic_score_gemma":0.0032379956,"teacher_disagreement_score":0.0032231705,"about_ca_system_score_codex":0.00064197567,"about_ca_system_score_gemma":0.0009688585,"threshold_uncertainty_score":0.010594785},"labels":[],"label_agreement":null},{"id":"W2329368040","doi":"10.6004/jnccn.2007.0016","title":"Role of Bone Marrow Transplantation in the Disease Pathway of Myeloma","year":2007,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Celgene","keywords":"Medicine; Multiple myeloma; Thalidomide; Bortezomib; Autologous stem-cell transplantation; Lenalidomide; Oncology; Transplantation; Internal medicine; Surgery","score_opus":0.08784823920259621,"score_gpt":0.3916811902525102,"score_spread":0.303832951049914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329368040","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039555645,0.9994529,0.000025966723,0.00013006659,0.000063463434,0.0000017629606,0.0000022594438,0.0000017760184,0.0002821758],"genre_scores_gemma":[0.00043965265,0.99914694,0.00005235022,0.00012533208,0.00007939272,0.000002556123,0.0000063474236,4.9031195e-7,0.00014697897],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965084,0.00011109862,0.000045404162,0.000046638426,0.000123479,0.00002253894],"domain_scores_gemma":[0.99947613,0.0002835222,0.000089722496,0.000018275941,0.000095199,0.000037153048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010176726,0.000723082,0.0020016932,0.0024749057,0.00034870298,0.00111602,0.0010005292,0.0013351592,0.003819059],"category_scores_gemma":[0.0011320561,0.00026086456,0.0006656036,0.002563913,0.00075925916,0.0014412572,0.000646356,0.0016283758,0.0016544792],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112484115,0.000056524386,0.0002093862,0.016719623,0.00012666073,0.00031532423,0.000043515924,0.00022402652,0.000601343,0.0024826925,0.017911552,0.96119696],"study_design_scores_gemma":[0.00008244623,0.0001566119,0.0019921523,0.009202596,0.00028868698,0.0040488453,0.00008417719,0.00010500076,0.00042926826,0.0034245686,0.98016465,0.000020972253],"about_ca_topic_score_codex":0.0015488393,"about_ca_topic_score_gemma":0.0026061644,"teacher_disagreement_score":0.003819059,"about_ca_system_score_codex":0.0008764472,"about_ca_system_score_gemma":0.0015181286,"threshold_uncertainty_score":0.012776017},"labels":[],"label_agreement":null},{"id":"W2336174752","doi":"10.6004/jnccn.2016.0043","title":"Letting Nature Loose","year":2016,"lang":"en","type":"letter","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Interim; Program director; Clinical Oncology; Family medicine; Advisory committee; Library science; Management; Internal medicine; Cancer; Oncology; Medical education; Political science; Law","score_opus":0.05524643350920548,"score_gpt":0.3840717427323899,"score_spread":0.3288253092231844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336174752","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00077075826,0.0028261272,0.00013868291,0.95969373,0.022364339,0.000013493091,0.000017287462,0.000039106086,0.014136465],"genre_scores_gemma":[0.009185298,0.0019107644,0.00018082102,0.94581187,0.021853967,0.000024457231,0.000016508096,0.000028232154,0.020988064],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99720424,0.00079463446,0.00021319564,0.00048752173,0.0008153579,0.0004850536],"domain_scores_gemma":[0.9950106,0.001784934,0.00025616115,0.00034342412,0.0008578426,0.0017469832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024372486,0.00066418806,0.0006513573,0.0006329043,0.0048247715,0.004345015,0.0012821729,0.028648421,0.019317826],"category_scores_gemma":[0.02248625,0.0005228581,0.0007206818,0.00045002057,0.0041079116,0.0073317443,0.0023553506,0.03289514,0.010254573],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032814478,0.000046851248,0.00091865024,0.00003013001,0.0000086831715,0.0039794324,0.00039157722,0.000042079853,0.0001497468,0.005330519,0.9780764,0.010993205],"study_design_scores_gemma":[0.000052433432,0.00005166884,0.0007159477,0.00027444612,0.000010965413,0.008308978,0.0011881216,0.00017415035,0.00011935734,0.009131887,0.97993886,0.00003315781],"about_ca_topic_score_codex":0.0033089234,"about_ca_topic_score_gemma":0.004418234,"teacher_disagreement_score":0.028648421,"about_ca_system_score_codex":0.002822951,"about_ca_system_score_gemma":0.002827458,"threshold_uncertainty_score":0.06462461},"labels":[],"label_agreement":null},{"id":"W2336746419","doi":"10.6004/jnccn.2014.0084","title":"Insights Into Preferences for Psycho-Oncology Services Among Women With Gynecologic Cancer Following Distress Screening","year":2014,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Referral; Distress; Psychosocial; Gynecologic oncology; Psycho-oncology; Coping (psychology); Social support; Family medicine; Stressor; Gynecologic cancer; Psychiatry; Nursing; Clinical psychology; Cancer; Psychotherapist; Ovarian cancer; Oncology; Psychology; Internal medicine","score_opus":0.030797715207918484,"score_gpt":0.3262946043522757,"score_spread":0.29549688914435723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336746419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921034,0.0003579235,0.0004394556,0.003888424,0.00003042686,0.000045653003,0.00005284359,0.000006470504,0.0030754653],"genre_scores_gemma":[0.99792755,0.0003573565,0.00030567255,0.00073509116,0.0000088286715,0.000026067271,0.000018658171,0.000006154167,0.000614688],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9942509,0.0043138824,0.00017668169,0.000156315,0.0004198185,0.00068244006],"domain_scores_gemma":[0.9925568,0.0053740223,0.00076450285,0.000092836395,0.00039704537,0.000814695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056789075,0.00026382576,0.00032167503,0.00071908155,0.0031927882,0.0026265625,0.00094865606,0.0009409847,0.0022974352],"category_scores_gemma":[0.015848493,0.00043789198,0.00031734628,0.0005540029,0.0031760777,0.0020068828,0.0021949771,0.0020438868,0.0001795492],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091810485,0.00010043169,0.03609981,0.00017001828,0.000017213048,0.0019224475,0.9448814,0.00009355149,0.0015711794,0.0013025979,0.00090608775,0.012843431],"study_design_scores_gemma":[0.0000052315527,0.000070631155,0.009470626,0.000083462284,0.0000056332715,0.00056796416,0.9859401,0.00011216681,0.00017047118,0.00027776777,0.0032802993,0.000015618249],"about_ca_topic_score_codex":0.011983581,"about_ca_topic_score_gemma":0.024670225,"teacher_disagreement_score":0.011983581,"about_ca_system_score_codex":0.0033474825,"about_ca_system_score_gemma":0.0032025506,"threshold_uncertainty_score":0.03003329},"labels":[],"label_agreement":null},{"id":"W2336799541","doi":"10.6004/jnccn.2014.0023","title":"The International Endorsement of US Distress Screening and Psychosocial Guidelines in Oncology: A Model for Dissemination","year":2014,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Tata Memorial Centre; Peter MacCallum Cancer Centre; Israel Cancer Association; Cancerfonden; Irish Cancer Society; Prostate Cancer Foundation of Australia; Macmillan Cancer Support; Livestrong Foundation; Breast Cancer Alliance; Prostate Cancer Foundation","keywords":"Medicine; Distress; Psychosocial; Context (archaeology); Sign (mathematics); Clinical Oncology; Psycho-oncology; Cancer; Family medicine; Intensive care medicine; Psychiatry; Internal medicine; Clinical psychology","score_opus":0.062482567009147845,"score_gpt":0.4051274239786391,"score_spread":0.34264485696949126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336799541","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002180271,0.010828236,0.038094237,0.78860235,0.0078112697,0.004737314,0.00034736836,0.00041479146,0.14698409],"genre_scores_gemma":[0.29050425,0.037132513,0.35227168,0.22864218,0.0073262546,0.034759916,0.0017021394,0.0012103737,0.046450723],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.41800207,0.43807375,0.06279296,0.011219243,0.061585862,0.008326166],"domain_scores_gemma":[0.2860405,0.447058,0.036527593,0.06368923,0.13567163,0.031013003],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.44709244,0.0014648234,0.0024954586,0.01155309,0.006542379,0.023658693,0.006261844,0.03006108,0.0148729235],"category_scores_gemma":[0.67945784,0.002199729,0.0026870996,0.013714127,0.028871903,0.025684694,0.032556508,0.026865564,0.005612636],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010080742,0.00031299016,0.003275156,0.0042290986,0.00016761075,0.0005165355,0.023094246,0.0005972081,0.00030666325,0.4733675,0.21972178,0.27431035],"study_design_scores_gemma":[0.0004144976,0.00039637828,0.0026924524,0.023796597,0.00017068391,0.0004448191,0.013649845,0.0017276269,0.0003475522,0.15406753,0.8020926,0.0001993211],"about_ca_topic_score_codex":0.010067326,"about_ca_topic_score_gemma":0.0061020483,"teacher_disagreement_score":0.44709244,"about_ca_system_score_codex":0.015819386,"about_ca_system_score_gemma":0.13088001,"threshold_uncertainty_score":0.68183345},"labels":[],"label_agreement":null},{"id":"W2339449145","doi":"10.6004/jnccn.2004.0040","title":"Relationship Between Hemoglobin Levels and Quality of Life During Radiation Therapy Plus Concomitant or Sequential Chemotherapy in Patients With Cancer and Anemia Treated With Epoetin Alfa","year":2004,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Medicine; Epoetin alfa; Hemoglobin; Anemia; Quality of life (healthcare); Concomitant; Internal medicine; Cancer; Radiation therapy; Chemotherapy; Gastroenterology","score_opus":0.07720077244212115,"score_gpt":0.3353597564653536,"score_spread":0.25815898402323245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339449145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996113,0.00018792521,0.0000417546,0.000022991953,0.000002995199,0.0000044079547,0.000023138009,0.0000010258312,0.00010435899],"genre_scores_gemma":[0.999764,0.00004234724,0.000053344284,0.000025808775,0.000006511015,0.000005606763,0.000060855295,5.1631747e-7,0.000040964384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994553,0.00022975884,0.00006096881,0.000064746964,0.00010599788,0.00008320084],"domain_scores_gemma":[0.99753356,0.0007936838,0.0009963036,0.0000995774,0.00023000214,0.00034687913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000949545,0.00015726792,0.00042897594,0.00045091202,0.0002773143,0.00042712587,0.00014502989,0.00033680076,0.00038656723],"category_scores_gemma":[0.004290599,0.00015407296,0.00046596446,0.00048521848,0.00017467902,0.0003535488,0.0002187969,0.00066358666,0.00006569246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010321019,0.0002079594,0.9944858,0.0000075519183,0.000107014544,0.000073350035,0.00008151927,0.00010777182,0.00031798298,0.000008481786,0.00004792161,0.0035224522],"study_design_scores_gemma":[0.000059680293,0.0016789151,0.9970656,0.0000041075227,0.00007737882,0.00024567734,0.000073639545,0.0005419167,0.00010603518,0.0000148914305,0.00012676827,0.000005299848],"about_ca_topic_score_codex":0.0014267402,"about_ca_topic_score_gemma":0.001783437,"teacher_disagreement_score":0.0014267402,"about_ca_system_score_codex":0.00035715345,"about_ca_system_score_gemma":0.0002746921,"threshold_uncertainty_score":0.005021751},"labels":[],"label_agreement":null},{"id":"W2341473062","doi":"10.6004/jnccn.2014.0172","title":"Analysis of Recurrence Patterns in Acral Versus Nonacral Melanoma: Should Histologic Subtype Influence Treatment Guidelines?","year":2014,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; York University; National Cancer Institute; Melanoma Research Alliance","keywords":"Medicine; Melanoma; Acral lentiginous melanoma; Hazard ratio; Stage (stratigraphy); Overall survival; Internal medicine; Dermatology; Oncology; Surgery; Confidence interval","score_opus":0.11275097229597587,"score_gpt":0.3753103503837248,"score_spread":0.26255937808774893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341473062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431145,0.0030929786,0.00061277696,0.0005034171,0.000024262228,0.000029864375,0.0005148744,0.000010793244,0.0008994782],"genre_scores_gemma":[0.9987317,0.0003425995,0.00032108612,0.00012485513,0.000030704927,0.000014937525,0.00031063624,0.000008912766,0.00011450239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965575,0.0020262834,0.00048102203,0.00033012824,0.00039161768,0.00021354151],"domain_scores_gemma":[0.9857889,0.004890929,0.0065484014,0.00092140917,0.0012009753,0.0006493476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004769791,0.00013336785,0.00058023684,0.0009009011,0.00016532079,0.00051988557,0.00052555074,0.00041212223,0.0007936372],"category_scores_gemma":[0.020823743,0.00014273613,0.00078110024,0.0012786114,0.00018032813,0.00050273526,0.00028046462,0.00043933338,0.00023101256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000249842,0.000016713024,0.99104416,0.0000262601,0.00009701641,0.000019635634,0.00005607211,0.000055007768,0.000068899535,0.000022795552,0.00019033026,0.008153288],"study_design_scores_gemma":[0.000020707514,0.00014160211,0.99825567,0.000030622057,0.00013487473,0.000115037634,0.0001952764,0.0006120442,0.00007558114,0.000068547684,0.00034496599,0.0000049514097],"about_ca_topic_score_codex":0.005627236,"about_ca_topic_score_gemma":0.01854531,"teacher_disagreement_score":0.005627236,"about_ca_system_score_codex":0.00047786318,"about_ca_system_score_gemma":0.00056721026,"threshold_uncertainty_score":0.025225341},"labels":[],"label_agreement":null},{"id":"W2346494368","doi":"10.6004/jnccn.2004.0043","title":"Patients and Clinical Practice Guidelines Development","year":2004,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paternalism; Medicine; Set (abstract data type); Health care; Guideline; Function (biology); MEDLINE; Medical education","score_opus":0.3354320687749796,"score_gpt":0.54763007206618,"score_spread":0.21219800329120037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346494368","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002131976,0.041260596,0.0725049,0.56861705,0.024624074,0.059764557,0.008854883,0.001894171,0.22034779],"genre_scores_gemma":[0.036393095,0.055104855,0.56855166,0.14535801,0.012855406,0.097006865,0.019883296,0.0014866844,0.06336009],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.72304076,0.17451414,0.055206917,0.0073198373,0.035332426,0.0045860005],"domain_scores_gemma":[0.45410538,0.19903572,0.037492346,0.029499542,0.24576677,0.034100246],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.18194905,0.0015938454,0.003190896,0.013513289,0.0045900843,0.015419782,0.009672582,0.01675917,0.053840414],"category_scores_gemma":[0.55581886,0.0023681205,0.0038680346,0.010038385,0.00508629,0.010536655,0.012564741,0.021274416,0.03180601],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010422166,0.00019977066,0.0008870812,0.0053597735,0.00011262796,0.00041954571,0.0025985055,0.00045917952,0.00011566934,0.028296879,0.76905733,0.1923894],"study_design_scores_gemma":[0.00039305995,0.00008350767,0.00087155105,0.020301448,0.00010112883,0.0004219826,0.00096855266,0.00049931335,0.00017498875,0.029389188,0.94671106,0.00008428641],"about_ca_topic_score_codex":0.008652952,"about_ca_topic_score_gemma":0.016341232,"teacher_disagreement_score":0.818051,"about_ca_system_score_codex":0.01642317,"about_ca_system_score_gemma":0.11875719,"threshold_uncertainty_score":0.96225005},"labels":[],"label_agreement":null},{"id":"W2402411756","doi":"10.6004/jnccn.2011.0114","title":"The Changing Paradigm of Treating Pancreatic Neuroendocrine Tumors","year":2011,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Medicine; Neuroendocrine tumors; Internal medicine; Oncology","score_opus":0.09535950678860665,"score_gpt":0.39411798062022296,"score_spread":0.2987584738316163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402411756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000091391455,0.9958794,0.00014597963,0.0030246414,0.00031566079,0.0000025410761,0.000005893615,0.000004283115,0.00053017074],"genre_scores_gemma":[0.0006818785,0.99725765,0.0002625475,0.00114602,0.00044188678,0.00000444288,0.000009427271,0.0000014766717,0.00019479115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99941254,0.00018363065,0.000068429945,0.00008670359,0.00020354595,0.000045297853],"domain_scores_gemma":[0.9988219,0.0006392434,0.00011711369,0.000041870506,0.00028886404,0.00009097845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031603603,0.0009227853,0.0018713662,0.0020485255,0.00047714176,0.0018602437,0.0016688037,0.0022120345,0.0028525086],"category_scores_gemma":[0.0021690065,0.00030673633,0.00081194943,0.0023056308,0.0018488702,0.0046195597,0.001039682,0.0048365793,0.0015463791],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013001081,0.00007353538,0.00022734981,0.013979246,0.00012269679,0.00037646396,0.00013577049,0.0007444911,0.0012249021,0.019889463,0.038957555,0.9241384],"study_design_scores_gemma":[0.000069433365,0.00016088516,0.0008228621,0.006125174,0.00010584325,0.0023786216,0.00025762097,0.00017575783,0.00031531797,0.012136563,0.97741824,0.000033781755],"about_ca_topic_score_codex":0.0019477523,"about_ca_topic_score_gemma":0.004076829,"teacher_disagreement_score":0.0031603603,"about_ca_system_score_codex":0.0018051639,"about_ca_system_score_gemma":0.0028014332,"threshold_uncertainty_score":0.016713738},"labels":[],"label_agreement":null},{"id":"W2471651470","doi":"10.6004/jnccn.2008.0020","title":"Should Cost of Care be Considered in a Clinical Practice Guideline?","year":2008,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Guideline; Intensive care medicine; Clinical Practice; Medical physics; Family medicine; Pathology","score_opus":0.7874786500660446,"score_gpt":0.6385482320829241,"score_spread":0.14893041798312046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471651470","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0061537195,0.006430054,0.0027242652,0.964655,0.0085622845,0.00020622484,0.00026079582,0.000074380696,0.010933265],"genre_scores_gemma":[0.17428163,0.016995525,0.08318222,0.6820853,0.03458839,0.0017381604,0.0013743052,0.00021997723,0.0055344873],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.968613,0.011182836,0.008996362,0.00084496767,0.008883212,0.0014797314],"domain_scores_gemma":[0.8552226,0.062102586,0.015755568,0.0032192464,0.051573757,0.012126228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027529376,0.000844747,0.0031027277,0.0032646041,0.0028821593,0.006230662,0.003525654,0.02278061,0.0041064178],"category_scores_gemma":[0.19075383,0.0011646688,0.0031589454,0.0032035674,0.002206365,0.00716574,0.0021236988,0.019239265,0.0017451114],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036937164,0.00089960877,0.051428467,0.0025315282,0.0009963138,0.0029983802,0.001399494,0.0025908744,0.0008805395,0.01890928,0.7636801,0.15331596],"study_design_scores_gemma":[0.0013842669,0.0008815015,0.07971606,0.027787838,0.0019633742,0.0069234567,0.004585028,0.010365227,0.0013754757,0.047544666,0.8168578,0.0006153743],"about_ca_topic_score_codex":0.014821397,"about_ca_topic_score_gemma":0.05131118,"teacher_disagreement_score":0.027529376,"about_ca_system_score_codex":0.006293971,"about_ca_system_score_gemma":0.023572449,"threshold_uncertainty_score":0.14559096},"labels":[],"label_agreement":null},{"id":"W2497337193","doi":"10.6004/jnccn.2016.0091","title":"Care and Outcomes of Patients With Cancer Admitted to the Hospital on Weekends and Holidays: A Retrospective Cohort Study","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Hospital Admissions and Outcomes","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Weekend effect; Retrospective cohort study; Emergency medicine; Odds ratio; Hospital admission; Cancer; Pediatrics; Internal medicine","score_opus":0.01222804662223706,"score_gpt":0.2928450423484863,"score_spread":0.2806169957262492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497337193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99884146,0.0002030145,0.00003320065,0.00002322999,0.0000067324795,0.000029517723,0.0006293182,0.0000018655134,0.00023160476],"genre_scores_gemma":[0.998814,0.00018916992,0.000058432288,0.000040721297,0.000011504671,0.000027814038,0.00079320185,0.0000022894405,0.00006277556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886346,0.00014248985,0.00017563697,0.00029803914,0.00023947777,0.0002809271],"domain_scores_gemma":[0.99710697,0.00022646599,0.0015833918,0.00015703995,0.00036441445,0.0005617261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007665999,0.0003645845,0.0006255136,0.0014012253,0.0010614424,0.00094446517,0.00076181605,0.0005032972,0.0011694769],"category_scores_gemma":[0.0020525614,0.00044189402,0.0008934163,0.0023525278,0.00045484304,0.0007367051,0.0008752876,0.0007276509,0.00017679232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005742542,0.00002236851,0.9993468,0.000010341067,0.000046360605,0.000077385484,0.00008152844,0.0000108034155,0.00004190981,0.0000063871403,0.00006362503,0.00023506526],"study_design_scores_gemma":[0.000008605053,0.0001012703,0.99868613,0.00001742687,0.000034183144,0.00035448384,0.00053506583,0.00006681836,0.00002250098,0.0000087663075,0.00015771209,0.000007147991],"about_ca_topic_score_codex":0.0687416,"about_ca_topic_score_gemma":0.08298683,"teacher_disagreement_score":0.0687416,"about_ca_system_score_codex":0.001791112,"about_ca_system_score_gemma":0.0018473442,"threshold_uncertainty_score":0.13668293},"labels":[],"label_agreement":null},{"id":"W2507079668","doi":"10.6004/jnccn.2016.0103","title":"NCCN Framework for Resource Stratification: A Framework for Providing and Improving Global Quality Oncology Care","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Health care; Global health; Context (archaeology); Cancer; Breast cancer; Family medicine; Intensive care medicine; Internal medicine; Nursing; Public health; Economic growth; Pathology","score_opus":0.1776502830492418,"score_gpt":0.4605876596149657,"score_spread":0.28293737656572393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507079668","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002261747,0.03861132,0.26785553,0.53601587,0.009764371,0.013930545,0.003375355,0.0019743664,0.12621096],"genre_scores_gemma":[0.02602965,0.025610052,0.8569476,0.056501403,0.0026285073,0.01654996,0.0055861743,0.000831577,0.009315024],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.77377045,0.12296545,0.028902804,0.0063797077,0.058762684,0.009218887],"domain_scores_gemma":[0.8136388,0.04480376,0.010274288,0.006209149,0.0976123,0.027461654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.18057334,0.004579823,0.003835399,0.017915793,0.009971502,0.020915566,0.01542934,0.011201315,0.006363486],"category_scores_gemma":[0.18910067,0.0023780104,0.005294185,0.017841568,0.018094001,0.013955644,0.02825265,0.021683436,0.003919648],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005292612,0.0001439627,0.0026331476,0.0036535347,0.0001830473,0.000403042,0.004388866,0.006415031,0.00017591957,0.34344846,0.48323762,0.15526447],"study_design_scores_gemma":[0.000112462134,0.00018614177,0.0023485138,0.020056672,0.00014397275,0.00032323232,0.003159974,0.0035228396,0.00031726924,0.12948477,0.8400741,0.00027001533],"about_ca_topic_score_codex":0.15555558,"about_ca_topic_score_gemma":0.17970708,"teacher_disagreement_score":0.18057334,"about_ca_system_score_codex":0.0619769,"about_ca_system_score_gemma":0.2966903,"threshold_uncertainty_score":0.95497453},"labels":[],"label_agreement":null},{"id":"W2507815012","doi":"10.6004/jnccn.2016.0120","title":"The Population Benefit of Radiotherapy for Malignant Brain Tumors: Local Control and Survival Estimates for Guideline-Based Use","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Government of Ontario; Ontario Institute for Cancer Research","keywords":"Medicine; Guideline; Radiation therapy; Oncology; Population; Internal medicine; Environmental health; Pathology","score_opus":0.03232647556880424,"score_gpt":0.3788988547676054,"score_spread":0.34657237919880113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507815012","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12278383,0.7542223,0.07098074,0.016972281,0.0012139772,0.0030375202,0.018506318,0.0003142709,0.01196882],"genre_scores_gemma":[0.91516227,0.038245283,0.034698516,0.0033508919,0.00046219467,0.0026706622,0.0050252406,0.00006030812,0.0003245876],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9143375,0.06683953,0.00637649,0.0027464465,0.009227495,0.00047254952],"domain_scores_gemma":[0.8665877,0.09780757,0.021506762,0.003630941,0.009913441,0.0005536254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07040499,0.0015991057,0.0049088867,0.006924957,0.00018580117,0.002973285,0.0018563803,0.002771697,0.0016639259],"category_scores_gemma":[0.2135243,0.0008336374,0.009557183,0.0061950358,0.000809654,0.0020563428,0.0016809136,0.0020697196,0.00034482343],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005964794,0.00040368573,0.17733447,0.090874076,0.2526517,0.00039281536,0.00086385553,0.113715164,0.0011673734,0.014443182,0.02126684,0.32092214],"study_design_scores_gemma":[0.0090641705,0.00714202,0.33135086,0.09606577,0.3031855,0.0016328233,0.0008593295,0.11747387,0.0026409845,0.060743857,0.069293655,0.0005471357],"about_ca_topic_score_codex":0.0051196762,"about_ca_topic_score_gemma":0.004867216,"teacher_disagreement_score":0.07040499,"about_ca_system_score_codex":0.004488231,"about_ca_system_score_gemma":0.0037785354,"threshold_uncertainty_score":0.37234163},"labels":[],"label_agreement":null},{"id":"W2529727747","doi":"10.6004/jnccn.2016.0135","title":"Effects of a Provincial-Wide Implementation of Screening for Distress on Healthcare Professionals' Confidence and Understanding of Person-Centered Care in Oncology","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Distress; Cohort; Intervention (counseling); Health care; Confidence interval; Health professionals; Family medicine; Cohort study; Nursing; Internal medicine; Clinical psychology","score_opus":0.0833770864487617,"score_gpt":0.39675851763553655,"score_spread":0.31338143118677486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529727747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981553,0.00008568105,0.00014220671,0.00052797113,0.000011462926,0.00030001006,0.00008270358,0.000031148647,0.0006636103],"genre_scores_gemma":[0.99819666,0.000094005045,0.0010295748,0.00013362135,0.000005656662,0.00021744143,0.000080077254,0.0000023692032,0.00024059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956423,0.0018020867,0.00020865207,0.00029704234,0.0006576216,0.0013922858],"domain_scores_gemma":[0.98717505,0.0034192607,0.0027743888,0.0011364069,0.002050071,0.0034447557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051273857,0.000283385,0.00037463076,0.00040846303,0.0013603631,0.0008279557,0.0011229871,0.00044893916,0.0014219201],"category_scores_gemma":[0.0176743,0.00033534245,0.00076722,0.00059790123,0.00078802515,0.00032349137,0.0020932925,0.0011270897,0.00010962664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005934813,0.027705299,0.55528176,0.0013154977,0.0004794299,0.0002496263,0.013491189,0.004342315,0.005084784,0.0003614184,0.003900359,0.38185352],"study_design_scores_gemma":[0.00094712694,0.007926367,0.9835316,0.0001723559,0.0001856114,0.000034575183,0.0034581253,0.0011453457,0.0009116748,0.000065907174,0.0015967381,0.000024411203],"about_ca_topic_score_codex":0.42477095,"about_ca_topic_score_gemma":0.5235621,"teacher_disagreement_score":0.42477095,"about_ca_system_score_codex":0.012770255,"about_ca_system_score_gemma":0.031486176,"threshold_uncertainty_score":0.844597},"labels":[],"label_agreement":null},{"id":"W2547811651","doi":"10.6004/jnccn.2016.0151","title":"Psychotropic and Opioid Medication Use in Older Patients With Breast Cancer Across the Care Trajectory: A Population-Based Cohort Study","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Breast cancer; Survivorship curve; Population; Cohort; Antipsychotic; Cancer; Internal medicine; Psychiatry; Schizophrenia (object-oriented programming); Environmental health","score_opus":0.015176101626621068,"score_gpt":0.29965681875267947,"score_spread":0.2844807171260584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547811651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983339,0.00013010125,0.00005761564,0.00006241988,0.000005646508,0.00004073391,0.0011429252,0.0000026524508,0.00022404188],"genre_scores_gemma":[0.9985195,0.00014680265,0.00010357471,0.000082882376,0.000007666342,0.000032265674,0.00091353647,0.0000018448699,0.00019199516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999493,0.000074506504,0.000046835994,0.000121017314,0.00012394118,0.00014072986],"domain_scores_gemma":[0.9990657,0.00006279874,0.00033728336,0.00007159144,0.00022657265,0.0002361136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005672973,0.00032327496,0.00038454292,0.0008937862,0.0012044057,0.0008206223,0.0005177519,0.00053143926,0.0010452888],"category_scores_gemma":[0.0013379736,0.00034259117,0.00066011614,0.0018470585,0.0002840645,0.0005339093,0.0005355597,0.0008417407,0.0002101943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000453235,0.00003790519,0.9990671,0.0000041904013,0.000035274825,0.00004756875,0.0001480774,0.000011360555,0.00008980953,0.0000045640027,0.000110012086,0.00039874337],"study_design_scores_gemma":[0.000008305951,0.000049690203,0.9993332,0.0000062851964,0.000021613596,0.00007774786,0.0002832506,0.000073558476,0.000015411859,0.000004250279,0.00012319515,0.0000034161949],"about_ca_topic_score_codex":0.40326285,"about_ca_topic_score_gemma":0.45419258,"teacher_disagreement_score":0.40326285,"about_ca_system_score_codex":0.0017036994,"about_ca_system_score_gemma":0.0016050051,"threshold_uncertainty_score":0.8018312},"labels":[],"label_agreement":null},{"id":"W2561994402","doi":"10.6004/jnccn.2016.0167","title":"Effective Translation of Research to Practice: Hospital-Based Rehabilitation Program Improves Health-Related Physical Fitness and Quality of Life of Cancer Survivors","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia; TRIUMF","funders":"Canadian Institutes of Health Research; Alberta Innovates","keywords":"Medicine; Physical therapy; Quality of life (healthcare); Rehabilitation; Aerobic exercise; Cancer; Physical fitness; Flexibility (engineering); Health care; Internal medicine; Nursing","score_opus":0.05737214392641822,"score_gpt":0.44571760098379665,"score_spread":0.38834545705737844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561994402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98245263,0.0014875879,0.0034336725,0.003750439,0.00021283844,0.0032490669,0.00014961678,0.00016083181,0.0051032607],"genre_scores_gemma":[0.98535186,0.0012363624,0.010534934,0.0006653192,0.00015347598,0.0016092053,0.00012375166,0.000012695708,0.00031237994],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9947366,0.0037258156,0.00031451206,0.00025951635,0.00069568184,0.00026786106],"domain_scores_gemma":[0.99433374,0.0025507633,0.0012498915,0.0006211519,0.00063132687,0.0006131648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007795223,0.00033174924,0.00039716973,0.00047774886,0.00037169058,0.0008096514,0.0007447937,0.00067460473,0.0027327102],"category_scores_gemma":[0.0196747,0.00014644749,0.00037917704,0.0004949456,0.00044816328,0.0004886406,0.00085739733,0.0006094464,0.00029554148],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023152328,0.035689875,0.07330011,0.0024844971,0.0003347402,0.00025862796,0.0016366567,0.0022247124,0.004534095,0.00038246927,0.004375157,0.8724638],"study_design_scores_gemma":[0.013534925,0.06538165,0.87973136,0.00409153,0.0009464782,0.0007338351,0.004704739,0.006350668,0.008682031,0.0017962201,0.013949781,0.00009677652],"about_ca_topic_score_codex":0.0011741013,"about_ca_topic_score_gemma":0.0019280087,"teacher_disagreement_score":0.007795223,"about_ca_system_score_codex":0.00084644073,"about_ca_system_score_gemma":0.0038351458,"threshold_uncertainty_score":0.041225612},"labels":[],"label_agreement":null},{"id":"W2564952891","doi":"10.6004/jnccn.2016.0166","title":"Delivery of Adjuvant Oxaliplatin for Colon Cancer: Insights From Routine Clinical Practice","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Oxaliplatin; Medicine; Colorectal cancer; Hazard ratio; Internal medicine; Proportional hazards model; Cancer registry; Poisson regression; Stage (stratigraphy); Population; Cancer; Oncology; Surgery; Confidence interval","score_opus":0.07993162547078687,"score_gpt":0.402997621087353,"score_spread":0.3230659956165661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564952891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9475396,0.026536383,0.00096138223,0.018163515,0.00003610992,0.000062202875,0.0006170851,0.00002620174,0.0060575097],"genre_scores_gemma":[0.9900225,0.008595542,0.00054995494,0.0004941372,0.00004057599,0.000011650587,0.00014319996,0.0000040212926,0.0001384861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984119,0.0005709674,0.00010449444,0.00021434386,0.00051627686,0.000181947],"domain_scores_gemma":[0.9901591,0.0030024752,0.0047340915,0.00021988282,0.0011753825,0.0007090773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002567565,0.00014740997,0.00019946632,0.000621362,0.00025789943,0.0010073617,0.00057300134,0.00041706068,0.0009571954],"category_scores_gemma":[0.0154888285,0.0001590952,0.0001662815,0.0012397115,0.0006345215,0.00056232815,0.00050751003,0.000426293,0.00011833789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021378223,0.00012284116,0.9014602,0.0005620044,0.00006433725,0.00039786816,0.0025395101,0.0005629869,0.0005534771,0.0005855474,0.003089408,0.08984804],"study_design_scores_gemma":[0.00003483332,0.00023017697,0.9863688,0.0004836049,0.000050417417,0.0006322866,0.0023986218,0.001278913,0.0002192135,0.00088048447,0.007401346,0.00002131431],"about_ca_topic_score_codex":0.13329163,"about_ca_topic_score_gemma":0.20711263,"teacher_disagreement_score":0.13329163,"about_ca_system_score_codex":0.006568604,"about_ca_system_score_gemma":0.00892113,"threshold_uncertainty_score":0.26503158},"labels":[],"label_agreement":null},{"id":"W2609928112","doi":"10.6004/jnccn.2017.0044","title":"NCCN Guidelines Insights: Breast Cancer, Version 1.2017","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":542,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Kyowa Hakko Kirin; Astellas Pharma; Clovis Oncology; National Comprehensive Cancer Network; Novocure; Jazz Pharmaceuticals; AstraZeneca; Novartis Pharmaceuticals Corporation; Celldex Therapeutics; Genomic Health","keywords":"Medicine; Breast cancer; Radiation therapy; Cancer; Medical physics; Systemic therapy; Intensive care medicine; Oncology; Internal medicine","score_opus":0.0616633971341642,"score_gpt":0.3633957124153162,"score_spread":0.301732315281152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609928112","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002600299,0.115332484,0.020662377,0.22690052,0.029605081,0.0058152047,0.094025224,0.0059373183,0.49912155],"genre_scores_gemma":[0.020294065,0.16144404,0.08304147,0.17020808,0.013565126,0.012934832,0.24521156,0.005714615,0.2875862],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925222,0.0022501368,0.0014321455,0.00023562202,0.0030591327,0.00050085894],"domain_scores_gemma":[0.97523946,0.0071467706,0.0026303364,0.00095196994,0.012776915,0.0012545766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007495763,0.0008625873,0.0012219405,0.0044502527,0.0010863354,0.0035492242,0.0026778383,0.00543342,0.05583348],"category_scores_gemma":[0.052632425,0.0010478107,0.0012020533,0.0043911026,0.0011501219,0.0022510353,0.0022315842,0.0057363138,0.04438723],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042575284,0.000028448265,0.00022407343,0.0003881979,0.000008308363,0.00006189925,0.000042070602,0.00014616098,0.00010983678,0.0019145637,0.95250386,0.044530112],"study_design_scores_gemma":[0.00008617866,0.000027407286,0.0010166469,0.0015794684,0.00001819151,0.00033811465,0.00004707556,0.00013830722,0.0001598614,0.0019178119,0.9946443,0.000026737594],"about_ca_topic_score_codex":0.027357364,"about_ca_topic_score_gemma":0.050179306,"teacher_disagreement_score":0.05583348,"about_ca_system_score_codex":0.0037039255,"about_ca_system_score_gemma":0.013471362,"threshold_uncertainty_score":0.18678164},"labels":[],"label_agreement":null},{"id":"W2610066140","doi":"10.6004/jnccn.2017.0032","title":"Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Comorbidity; Cohort; Akaike information criterion; Internal medicine; Logistic regression; Retrospective cohort study; Hazard ratio; Population; Charlson comorbidity index; Perioperative; Proportional hazards model; Bladder cancer; Database; Surgery; Cancer; Confidence interval; Statistics","score_opus":0.11222096430922492,"score_gpt":0.42711369084857614,"score_spread":0.31489272653935124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610066140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85488504,0.004135044,0.015316042,0.00090595515,0.0003400369,0.0025397334,0.11401944,0.0003057469,0.0075528426],"genre_scores_gemma":[0.9242146,0.0009787895,0.0126399845,0.0002136378,0.00011825561,0.0024981066,0.05804573,0.000031163916,0.0012596885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975636,0.000767744,0.00054091815,0.00028087661,0.0006828639,0.00016405401],"domain_scores_gemma":[0.9925851,0.0010016945,0.0036509868,0.00045487384,0.0018212808,0.00048607332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002746909,0.00073505356,0.00088810024,0.0030313635,0.00055943755,0.0005561517,0.0009662189,0.00043320595,0.0027169047],"category_scores_gemma":[0.013691366,0.00022928318,0.0013665069,0.0023745685,0.00021147323,0.0005418117,0.0010463892,0.0010342184,0.0003944479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000456624,0.000079889454,0.9780191,0.00013544614,0.00045261774,0.000058279275,0.000047881884,0.0014771279,0.00017765253,0.0002650597,0.008325629,0.010504632],"study_design_scores_gemma":[0.00010071485,0.00015318536,0.98930055,0.000078346864,0.00009991221,0.00020410256,0.00004970996,0.006982168,0.00012646841,0.00033660198,0.0025429141,0.00002518222],"about_ca_topic_score_codex":0.016411668,"about_ca_topic_score_gemma":0.030559631,"teacher_disagreement_score":0.016411668,"about_ca_system_score_codex":0.0019552538,"about_ca_system_score_gemma":0.0019652403,"threshold_uncertainty_score":0.03263229},"labels":[],"label_agreement":null},{"id":"W2612400171","doi":"10.6004/jnccn.2017.0059","title":"NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":351,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Center for Advancing Translational Sciences; Kyowa Hakko Kirin; Advanced Accelerator Applications; Jazz Pharmaceuticals; Cook Medical; Boston Scientific Corporation; National Cancer Institute; Sirtex Medical; Genomic Health; Clovis Oncology; Varian Medical Systems; Novartis Pharmaceuticals Corporation; AstraZeneca; Celgene; Gilead Sciences; Astellas Pharma; Novocure; Celldex Therapeutics; Amgen","keywords":"Medicine; Hepatocellular carcinoma; Gallbladder; Gallbladder cancer; General surgery; Internal medicine; Intensive care medicine; Oncology","score_opus":0.21004862632452748,"score_gpt":0.3705305788115665,"score_spread":0.160481952487039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612400171","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032492836,0.18477498,0.028445302,0.33802953,0.04833896,0.01086077,0.08631044,0.005864095,0.29412663],"genre_scores_gemma":[0.022775574,0.2400875,0.115999386,0.1470977,0.02284122,0.019388929,0.22615735,0.0052861725,0.20036621],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98846763,0.0036286367,0.003144081,0.00029479412,0.003837915,0.0006270131],"domain_scores_gemma":[0.949535,0.013191689,0.0060349517,0.0017098304,0.027445389,0.0020831914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011883844,0.0012927977,0.0018686925,0.006957154,0.0012966378,0.0043167574,0.0034962378,0.0052976143,0.03384338],"category_scores_gemma":[0.095225304,0.0014432281,0.0021436561,0.0061262934,0.0016690508,0.0030687833,0.002934546,0.007381852,0.030617954],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048383998,0.000028800043,0.00036220008,0.00081863895,0.000019833718,0.00008215676,0.00005559889,0.00022039883,0.00008364191,0.0011439327,0.9502309,0.046905555],"study_design_scores_gemma":[0.00019115793,0.000040959865,0.0023850496,0.0058270865,0.0000671514,0.00052806205,0.00010014322,0.00032322557,0.00024379877,0.0031269505,0.98710895,0.000057418085],"about_ca_topic_score_codex":0.03344128,"about_ca_topic_score_gemma":0.05921075,"teacher_disagreement_score":0.03384338,"about_ca_system_score_codex":0.0044041756,"about_ca_system_score_gemma":0.021059748,"threshold_uncertainty_score":0.113217354},"labels":[],"label_agreement":null},{"id":"W2614394261","doi":"10.6004/jnccn.2017.0070","title":"Use of Biomarkers and Multigene Assays in Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Medicine; Breast cancer; Oncology; Estrogen receptor; Internal medicine; Endocrine system; Adjuvant therapy; Adjuvant; Chemotherapy; Estrogen; Cancer; Bioinformatics; Hormone","score_opus":0.05250035401155284,"score_gpt":0.32708279851086314,"score_spread":0.2745824444993103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614394261","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2754225,0.5895553,0.08341645,0.0122649195,0.0034320895,0.00057737116,0.003573181,0.0008157767,0.030942407],"genre_scores_gemma":[0.8662159,0.047637805,0.076339684,0.003363759,0.0015687542,0.000556422,0.00093916507,0.00006754721,0.0033109789],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931289,0.0043583047,0.0004471618,0.00059980835,0.0013140304,0.00015182795],"domain_scores_gemma":[0.99199414,0.0034381372,0.0024064418,0.0007313553,0.0010786498,0.00035130707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00921761,0.00059258344,0.00076935894,0.004566437,0.00039045402,0.0017593347,0.0007087931,0.0011316264,0.0009697455],"category_scores_gemma":[0.011992923,0.00030961237,0.00042532268,0.003927542,0.0007674986,0.001090649,0.0010965905,0.0009715368,0.00050678034],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016486653,0.0002869108,0.5034657,0.001160807,0.00054434885,0.0006063371,0.0002174145,0.002191525,0.013905603,0.008326553,0.0062302244,0.46141583],"study_design_scores_gemma":[0.00016486045,0.004083245,0.73277545,0.0017627695,0.0011815663,0.009601949,0.0007119619,0.013883538,0.03773779,0.04282937,0.15498272,0.00028483215],"about_ca_topic_score_codex":0.00081820367,"about_ca_topic_score_gemma":0.0008955342,"teacher_disagreement_score":0.00921761,"about_ca_system_score_codex":0.0007429237,"about_ca_system_score_gemma":0.0007223072,"threshold_uncertainty_score":0.048747957},"labels":[],"label_agreement":null},{"id":"W2615945276","doi":"10.6004/jnccn.2017.0075","title":"Immunotherapies for Lung Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Pembrolizumab; Atezolizumab; Medicine; Nivolumab; Immunotherapy; Oncology; Lung cancer; PD-L1; Internal medicine; Standard of care; First line; Cancer","score_opus":0.05760166304265469,"score_gpt":0.3876294147813151,"score_spread":0.3300277517386604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615945276","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018441947,0.8894203,0.0060702516,0.023896044,0.007850977,0.00022366137,0.0004903782,0.0002864694,0.05332001],"genre_scores_gemma":[0.22290465,0.67683333,0.0098859845,0.017781176,0.006410017,0.00038365,0.0015887873,0.000083022365,0.06412941],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981993,0.000044660235,0.000011677484,0.000021476806,0.00007110551,0.00003110772],"domain_scores_gemma":[0.99985826,0.00002553474,0.000023759629,0.000013677201,0.00004582453,0.000033066914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004981889,0.0002676841,0.00032444886,0.0005539374,0.00024751236,0.00068983407,0.0002551465,0.00046079585,0.005798281],"category_scores_gemma":[0.00049202406,0.00007510218,0.00044116966,0.000282076,0.00023331953,0.00051260664,0.00052310486,0.0016590813,0.002683376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032210597,0.00035531278,0.0010161394,0.0013679384,0.000114259405,0.00040455832,0.00007811471,0.00040447598,0.020043425,0.014031099,0.08206265,0.8797999],"study_design_scores_gemma":[0.00017899153,0.0005267566,0.002140886,0.00052578415,0.00006683489,0.0013615445,0.000037912007,0.0003289302,0.005319566,0.0064591873,0.9830403,0.000013342932],"about_ca_topic_score_codex":0.00033097432,"about_ca_topic_score_gemma":0.0010774656,"teacher_disagreement_score":0.005798281,"about_ca_system_score_codex":0.0006064568,"about_ca_system_score_gemma":0.00045796987,"threshold_uncertainty_score":0.0193972},"labels":[],"label_agreement":null},{"id":"W2742308385","doi":"10.6004/jnccn.2017.0136","title":"Costs and Benefits of Extended Endocrine Strategies for Premenopausal Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Endocrine system; Breast cancer; Oncology; Gynecology; Cancer; Internal medicine; Hormone","score_opus":0.024812774516495623,"score_gpt":0.31948362384133916,"score_spread":0.29467084932484355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742308385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96362764,0.005357398,0.017730998,0.002578872,0.00008813864,0.0008272294,0.0021509589,0.000087321234,0.0075514046],"genre_scores_gemma":[0.9952525,0.0011170133,0.0024224587,0.00021177992,0.000011343673,0.00016805273,0.00033850374,0.0000058652695,0.00047246943],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9988686,0.00078019185,0.00005070203,0.000080107464,0.000103304774,0.00011711882],"domain_scores_gemma":[0.9944371,0.0044731274,0.0005508328,0.00009769583,0.00018629483,0.000255012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026217266,0.0006977358,0.0007535585,0.0009205316,0.0003480346,0.0011251759,0.00075200194,0.0008753101,0.005203209],"category_scores_gemma":[0.012543296,0.00049749675,0.0020825297,0.00083937723,0.0004276596,0.00089526403,0.00057415897,0.0011435155,0.00022488931],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023272638,0.00043291456,0.02836461,0.0003158499,0.0008283353,0.00038071675,0.0000601802,0.92972344,0.00028447655,0.004869621,0.0010666001,0.031346053],"study_design_scores_gemma":[0.001571592,0.0028760359,0.02487757,0.00063482125,0.002200716,0.0008079757,0.00024442468,0.9420349,0.00080626504,0.020071726,0.0037908033,0.00008319566],"about_ca_topic_score_codex":0.016845467,"about_ca_topic_score_gemma":0.014340952,"teacher_disagreement_score":0.016845467,"about_ca_system_score_codex":0.0043496555,"about_ca_system_score_gemma":0.0038006483,"threshold_uncertainty_score":0.03349483},"labels":[],"label_agreement":null},{"id":"W2744712610","doi":"10.6004/jnccn.2017.0139","title":"Targeted MAPK Pathway Inhibitors in Patients With Disseminated Pilocytic Astrocytomas","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children’s Health Research Institute","funders":"","keywords":"Dabrafenib; Medicine; Trametinib; Pilocytic astrocytoma; KRAS; Cancer research; MAPK/ERK pathway; Oncology; Internal medicine; Astrocytoma; Vemurafenib; Glioma; Melanoma; Kinase; Cancer; Metastatic melanoma; Genetics; Biology","score_opus":0.019482378393887785,"score_gpt":0.2836547623742144,"score_spread":0.2641723839803266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744712610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99055016,0.0036384426,0.00060823845,0.0004703793,0.000025866766,0.000031512634,0.00012068905,0.00004464018,0.004510085],"genre_scores_gemma":[0.99814093,0.0010071773,0.00031139248,0.00019053074,0.000021840511,0.000010348485,0.00010066266,0.0000059612703,0.00021103692],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99989593,0.000012994575,0.000009854537,0.000016722815,0.000023804616,0.00004060113],"domain_scores_gemma":[0.999848,0.00003058077,0.000051953753,0.000005403838,0.000013124132,0.000050963354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078599696,0.00030119123,0.0003858476,0.00021778206,0.00039257022,0.0003332432,0.00015350603,0.0003774178,0.0006683194],"category_scores_gemma":[0.0003720449,0.00010764827,0.00024732365,0.0003547377,0.00019014697,0.00023958336,0.00018002765,0.00042841752,0.00013928369],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001148527,0.00028426503,0.6242058,0.0002129977,0.00017105593,0.24864218,0.0006459494,0.0016458941,0.021553384,0.0008537326,0.0034577209,0.097178474],"study_design_scores_gemma":[0.00023863498,0.002497965,0.22728355,0.00008123468,0.00037682985,0.7418664,0.0006555341,0.001981485,0.008117087,0.00060556614,0.016269423,0.000026255519],"about_ca_topic_score_codex":0.00084849505,"about_ca_topic_score_gemma":0.002705075,"teacher_disagreement_score":0.00084849505,"about_ca_system_score_codex":0.00043042947,"about_ca_system_score_gemma":0.0004348139,"threshold_uncertainty_score":0.003123045},"labels":[],"label_agreement":null},{"id":"W2752378953","doi":"10.6004/jnccn.2017.0149","title":"A Double-Blind, Randomized, Placebo-Controlled Trial of<i>Panax Ginseng</i>for Cancer-Related Fatigue in Patients With Advanced Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Genentech; GlaxoSmithKline; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Placebo; Quality of life (healthcare); Mood; Internal medicine; Ginseng; Anxiety; Randomized controlled trial; Cancer-related fatigue; Clinical endpoint; Profile of mood states; Physical therapy; Depression (economics); Placebo-controlled study; Cancer; Double blind; Psychiatry; Alternative medicine","score_opus":0.03422671687455836,"score_gpt":0.3393581911611152,"score_spread":0.30513147428655685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752378953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97913796,0.005572299,0.000782814,0.00092605397,0.001382386,0.008768,0.0007747165,0.0001977905,0.0024579607],"genre_scores_gemma":[0.9823401,0.0027479858,0.0018480977,0.0014488408,0.0007042297,0.008342128,0.00056830945,0.000017265209,0.0019829783],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994856,0.00027074962,0.0000498832,0.00009144003,0.000032550262,0.00006971899],"domain_scores_gemma":[0.9992299,0.00022840749,0.00018212179,0.00005935764,0.000060382266,0.0002398619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012524424,0.0011813815,0.003109833,0.0003609832,0.00055142754,0.00074009673,0.00072455883,0.0014915769,0.005378756],"category_scores_gemma":[0.001503129,0.0006114502,0.0011655671,0.0003251995,0.0011956972,0.0008029756,0.00034842896,0.0020908117,0.0007816982],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97835255,0.0067455056,0.0002327582,0.0006534359,0.0005018732,0.000023133316,0.000034501725,0.000112275244,0.0022127004,0.000063902204,0.00046027993,0.010607141],"study_design_scores_gemma":[0.9536843,0.044914663,0.00063149806,0.000020855072,0.00015336566,0.000010110074,0.000009340896,0.00011791664,0.00015777953,0.00004279195,0.00025188172,0.0000055809655],"about_ca_topic_score_codex":0.0007186921,"about_ca_topic_score_gemma":0.0015884384,"teacher_disagreement_score":0.005378756,"about_ca_system_score_codex":0.00049610855,"about_ca_system_score_gemma":0.0011904485,"threshold_uncertainty_score":0.017993748},"labels":[],"label_agreement":null},{"id":"W2803149877","doi":"10.6004/jnccn.2018.0046","title":"Targeted Therapy for Patients With Metastatic Non–Small Cell Lung Cancer","year":2018,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"Ariad Pharmaceuticals","keywords":"Medicine; Alectinib; Osimertinib; ROS1; Targeted therapy; Lung cancer; Oncology; Anaplastic lymphoma kinase; Erlotinib; Ceritinib; Internal medicine; Tyrosine-kinase inhibitor; Tyrosine kinase; Cancer research; Cancer; Epidermal growth factor receptor; Adenocarcinoma; Receptor","score_opus":0.02476331531661414,"score_gpt":0.3389768553128095,"score_spread":0.3142135399961954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803149877","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16668358,0.25822577,0.005996111,0.09118898,0.00727168,0.0009016027,0.0094235,0.0009282898,0.45938042],"genre_scores_gemma":[0.74931717,0.1273734,0.0054004774,0.035885066,0.0066311657,0.00056912744,0.0102101425,0.00015494274,0.06445846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999231,0.000015780513,0.0000065490894,0.0000093436,0.000027205242,0.000017996457],"domain_scores_gemma":[0.99989855,0.000018519064,0.00002215271,0.0000038767603,0.000020336924,0.000036546502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012359642,0.00012497162,0.00021991646,0.00024365877,0.0002704098,0.00028147854,0.00016032904,0.0003258624,0.01401406],"category_scores_gemma":[0.00045408166,0.00003682344,0.00033639735,0.00022321113,0.00008646286,0.00030714218,0.00022123363,0.00052311335,0.0031104276],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007269484,0.00020382415,0.015036048,0.0007656477,0.00007118597,0.0015048134,0.00007979844,0.00022640101,0.0062522707,0.0014772989,0.3595271,0.61412877],"study_design_scores_gemma":[0.0006755851,0.001292157,0.09023493,0.0012109415,0.00016744134,0.007102883,0.000115885916,0.000939841,0.0029560847,0.0035620583,0.8917185,0.000023780956],"about_ca_topic_score_codex":0.0009639256,"about_ca_topic_score_gemma":0.0047069,"teacher_disagreement_score":0.01401406,"about_ca_system_score_codex":0.00035732237,"about_ca_system_score_gemma":0.0004365984,"threshold_uncertainty_score":0.046881735},"labels":[],"label_agreement":null},{"id":"W2808656455","doi":"10.6004/jnccn.2018.7014","title":"Outcomes From a Patient-Centered, Interprofessional, Palliative Consult Team in Oncology","year":2018,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"Alberta Cancer Foundation","keywords":"Medicine; Psychosocial; Palliative care; Referral; Anxiety; Distress; Quality of life (healthcare); Family medicine; Depression (economics); Physical therapy; Psychiatry; Nursing; Clinical psychology","score_opus":0.1782823076023507,"score_gpt":0.46578988694121953,"score_spread":0.28750757933886883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808656455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967913,0.0006354861,0.00015178058,0.000413415,0.000023994204,0.00007875466,0.000097815486,0.000010561715,0.0017968072],"genre_scores_gemma":[0.9991105,0.00016437408,0.00022523566,0.00014635567,0.000015788995,0.000042725693,0.00014595076,0.000002771836,0.00014616262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816364,0.00082150585,0.00012258175,0.00012058512,0.0004461371,0.0003256233],"domain_scores_gemma":[0.99304914,0.00071245775,0.0020059806,0.00011861291,0.0007377694,0.0033760797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013235555,0.00014596303,0.00015697158,0.00048108213,0.0010227048,0.0008658857,0.0003242154,0.0003131244,0.0025846653],"category_scores_gemma":[0.008105077,0.00009843881,0.00023137935,0.0005214086,0.00026129343,0.00048013404,0.0015990281,0.0005052073,0.0001965781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010779296,0.0023853867,0.8364873,0.00046367405,0.00020917675,0.0010239715,0.0032644728,0.00075877446,0.00058519444,0.00014838779,0.0062636943,0.1473321],"study_design_scores_gemma":[0.00035340982,0.0053015472,0.979625,0.0003621414,0.00013200786,0.0024996172,0.0066782665,0.000948583,0.00026796485,0.00023893756,0.0035651114,0.000027432772],"about_ca_topic_score_codex":0.0021657352,"about_ca_topic_score_gemma":0.00714119,"teacher_disagreement_score":0.0025846653,"about_ca_system_score_codex":0.0014057108,"about_ca_system_score_gemma":0.001539682,"threshold_uncertainty_score":0.010199249},"labels":[],"label_agreement":null},{"id":"W2886592807","doi":"10.6004/jnccn.2018.7020","title":"DNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancer","year":2018,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Cilag; National Cancer Institute; Janssen Biotech; Astellas Pharma; Celgene; University of Michigan; Valeant Pharmaceuticals International; Varian Medical Systems; Gilead Sciences","keywords":"DNA repair; PARP inhibitor; Prostate cancer; Medicine; Cancer research; Mutation; Cancer; Poly ADP ribose polymerase; Gene; Homologous recombination; DNA damage; Gene mutation; Oncology; Internal medicine; DNA; Biology; Genetics","score_opus":0.035890937354533,"score_gpt":0.3342492008840909,"score_spread":0.29835826352955785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886592807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993032,0.00035407106,0.000068724854,0.000035424866,0.0000022272588,0.0000059845524,0.000069318914,0.0000049157356,0.00015610938],"genre_scores_gemma":[0.9997032,0.00008235466,0.00008033452,0.000018922721,0.0000066913362,0.0000030000945,0.00007352216,0.0000010721535,0.000030848856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997131,0.00009096536,0.000033129032,0.0000535507,0.00006265328,0.000046508616],"domain_scores_gemma":[0.9987663,0.00039640843,0.00055172597,0.000028020424,0.00007912759,0.00017841408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004826942,0.00015833353,0.0002506796,0.0004938648,0.0002444003,0.0002984816,0.00018728207,0.0002575785,0.0010365068],"category_scores_gemma":[0.00174019,0.00011492011,0.00018609494,0.0005374116,0.00017890238,0.00019954963,0.00012948357,0.00035836356,0.00012209773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003653213,0.00007371537,0.994495,0.000015022044,0.00002450202,0.00035421323,0.00005001254,0.00012461202,0.0010915843,0.000010206269,0.000098675366,0.0032971813],"study_design_scores_gemma":[0.00003778624,0.0010693505,0.99244666,0.000008492727,0.00004996882,0.0042903936,0.00014168253,0.0005261309,0.0010281769,0.000027446145,0.00036667386,0.000007202379],"about_ca_topic_score_codex":0.0010640774,"about_ca_topic_score_gemma":0.00150361,"teacher_disagreement_score":0.0010640774,"about_ca_system_score_codex":0.0003314603,"about_ca_system_score_gemma":0.00027097034,"threshold_uncertainty_score":0.0034674406},"labels":[],"label_agreement":null},{"id":"W2887093231","doi":"10.6004/jnccn.2018.7027","title":"Swedish Version of the Distress Thermometer: Validity Evidence in Patients With Colorectal Cancer","year":2018,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Trinity Western University; Providence Health Care","funders":"Centrum fÖr Personcentrerad Vård; Göteborgs Universitet; Canada Research Chairs; Västra Götalandsregionen","keywords":"Medicine; Discriminant validity; Cronbach's alpha; Quality of life (healthcare); Distress; Construct validity; Convergent validity; Clinical psychology; Population; Colorectal cancer; Confirmatory factor analysis; Internal medicine; Psychometrics; Cancer; Internal consistency; Statistics","score_opus":0.04888381308805103,"score_gpt":0.31291428675480243,"score_spread":0.2640304736667514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887093231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952114,0.0019193685,0.00033486783,0.00015254033,0.000089329595,0.000068810026,0.00060518505,0.000010161256,0.0016083186],"genre_scores_gemma":[0.9948002,0.0012826788,0.001448452,0.00013003401,0.000045335866,0.00015051231,0.0016239975,0.0000108883405,0.0005078865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660265,0.0015920886,0.0005827854,0.00028779785,0.00077567046,0.0001590044],"domain_scores_gemma":[0.98826027,0.0055445908,0.0033120504,0.0004786211,0.0021316155,0.00027272425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047196415,0.0006097906,0.0005880441,0.0017354988,0.0005108331,0.0011237416,0.00043593172,0.0006108822,0.0016584243],"category_scores_gemma":[0.020200333,0.00030114275,0.00074902305,0.0017505809,0.00063508534,0.00044149993,0.0010734459,0.0004750655,0.00048683188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002707546,0.00007911771,0.9795671,0.000239457,0.00012560327,0.00009437794,0.0009812696,0.00017590451,0.00029330296,0.0000738933,0.00047422276,0.017624976],"study_design_scores_gemma":[0.000071413095,0.0005995559,0.9913878,0.0002886392,0.00016839433,0.0011304788,0.0017230625,0.00067105953,0.0003376607,0.00017548958,0.0034195893,0.000026854412],"about_ca_topic_score_codex":0.0032434775,"about_ca_topic_score_gemma":0.0051900726,"teacher_disagreement_score":0.0047196415,"about_ca_system_score_codex":0.00070083304,"about_ca_system_score_gemma":0.00080883934,"threshold_uncertainty_score":0.02496016},"labels":[],"label_agreement":null},{"id":"W2892196452","doi":"10.6004/jnccn.2018.7038","title":"Ability to Predict New-Onset Psychological Distress Using Routinely Collected Health Data: A Population-Based Cohort Study of Women Diagnosed With Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Canadian Foundation for Healthcare Improvement; McGill University; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Survivorship curve; Population; Anxiety; Cohort; Incidence (geometry); Distress; Cancer; Internal medicine; Psychiatry; Clinical psychology","score_opus":0.06772431429818167,"score_gpt":0.38580396908505094,"score_spread":0.3180796547868693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892196452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992872,0.00008510532,0.00009441023,0.00004141145,0.0000067232904,0.000009691182,0.00035800127,0.0000029382022,0.00011464576],"genre_scores_gemma":[0.9992399,0.00005966306,0.0001027355,0.00001904536,0.00000785604,0.000010145472,0.00047788705,0.0000016052988,0.000081275895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989796,0.0003331288,0.000110783934,0.0002406722,0.00019519507,0.00014060004],"domain_scores_gemma":[0.9961039,0.0009845058,0.0014988983,0.0006638212,0.0003366221,0.00041230963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001981615,0.00034498048,0.00043693127,0.0006870158,0.00042034037,0.0011390782,0.0005482315,0.00063475186,0.0010325772],"category_scores_gemma":[0.009663916,0.0005424284,0.0008639366,0.0009624688,0.0002658645,0.0007331036,0.0007025928,0.0012285559,0.00022255763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028606248,0.000021792392,0.9995272,0.0000014724441,0.000042272903,0.0000138419455,0.000029590854,0.000021158039,0.000031062536,0.0000038176345,0.000024098112,0.00025509458],"study_design_scores_gemma":[0.0000071514246,0.00005968146,0.9992574,0.000003602034,0.00002667092,0.00009207994,0.0000969221,0.0003610295,0.00001727007,0.000012545313,0.00006219001,0.0000034218604],"about_ca_topic_score_codex":0.009451428,"about_ca_topic_score_gemma":0.009792957,"teacher_disagreement_score":0.009451428,"about_ca_system_score_codex":0.00027369193,"about_ca_system_score_gemma":0.00041399593,"threshold_uncertainty_score":0.018792808},"labels":[],"label_agreement":null},{"id":"W2908650768","doi":"10.6004/jnccn.2018.7079","title":"Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Multiple myeloma; Internal medicine; Oncology","score_opus":0.03695116062310916,"score_gpt":0.2964003712810561,"score_spread":0.25944921065794696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908650768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958574,0.0022942375,0.00008270139,0.00020456983,0.000017646184,0.000013522368,0.00073686877,0.0000057413695,0.0007871638],"genre_scores_gemma":[0.9983973,0.00082996604,0.00010441341,0.00011007008,0.000036507397,0.000007312008,0.00037874663,9.517045e-7,0.00013458547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954957,0.00008408914,0.000081051956,0.000068794456,0.00015791904,0.000058609254],"domain_scores_gemma":[0.9975635,0.00029193147,0.0017584729,0.00005594617,0.00013853454,0.00019170895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005627794,0.00016334472,0.00030024713,0.0006520384,0.00032546095,0.00038245504,0.00024006148,0.0002963459,0.0012739325],"category_scores_gemma":[0.002547956,0.00015435867,0.00054668146,0.00097422337,0.00012443817,0.00032396914,0.00034519675,0.0004668681,0.00015374407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058736347,0.000026638127,0.9979602,0.000023304136,0.000045292716,0.000067316505,0.000025016067,0.000026190673,0.00006022238,0.000007547332,0.00011523106,0.0015842225],"study_design_scores_gemma":[0.00000996882,0.00006775585,0.9986488,0.000021170394,0.000059672253,0.00050729176,0.000076377095,0.00015686754,0.0000450085,0.00001805685,0.0003862584,0.0000026301627],"about_ca_topic_score_codex":0.0058353418,"about_ca_topic_score_gemma":0.010573088,"teacher_disagreement_score":0.0058353418,"about_ca_system_score_codex":0.00037807648,"about_ca_system_score_gemma":0.00043721125,"threshold_uncertainty_score":0.011602759},"labels":[],"label_agreement":null},{"id":"W2911213912","doi":"10.6004/jnccn.2018.7066","title":"Real-World Outcomes of Adjuvant Chemotherapy for Node-Negative and Node-Positive HER2-Positive Breast Cancer","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; Alberta Health Services; Baker Hughes (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Trastuzumab; Epirubicin; Docetaxel; Breast cancer; Internal medicine; Oncology; Carboplatin; Cyclophosphamide; Chemotherapy; Cancer; Gynecology; Cisplatin","score_opus":0.01437594280338184,"score_gpt":0.30522759471591804,"score_spread":0.2908516519125362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911213912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573094,0.0011115925,0.00015082922,0.000120350785,0.0000071016543,0.000024738185,0.0020273386,0.000005447505,0.0008216765],"genre_scores_gemma":[0.9974209,0.00019797319,0.00010425571,0.00004170986,0.000007295306,0.000012580071,0.0021188986,0.0000013816577,0.000095175084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993311,0.0001508103,0.0000773952,0.000099414654,0.00022792206,0.00011341735],"domain_scores_gemma":[0.99645007,0.00041167132,0.0020493388,0.00011834083,0.00059485616,0.0003756956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012298498,0.0001615857,0.000227125,0.00061960536,0.00026016537,0.00060311327,0.00034862186,0.00021738041,0.0005890642],"category_scores_gemma":[0.003311406,0.00006771818,0.00024798952,0.0009709519,0.000354568,0.00026628462,0.00037741207,0.0002881517,0.0000929307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038056535,0.000019797442,0.9953837,0.000027889011,0.0000863325,0.000028694996,0.000052342388,0.00030491836,0.00009958886,0.00002667932,0.0002669048,0.003322652],"study_design_scores_gemma":[0.000013470512,0.000111424524,0.9985984,0.000014794194,0.000043803077,0.000096296724,0.0000907717,0.00023546856,0.000094911346,0.000025248444,0.0006713849,0.00000402168],"about_ca_topic_score_codex":0.07361654,"about_ca_topic_score_gemma":0.15894778,"teacher_disagreement_score":0.07361654,"about_ca_system_score_codex":0.0038262606,"about_ca_system_score_gemma":0.002075398,"threshold_uncertainty_score":0.14637607},"labels":[],"label_agreement":null},{"id":"W2923871137","doi":"10.6004/jnccn.2018.7184","title":"CLO19-033: Afatinib Followed by Osimertinib in EGFR Mutation-Positive (EGFRm+) Advanced NSCLC: Subgroup Analyses of the GioTag Study by ECOG PS, Age, and Ethnicity","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Afatinib; Medicine; Osimertinib; T790M; Discontinuation; Internal medicine; Oncology; Clinical trial; Erlotinib; Cancer; Epidermal growth factor receptor; Gefitinib","score_opus":0.03281158859745364,"score_gpt":0.3887960014115104,"score_spread":0.35598441281405674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923871137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98350704,0.0113528855,0.0003142594,0.00029590065,0.00011480664,0.00044754104,0.0027808405,0.000019752397,0.0011670302],"genre_scores_gemma":[0.9958549,0.0008767367,0.00023240372,0.00029021973,0.00009664295,0.00035536563,0.0020359978,0.000015654052,0.00024211446],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9952172,0.0022685495,0.0008601488,0.0007291701,0.00046083715,0.00046422172],"domain_scores_gemma":[0.9965479,0.001403499,0.0010880905,0.00047008868,0.000205045,0.00028548154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063712033,0.0009697423,0.0026222353,0.0010995227,0.00034199565,0.0014330776,0.0008933196,0.0011773115,0.0019902466],"category_scores_gemma":[0.0064300913,0.00039664967,0.010324434,0.0019078945,0.0004923473,0.0009668054,0.0009202623,0.0014269929,0.00026461348],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4971644,0.0007645188,0.37227893,0.0031432256,0.093385644,0.00068364426,0.00038232427,0.0015283647,0.003620692,0.0003592048,0.003106375,0.023582704],"study_design_scores_gemma":[0.09140161,0.040133364,0.719393,0.00078404,0.12916662,0.0014254285,0.001288754,0.003921565,0.0022038438,0.0020222133,0.008045236,0.00021426736],"about_ca_topic_score_codex":0.0023480107,"about_ca_topic_score_gemma":0.0063260347,"teacher_disagreement_score":0.0063712033,"about_ca_system_score_codex":0.0007998964,"about_ca_system_score_gemma":0.0011678871,"threshold_uncertainty_score":0.033694506},"labels":[],"label_agreement":null},{"id":"W2924703224","doi":"10.6004/jnccn.2018.7181","title":"CLO19-042: Quality Assurance for Cancer Radiotherapy: An Update on the Ottawa Hospital Peer Review Experience","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Radiation therapy; Quality assurance; Peer review; Cancer; Medical physics; Surgery; Internal medicine; Pathology","score_opus":0.0546913518596147,"score_gpt":0.44729871715032343,"score_spread":0.3926073652907087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924703224","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020429682,0.39423063,0.015637748,0.45756766,0.016831504,0.002581276,0.0012484835,0.0028854245,0.088587604],"genre_scores_gemma":[0.17994231,0.54951334,0.084401764,0.053460978,0.015935825,0.003171192,0.004231114,0.0033366126,0.1060069],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9075483,0.025888657,0.011783184,0.0036542322,0.0469298,0.004195856],"domain_scores_gemma":[0.4914974,0.058591858,0.031729944,0.016104238,0.31977615,0.08230039],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10581462,0.0011602113,0.0014824804,0.008862513,0.006515597,0.010869899,0.008230382,0.0043493663,0.010508103],"category_scores_gemma":[0.15802285,0.0011481056,0.0011318544,0.009356677,0.008715437,0.008012699,0.00934103,0.0052061565,0.004498895],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014814334,0.0002266646,0.011975466,0.0027974145,0.000060629067,0.00067854015,0.004599954,0.00031611236,0.00097321376,0.002908579,0.47442916,0.50088614],"study_design_scores_gemma":[0.000024724022,0.00015192704,0.016135832,0.0025368952,0.000023818893,0.000942051,0.0017846589,0.00025982448,0.00038459015,0.00053145364,0.9771253,0.000098989505],"about_ca_topic_score_codex":0.16258278,"about_ca_topic_score_gemma":0.2781448,"teacher_disagreement_score":0.95912284,"about_ca_system_score_codex":0.04087714,"about_ca_system_score_gemma":0.11990081,"threshold_uncertainty_score":0.55960786},"labels":[],"label_agreement":null},{"id":"W2924811243","doi":"10.6004/jnccn.2018.7118","title":"QIM19-115: Barriers and Trends in Cancer Patients` Pain Management in Qatar: A Randomized Cohort Prospective Study","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer pain; Pharmacy; Cancer; McGill Pain Questionnaire; Population; Physical therapy; Patient satisfaction; Pain medicine; Family medicine; Pain assessment; Pain control; Descriptive statistics; Pain management; Psychiatry; Nursing; Internal medicine; Surgery; Visual analogue scale","score_opus":0.01374777838173413,"score_gpt":0.3025226510876097,"score_spread":0.28877487270587554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924811243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401075,0.0011878344,0.0003022031,0.00025515902,0.00007850518,0.0020738903,0.0014846966,0.000020109142,0.00058684],"genre_scores_gemma":[0.9922929,0.00038393386,0.0010986208,0.00062700594,0.000089756955,0.0031457606,0.0014529427,0.0000062913405,0.0009028063],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99864036,0.00041317547,0.00015583112,0.00033475898,0.00016907406,0.00028686834],"domain_scores_gemma":[0.99808156,0.00021020087,0.0007397204,0.00018026408,0.00032877235,0.00045953487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034424968,0.0010533019,0.0013929465,0.0009444504,0.0012630654,0.0009843671,0.00076797855,0.0015071356,0.0069812513],"category_scores_gemma":[0.0029019255,0.0008821447,0.0022758555,0.0010911272,0.0006024721,0.0010718891,0.00090508466,0.0015118553,0.0009057628],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10240457,0.020833882,0.8417456,0.0016078006,0.0030904426,0.00025186283,0.0016271485,0.00033767865,0.0010004849,0.00036494344,0.0049878284,0.021747714],"study_design_scores_gemma":[0.0316375,0.06219823,0.89568895,0.0004058566,0.0028916637,0.00029924308,0.0015177054,0.0016955966,0.00029223892,0.00032501228,0.0029200437,0.00012793469],"about_ca_topic_score_codex":0.0057845586,"about_ca_topic_score_gemma":0.0063373535,"teacher_disagreement_score":0.0069812513,"about_ca_system_score_codex":0.0010268453,"about_ca_system_score_gemma":0.0017159424,"threshold_uncertainty_score":0.02335465},"labels":[],"label_agreement":null},{"id":"W2925037395","doi":"10.6004/jnccn.2018.7120","title":"QIM19-119: Validity of the French-Language Mammography Satisfaction Instrument Evaluating Women’s Satisfaction With an Organized Breast Cancer Screening Program: A Confirmatory Study","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale; Centres Intégré Universitaires de Santé et de Services Sociaux; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Université Laval; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean","funders":"","keywords":"Medicine; Mammography; Confirmatory factor analysis; Breast cancer; Logistic regression; Structural equation modeling; Clinical psychology; Family medicine; Gerontology; Statistics; Cancer; Internal medicine","score_opus":0.08095070419248306,"score_gpt":0.37498865571731804,"score_spread":0.294037951524835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925037395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991987,0.00019283993,0.0015709542,0.00023906185,0.000028088283,0.0008024606,0.0026301546,0.00003377973,0.0025155854],"genre_scores_gemma":[0.99250233,0.00008758467,0.0031061945,0.00016190112,0.000024654444,0.0010864631,0.0024192499,0.000011100723,0.0006005835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953923,0.0021511659,0.0004996888,0.00034972437,0.0012155328,0.0003915771],"domain_scores_gemma":[0.9868845,0.0038406982,0.0025105944,0.00064308057,0.0054722796,0.00064884574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011007174,0.00059029565,0.0005568837,0.0020073012,0.00068162795,0.000751606,0.0008940043,0.0005065703,0.0031851758],"category_scores_gemma":[0.014688119,0.00023153581,0.0012900432,0.0018712672,0.0005123768,0.0004411343,0.00075149,0.00057606184,0.00039648297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002854735,0.00033671127,0.98026776,0.00012207075,0.00018394573,0.0000469495,0.00064844894,0.00018388995,0.0005237558,0.00010931546,0.00086822425,0.016423464],"study_design_scores_gemma":[0.00005002395,0.0005401265,0.9964101,0.000028343971,0.000048207043,0.000057677786,0.00049891864,0.0010132589,0.00026149407,0.000030462428,0.0010518632,0.000009701896],"about_ca_topic_score_codex":0.040366765,"about_ca_topic_score_gemma":0.044344947,"teacher_disagreement_score":0.040366765,"about_ca_system_score_codex":0.00237075,"about_ca_system_score_gemma":0.0032960188,"threshold_uncertainty_score":0.080263615},"labels":[],"label_agreement":null},{"id":"W2925222500","doi":"10.6004/jnccn.2018.7231","title":"EPR19-069: Opioid Use Among Cancer Patients Undergoing Surgery and Their Associated Risk of Re-admissions and Emergency Department Visits in the 1-Year Postsurgical Period","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Hydromorphone; Emergency department; Emergency medicine; Oxycodone; Medical prescription; Opioid; Pharmacy; Health care; Prospective cohort study; Medical emergency; Family medicine; Internal medicine; Psychiatry","score_opus":0.07602377924189122,"score_gpt":0.36072584305655375,"score_spread":0.28470206381466256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925222500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99091774,0.00026597147,0.00006420986,0.00028385947,0.000014834993,0.000037358426,0.0074175326,0.000009868731,0.0009886229],"genre_scores_gemma":[0.99334455,0.0001405206,0.0001138964,0.00012356171,0.000019739935,0.000029964222,0.0045489594,0.000004557985,0.0016741711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997242,0.000043421536,0.000023114948,0.00004671152,0.00007139542,0.00009118534],"domain_scores_gemma":[0.99872404,0.0001112105,0.00051941373,0.000043085038,0.00027581805,0.0003263033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004931566,0.00025560523,0.00021780883,0.00043459528,0.000455307,0.0005368031,0.000603098,0.00041571585,0.0058801766],"category_scores_gemma":[0.0015016154,0.00014910084,0.0004482421,0.00095378474,0.00019441845,0.00022479391,0.00040572672,0.00068252464,0.00056558615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013671702,0.0000480956,0.9974789,0.000014468392,0.000028015895,0.000027175725,0.000025352312,0.000032625365,0.000058441394,0.000008191802,0.00060696696,0.0015351181],"study_design_scores_gemma":[0.000007927719,0.00006203911,0.9994962,0.000005703324,0.000010994273,0.000025728614,0.000051988398,0.0000725357,0.0000134175125,0.0000031073116,0.0002485783,0.0000018241839],"about_ca_topic_score_codex":0.3622484,"about_ca_topic_score_gemma":0.43120292,"teacher_disagreement_score":0.3622484,"about_ca_system_score_codex":0.002158993,"about_ca_system_score_gemma":0.0025031595,"threshold_uncertainty_score":0.72027975},"labels":[],"label_agreement":null},{"id":"W2944970488","doi":"10.6004/jnccn.2018.7109","title":"Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Medicine; Internal medicine; Testicular cancer; Sex hormone-binding globulin; Odds ratio; Population; Gynecology; Chemotherapy; Endocrinology; Hormone; Androgen","score_opus":0.04068535105628981,"score_gpt":0.350278980485831,"score_spread":0.3095936294295412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944970488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99949884,0.0001132725,0.000025530673,0.000026118103,0.000003588738,0.000008396976,0.00021954533,0.0000011665669,0.00010351951],"genre_scores_gemma":[0.99965537,0.00004631888,0.000023720238,0.000022199363,0.000007059745,0.000007839572,0.0001941567,6.2523713e-7,0.000042755757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963844,0.00012718934,0.000035008907,0.000076052376,0.00006298918,0.00006023099],"domain_scores_gemma":[0.99867564,0.00012350001,0.00066722615,0.00007604264,0.00013870327,0.0003188437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047413894,0.00018891359,0.00030980044,0.00044178744,0.0004605833,0.0004447747,0.0003001813,0.00025839513,0.0010676902],"category_scores_gemma":[0.0012631797,0.00017352727,0.0003421243,0.0010628703,0.00021528827,0.00024662804,0.00033461113,0.00039722843,0.000101356425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002903902,0.000014531362,0.99954885,0.0000030768801,0.000028052275,0.000021300239,0.000034643206,0.000007660703,0.00006081922,0.0000022244794,0.000028986009,0.0002206897],"study_design_scores_gemma":[0.000005240218,0.00006602128,0.9995536,0.0000029374248,0.000023198207,0.00011841758,0.00011391735,0.000040443498,0.0000163219,0.0000037342018,0.00005483775,0.0000013141424],"about_ca_topic_score_codex":0.007195082,"about_ca_topic_score_gemma":0.008926934,"teacher_disagreement_score":0.007195082,"about_ca_system_score_codex":0.00024946217,"about_ca_system_score_gemma":0.00037108833,"threshold_uncertainty_score":0.014306426},"labels":[],"label_agreement":null},{"id":"W2953214266","doi":"10.6004/jnccn.2018.7276","title":"Maintenance of Fitness and Quality-of-Life Benefits From Supervised Exercise Offered as Supportive Care for Breast Cancer","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto; University of British Columbia; University of Alberta","funders":"","keywords":"Medicine; Waist; Physical therapy; Aerobic exercise; Quality of life (healthcare); Randomized controlled trial; Breast cancer; Physical fitness; Internal medicine; Cancer; Body mass index","score_opus":0.04801169281054981,"score_gpt":0.3285238128102642,"score_spread":0.2805121199997144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953214266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911748,0.0067125326,0.0002630115,0.000274799,0.00007264089,0.0005322423,0.00012381982,0.00002566427,0.000820342],"genre_scores_gemma":[0.99592113,0.0022736203,0.0008366664,0.00010864612,0.00010060512,0.0005036598,0.00012530269,0.0000019858112,0.00012832273],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99905807,0.00055518065,0.00008815293,0.000082671075,0.00014416827,0.00007170898],"domain_scores_gemma":[0.998256,0.00092266145,0.0004796575,0.000080281134,0.00007904901,0.0001823478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017697916,0.0002710838,0.00068493007,0.00040904092,0.00018599401,0.0004161264,0.0004221741,0.0005270663,0.0020886431],"category_scores_gemma":[0.0043809908,0.0001203852,0.00086509355,0.0003266453,0.00029871246,0.0002080929,0.00027748756,0.0006452107,0.00010865212],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3438,0.0608283,0.040001035,0.009621796,0.007075154,0.00010443822,0.00025092022,0.002987951,0.0046338127,0.0002468332,0.0011335916,0.52931625],"study_design_scores_gemma":[0.31248954,0.39579695,0.26966968,0.0030026778,0.008231007,0.00026357573,0.00019976754,0.0033801217,0.0038153874,0.0004593264,0.0026489226,0.000043129934],"about_ca_topic_score_codex":0.00079769775,"about_ca_topic_score_gemma":0.0013788897,"teacher_disagreement_score":0.0020886431,"about_ca_system_score_codex":0.00040230472,"about_ca_system_score_gemma":0.00078630174,"threshold_uncertainty_score":0.009359717},"labels":[],"label_agreement":null},{"id":"W2966508195","doi":"10.6004/jnccn.2019.7286","title":"Impact of Cumulative Chemotherapy Dose on Survival With Adjuvant FEC-D Chemotherapy for Breast Cancer","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Princess Margaret Cancer Centre; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Epirubicin; Internal medicine; Breast cancer; Docetaxel; Cyclophosphamide; Oncology; Chemotherapy; Anthracycline; Cumulative dose; Fluorouracil; Taxane; Cancer; Gastroenterology","score_opus":0.02260403580150976,"score_gpt":0.3359374223175592,"score_spread":0.3133333865160494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966508195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741423,0.0014223224,0.00013211674,0.0000990108,0.000007462364,0.000024756855,0.00018352881,0.000006177344,0.0007102858],"genre_scores_gemma":[0.99919313,0.00021430239,0.00014613206,0.00003701724,0.000006439242,0.000008565019,0.00024176746,0.0000016162746,0.00015108053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944955,0.00017681559,0.000035521334,0.00005260694,0.0002053332,0.000080242935],"domain_scores_gemma":[0.9985979,0.00051076006,0.0004608442,0.00005913641,0.00019314377,0.00017833653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001069731,0.00011806366,0.00021485516,0.0002315058,0.00012741963,0.0003377831,0.000285359,0.00013322983,0.0006174545],"category_scores_gemma":[0.003067735,0.000048904953,0.00029528915,0.00034297875,0.000233692,0.00012682287,0.00021503182,0.00027526653,0.000050281775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012769812,0.00037854342,0.90346116,0.0001077026,0.00043526018,0.00007146003,0.000063871834,0.004276454,0.002100105,0.00007555,0.0005874082,0.07567266],"study_design_scores_gemma":[0.00017741518,0.0045001577,0.9911004,0.000024513627,0.00030335967,0.00021343835,0.000045375436,0.001433634,0.00083896593,0.000056517463,0.0013012226,0.00000509534],"about_ca_topic_score_codex":0.02203638,"about_ca_topic_score_gemma":0.050484944,"teacher_disagreement_score":0.02203638,"about_ca_system_score_codex":0.0024387434,"about_ca_system_score_gemma":0.0019882803,"threshold_uncertainty_score":0.04381621},"labels":[],"label_agreement":null},{"id":"W2971731803","doi":"10.6004/jnccn.2019.7301","title":"Edmonton Symptom Assessment Scale and Clinical Characteristics Associated With Cannabinoid Use in Oncology Supportive Care Outpatients","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Quartile; Internal medicine; Cannabinoid; Population; Nausea; Statistical significance; Urine; Cancer; Confidence interval","score_opus":0.03876270851438969,"score_gpt":0.38467563807874994,"score_spread":0.34591292956436026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971731803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984877,0.0004326786,0.000033965476,0.000053809938,0.000006115177,0.000022232827,0.0003316622,0.0000027387598,0.00062910165],"genre_scores_gemma":[0.99917287,0.00014968478,0.000112926595,0.000026319734,0.000008921969,0.000021436517,0.00037879913,9.1491916e-7,0.00012819724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996222,0.00008621563,0.000056998368,0.000060454677,0.000112528876,0.00006161336],"domain_scores_gemma":[0.997336,0.0005234774,0.0014366435,0.000038516486,0.00022866458,0.00043671898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057075266,0.00019258745,0.00031669738,0.0011048797,0.0003223154,0.0003142297,0.00032828303,0.00025753406,0.0030085421],"category_scores_gemma":[0.002822551,0.00014432178,0.0002837221,0.0008258688,0.00023941461,0.00021992612,0.00039666935,0.0003612827,0.00018369083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003530744,0.00002208472,0.99892527,0.000011195002,0.000015101187,0.00009813919,0.000046295027,0.000009932572,0.00011171906,0.000002883481,0.0000835208,0.00063864747],"study_design_scores_gemma":[0.000004162283,0.000050681465,0.99939513,0.000006515133,0.0000058495425,0.0003523383,0.00006579989,0.000027264465,0.000019734714,0.0000022483705,0.00006905226,0.0000011897923],"about_ca_topic_score_codex":0.003182715,"about_ca_topic_score_gemma":0.005396901,"teacher_disagreement_score":0.003182715,"about_ca_system_score_codex":0.0004123073,"about_ca_system_score_gemma":0.00036832725,"threshold_uncertainty_score":0.010064602},"labels":[],"label_agreement":null},{"id":"W2972016640","doi":"10.6004/jnccn.2019.7298","title":"Influence of Treating Facility, Provider Volume, and Patient-Sharing on Survival of Patients With Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Decile; Multiple myeloma; Hazard ratio; Cancer; Proportional hazards model; Internal medicine; Population; Community hospital; Cohort; Emergency medicine; Family medicine; Nursing; Confidence interval; Environmental health","score_opus":0.02461337907977604,"score_gpt":0.2907486100880378,"score_spread":0.26613523100826175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972016640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99924505,0.00016977768,0.00007568715,0.00014939182,0.000004162547,0.0000042197917,0.00017049549,0.0000026138837,0.00017854197],"genre_scores_gemma":[0.9998018,0.000030578012,0.000033814227,0.000014229377,0.000004697813,0.0000022361533,0.00008964643,7.367471e-7,0.000022284732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987804,0.00053113484,0.000087809545,0.00016565832,0.0002080813,0.00022692894],"domain_scores_gemma":[0.991456,0.0022953956,0.0043753195,0.00029753818,0.00043282053,0.0011429008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015703741,0.00019028463,0.00021501316,0.00044538398,0.00045283805,0.0007553901,0.0005397769,0.00031546576,0.0018290317],"category_scores_gemma":[0.008581366,0.0001489248,0.0007726188,0.000721926,0.00031122498,0.00053587323,0.0008637712,0.00075987476,0.00009296429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033159173,0.000014804674,0.9990761,0.000002515543,0.000041315143,0.000013966066,0.000026821022,0.00011801227,0.000012771741,0.00000889595,0.000052185907,0.0005993364],"study_design_scores_gemma":[0.0000049173414,0.00006436182,0.9984825,0.000009423983,0.000047917983,0.00011149056,0.00021008628,0.000897748,0.000033973207,0.000042563654,0.00009042784,0.0000045926017],"about_ca_topic_score_codex":0.01489031,"about_ca_topic_score_gemma":0.014994283,"teacher_disagreement_score":0.01489031,"about_ca_system_score_codex":0.0010040791,"about_ca_system_score_gemma":0.0011453944,"threshold_uncertainty_score":0.029607296},"labels":[],"label_agreement":null},{"id":"W2984531433","doi":"10.6004/jnccn.2019.0029","title":"NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); Amgen (Canada)","funders":"National Comprehensive Cancer Network","keywords":"Medicine; Follicular lymphoma; Oncology; Lymphoma; Internal medicine; Refractory (planetary science); Diffuse large B-cell lymphoma; Cancer research; Biology","score_opus":0.054509489926656274,"score_gpt":0.3547670538761647,"score_spread":0.3002575639495084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984531433","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046227495,0.109100066,0.019443324,0.25533497,0.02640546,0.0063328887,0.087904096,0.009672017,0.4811844],"genre_scores_gemma":[0.030412236,0.1281034,0.10223055,0.18275245,0.012879738,0.012760629,0.22129707,0.006036832,0.30352712],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99338067,0.0021381816,0.0014575243,0.0001945321,0.0023956124,0.00043352015],"domain_scores_gemma":[0.98036605,0.004578357,0.002532393,0.0007242821,0.010117765,0.0016810548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062482837,0.0008450848,0.0012562355,0.0036459835,0.0009404195,0.0033128478,0.0035451471,0.0051309066,0.03280199],"category_scores_gemma":[0.030429557,0.0009990341,0.0013087833,0.00420522,0.0010702228,0.0018959399,0.0020001307,0.0045554256,0.025554419],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000640828,0.00003716252,0.00045496342,0.00062928343,0.000014778453,0.00013178878,0.000045370838,0.0002865169,0.00020030355,0.0016073238,0.94505525,0.0514732],"study_design_scores_gemma":[0.00013218194,0.000041261428,0.001817093,0.0020792107,0.00003311587,0.00043629928,0.000055761793,0.00033435386,0.00020082356,0.0015754503,0.9932637,0.000030720843],"about_ca_topic_score_codex":0.03211144,"about_ca_topic_score_gemma":0.08486043,"teacher_disagreement_score":0.03280199,"about_ca_system_score_codex":0.0034343794,"about_ca_system_score_gemma":0.013043655,"threshold_uncertainty_score":0.10973358},"labels":[],"label_agreement":null},{"id":"W2985558334","doi":"10.6004/jnccn.2019.0039","title":"NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":332,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"Genentech; Puma Biotechnology; Clovis Oncology; Eisai; National Comprehensive Cancer Network; Gilead Sciences; Novartis Pharmaceuticals Corporation; Biogen; Celgene; Bristol-Myers Squibb; AstraZeneca; Genomic Health; Amgen","keywords":"Medicine; Bevacizumab; Ovarian cancer; Chemotherapy; Oncology; Cytoreductive surgery; Internal medicine; Disease; Cancer; Hyperthermic intraperitoneal chemotherapy; Intensive care medicine","score_opus":0.05275035830377755,"score_gpt":0.3485380236263211,"score_spread":0.2957876653225435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985558334","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003827252,0.09506511,0.012911258,0.23329866,0.022122746,0.008323617,0.18461318,0.0052318093,0.43460637],"genre_scores_gemma":[0.02806801,0.12816101,0.06884464,0.15424034,0.010811219,0.019560633,0.3484076,0.004519345,0.23738724],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99514896,0.0015415965,0.0011479951,0.00016158742,0.001660327,0.00033946545],"domain_scores_gemma":[0.98426247,0.0041939374,0.0025853235,0.00050108816,0.0074170255,0.001040259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043858523,0.0008123368,0.001112284,0.0038687272,0.000924257,0.0027348695,0.002548989,0.0045111305,0.04687359],"category_scores_gemma":[0.03550039,0.0008418743,0.0012673711,0.004674398,0.00091151224,0.0017763444,0.0021357832,0.0041195764,0.025609769],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057076195,0.000030195335,0.0005060279,0.000933152,0.000015581309,0.00009518049,0.000054387845,0.0002725681,0.000115606694,0.0020791849,0.9531558,0.04268529],"study_design_scores_gemma":[0.00017856971,0.000031305353,0.0020022236,0.0032351934,0.00002878928,0.0003133231,0.00006145094,0.00022293579,0.00010810884,0.0023942557,0.9913931,0.000030737177],"about_ca_topic_score_codex":0.031012021,"about_ca_topic_score_gemma":0.06976656,"teacher_disagreement_score":0.04687359,"about_ca_system_score_codex":0.0029709535,"about_ca_system_score_gemma":0.012936854,"threshold_uncertainty_score":0.15680784},"labels":[],"label_agreement":null},{"id":"W2986820418","doi":"10.6004/jnccn.2019.7319","title":"Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Logistic regression; Odds ratio; Internal medicine; Palliative care; Genitourinary system; Cancer; Guideline; Bladder cancer; Oncology; Emergency medicine; Nursing","score_opus":0.03137088782638336,"score_gpt":0.3416066677829699,"score_spread":0.3102357799565865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986820418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997695,0.0005040062,0.00005752564,0.0007210889,0.000008124792,0.000008994422,0.0004379625,0.000002734895,0.00056460605],"genre_scores_gemma":[0.9992865,0.00023597645,0.00004819167,0.00006180066,0.00001025204,0.000008732491,0.00029679993,0.0000013841931,0.000050386905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926525,0.00018199522,0.00012071291,0.00011880607,0.00013959396,0.00017367695],"domain_scores_gemma":[0.9951042,0.000652396,0.0032050333,0.00007324482,0.000383237,0.00058185623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059358,0.000097857795,0.00019554675,0.0007023655,0.00043195483,0.0006847976,0.00045559485,0.0003301562,0.0016071514],"category_scores_gemma":[0.0055622575,0.00013908115,0.00047471895,0.001320196,0.00027296954,0.00061909563,0.00074021384,0.00076826365,0.00009352776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022498043,0.000021266496,0.99762577,0.000022045728,0.000035181904,0.000033519555,0.00025854184,0.00006273407,0.000032508782,0.000061632265,0.00028883884,0.0015354921],"study_design_scores_gemma":[0.0000019223714,0.000018001845,0.9983736,0.000030538584,0.000008259266,0.000072314375,0.00094255345,0.00024892646,0.000014935203,0.00003057723,0.0002547703,0.0000034422521],"about_ca_topic_score_codex":0.025298415,"about_ca_topic_score_gemma":0.041632902,"teacher_disagreement_score":0.025298415,"about_ca_system_score_codex":0.0011733683,"about_ca_system_score_gemma":0.0014339335,"threshold_uncertainty_score":0.050302327},"labels":[],"label_agreement":null},{"id":"W2994498882","doi":"10.6004/jnccn.2019.7333","title":"Are Surrogate Endpoints Unbiased Metrics in Clinical Benefit Scores of the ASCO Value Framework?","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Canadian Agency for Drugs and Technologies in Health; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Surrogate endpoint; Hazard ratio; Internal medicine; Clinical endpoint; Randomized controlled trial; Clinical trial; Progression-free survival; Overall survival; Oncology; Confidence interval","score_opus":0.39117253971620003,"score_gpt":0.47214923265836745,"score_spread":0.08097669294216742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994498882","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24522685,0.05336229,0.6496274,0.02164339,0.0013464704,0.0015203158,0.0038887563,0.0003644574,0.023020143],"genre_scores_gemma":[0.88967067,0.0022794914,0.10195538,0.0027691687,0.00062750373,0.0011649401,0.0010785314,0.00012916586,0.00032516394],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.851492,0.11516494,0.008299989,0.0057650493,0.017946117,0.001331829],"domain_scores_gemma":[0.6193419,0.28496316,0.050551344,0.017477496,0.025376914,0.0022892398],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17100784,0.0011782213,0.0021919508,0.004079643,0.00056307093,0.0048684822,0.0014470401,0.0012289557,0.0022195354],"category_scores_gemma":[0.42763278,0.00054909254,0.0021502841,0.0036489328,0.0035105841,0.0043272553,0.003107407,0.0031384274,0.0005358439],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003876758,0.00027182073,0.29450992,0.00232606,0.005212461,0.00017793383,0.0019992576,0.036916193,0.00080008514,0.13252863,0.018273404,0.50310755],"study_design_scores_gemma":[0.0014881147,0.004018759,0.17257732,0.0051650577,0.00248935,0.0008974719,0.0012619697,0.17827566,0.00316543,0.572966,0.05714294,0.0005519871],"about_ca_topic_score_codex":0.001832457,"about_ca_topic_score_gemma":0.0016627176,"teacher_disagreement_score":0.8289921,"about_ca_system_score_codex":0.003478145,"about_ca_system_score_gemma":0.0036698896,"threshold_uncertainty_score":0.9043867},"labels":[],"label_agreement":null},{"id":"W2999289987","doi":"10.6004/jnccn.2019.7350","title":"Conditional Survival of Patients With Nonmetastatic Renal Cell Carcinoma: How Cancer-Specific Mortality Changes After Nephrectomy","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Surgical Specialties (Canada)","funders":"Università degli Studi di Brescia","keywords":"Medicine; Renal cell carcinoma; Proportional hazards model; Nephrectomy; Stage (stratigraphy); Internal medicine; Kidney cancer; Cancer; Oncology; T-stage; Surgery; Kidney","score_opus":0.057162086944132565,"score_gpt":0.27677181937038,"score_spread":0.21960973242624743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999289987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800307,0.00033063767,0.00050020736,0.00014999912,0.0000065942418,0.0000033139277,0.00065764936,0.000008277267,0.0003404082],"genre_scores_gemma":[0.99938357,0.000042137108,0.00005016835,0.000012585942,0.0000069589414,0.0000016289229,0.00047003126,0.0000014410442,0.000031611467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936813,0.0002348386,0.00005682796,0.00016294369,0.0000647992,0.00011250842],"domain_scores_gemma":[0.9947931,0.0019465876,0.002163006,0.0003882728,0.0002961314,0.00041283818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016418135,0.00017954271,0.00021464385,0.00050230726,0.00016375066,0.00049797475,0.00036644246,0.00022175549,0.0013111501],"category_scores_gemma":[0.0077301413,0.00010491849,0.0006892104,0.0006382704,0.0002904174,0.00075430324,0.00052976416,0.0005441832,0.0001164789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017962015,0.000008672169,0.9965481,0.000010276136,0.00009819085,0.000016567652,0.000031308857,0.00065969676,0.00007982601,0.00009936838,0.00012329311,0.002145066],"study_design_scores_gemma":[0.0000033765932,0.000068553556,0.9962658,0.000006976609,0.00006590901,0.00007368658,0.000069210124,0.0029866202,0.00009173845,0.00022735973,0.00013411028,0.0000065620166],"about_ca_topic_score_codex":0.0053588846,"about_ca_topic_score_gemma":0.0062493887,"teacher_disagreement_score":0.0053588846,"about_ca_system_score_codex":0.00039982973,"about_ca_system_score_gemma":0.00038207675,"threshold_uncertainty_score":0.0106553435},"labels":[],"label_agreement":null},{"id":"W2999610977","doi":"10.6004/jnccn.2019.7342","title":"High-Cost Patients and Preventable Spending: A Population-Based Study","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Canadian Partnership Against Cancer; Health Sciences Centre; CARE Canada; University of Toronto; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Centre for Addiction and Mental Health","funders":"","keywords":"Medicine; Cancer; Emergency department; Population; Emergency medicine; Pancreatic cancer; Prostate cancer; Colorectal cancer; Health care; Internal medicine; Environmental health","score_opus":0.06240826885090329,"score_gpt":0.27654871673092896,"score_spread":0.21414044788002567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999610977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739695,0.00021448606,0.000030589123,0.00012702523,0.0000036602964,0.000021445343,0.0014774557,0.0000018905868,0.0007264528],"genre_scores_gemma":[0.9990004,0.00014471699,0.000028907012,0.00004893913,0.000007881964,0.000013940205,0.00066662923,0.0000011428693,0.00008758623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993892,0.000094013645,0.000050636037,0.000098841665,0.00018337401,0.00018400307],"domain_scores_gemma":[0.99832994,0.00012504436,0.00084834156,0.00008025845,0.00025526452,0.00036115648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005021096,0.00026393245,0.00031470487,0.0011334874,0.0009973984,0.0011242363,0.00061532843,0.00053678243,0.0016853712],"category_scores_gemma":[0.0020004963,0.00031487414,0.0006194935,0.0035566185,0.0005482683,0.00076896715,0.0007149963,0.0007095791,0.00021134704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018148972,0.000020318133,0.9993425,0.000005783581,0.00002595385,0.000022625458,0.00010817138,0.000013481924,0.000012925231,0.000013423781,0.00016183857,0.0002547922],"study_design_scores_gemma":[0.0000036174279,0.000017894467,0.9994535,0.0000063268253,0.000011776724,0.00004023119,0.00024883807,0.000048268772,0.00000306076,0.000008803324,0.00015536732,0.0000022818137],"about_ca_topic_score_codex":0.43825457,"about_ca_topic_score_gemma":0.53471094,"teacher_disagreement_score":0.43825457,"about_ca_system_score_codex":0.004310847,"about_ca_system_score_gemma":0.0028783167,"threshold_uncertainty_score":0.8714073},"labels":[],"label_agreement":null},{"id":"W3000286044","doi":"10.6004/jnccn.2019.7345","title":"Response Rates and Durations of Response for Biomarker-Based Cancer Drugs in Nonrandomized Versus Randomized Trials","year":2020,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Randomized controlled trial; Relative risk; Meta-analysis; Pharmacogenomics; Confidence interval; Biomarker; Internal medicine; Oncology; Pharmacology","score_opus":0.7160078237002326,"score_gpt":0.6306847045581461,"score_spread":0.08532311914208657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000286044","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23248506,0.5628092,0.14531733,0.008395078,0.0046435585,0.019609936,0.018542647,0.0007483346,0.007448789],"genre_scores_gemma":[0.9100596,0.016280103,0.043270633,0.0035245281,0.00115892,0.020739308,0.0038561693,0.00021057733,0.0009001206],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.43013218,0.41980186,0.09397611,0.0343137,0.019970352,0.0018057829],"domain_scores_gemma":[0.25350267,0.62123036,0.091019705,0.025314935,0.007995315,0.00093694654],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.36225152,0.0022881767,0.008712999,0.005884206,0.0007318534,0.00409894,0.0028266136,0.0033721304,0.004688024],"category_scores_gemma":[0.5460255,0.0014786497,0.035938773,0.0059223296,0.0037217387,0.005523054,0.0026312224,0.004495161,0.0005369807],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0569395,0.00037996806,0.17990468,0.08963669,0.5915701,0.0004906865,0.0010212561,0.0064895796,0.0011633107,0.0070754816,0.0040845005,0.061244313],"study_design_scores_gemma":[0.052426483,0.013331442,0.19086687,0.028492924,0.6120691,0.0020931778,0.00095775747,0.020044604,0.004971079,0.04656062,0.027424406,0.00076158793],"about_ca_topic_score_codex":0.00091353594,"about_ca_topic_score_gemma":0.0010293737,"teacher_disagreement_score":0.6377485,"about_ca_system_score_codex":0.0027853572,"about_ca_system_score_gemma":0.002501962,"threshold_uncertainty_score":0.7864574},"labels":[],"label_agreement":null},{"id":"W3009190269","doi":"10.6004/jnccn.2019.7355","title":"Screening Tool Identifies Older Adults With Cancer at Risk for Poor Outcomes","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Frailty in Older Adults","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Quality of life (healthcare); Depression (economics); Internal medicine; Cancer","score_opus":0.04537247242861947,"score_gpt":0.3190493510386566,"score_spread":0.27367687861003714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009190269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958852,0.0004646239,0.00015103714,0.0003972239,0.000024068444,0.00008695023,0.0010682723,0.000016200263,0.0019063428],"genre_scores_gemma":[0.9981927,0.00020102735,0.00042330936,0.000115454386,0.000020584512,0.000057308695,0.0007734125,0.0000016716369,0.00021459722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999653,0.00010146728,0.00006707813,0.000038761133,0.00006667333,0.00007309642],"domain_scores_gemma":[0.99814546,0.00033132065,0.00096617104,0.00004084965,0.00018102296,0.00033516763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081249553,0.0003289717,0.00036667136,0.0013434016,0.00037265173,0.00054185383,0.00023075895,0.00045729455,0.0023296103],"category_scores_gemma":[0.004578521,0.0001268312,0.00059397274,0.00080833695,0.00015497011,0.0004797045,0.0007669211,0.0004562233,0.00031384375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004912076,0.0000327948,0.99646497,0.000019465517,0.000018204206,0.000030506408,0.000039534814,0.000020714237,0.0000481238,0.000009679234,0.00036023936,0.0029064897],"study_design_scores_gemma":[0.00001051137,0.0001284096,0.9988123,0.000030476838,0.00003005586,0.00016646225,0.0001411878,0.00022650417,0.000040201277,0.000037576458,0.00037204172,0.000004286872],"about_ca_topic_score_codex":0.0021661073,"about_ca_topic_score_gemma":0.006463894,"teacher_disagreement_score":0.0023296103,"about_ca_system_score_codex":0.00023887742,"about_ca_system_score_gemma":0.00044174914,"threshold_uncertainty_score":0.007793367},"labels":[],"label_agreement":null},{"id":"W3009260200","doi":"10.6004/jnccn.2019.7361","title":"Benefits of High-Volume Medical Oncology Care for Noncurable Pancreatic Adenocarcinoma: A Population-Based Analysis","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; University of Manitoba; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Oncology; Adenocarcinoma; Volume (thermodynamics); Internal medicine; Cancer","score_opus":0.061142501798275815,"score_gpt":0.36747636222363167,"score_spread":0.3063338604253559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009260200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651366,0.00056221586,0.00028229636,0.00018918098,0.000016877746,0.000020076815,0.0020634802,0.000009525547,0.00034266524],"genre_scores_gemma":[0.9986965,0.000111533176,0.00013632997,0.000042935946,0.00001785404,0.000016278784,0.00089730695,0.0000041329918,0.000077129414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798644,0.0006830406,0.00020112137,0.00057014416,0.0003108737,0.00024833993],"domain_scores_gemma":[0.9952123,0.0010794362,0.0022330994,0.00055576273,0.00038508239,0.0005341976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022954054,0.00033138634,0.00038863052,0.0013153884,0.00048207393,0.001076353,0.0008311103,0.0006401702,0.0018945164],"category_scores_gemma":[0.006573575,0.00041440103,0.0022509166,0.0021636772,0.00028962604,0.0007310072,0.0010140067,0.0012027445,0.00020619095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095938354,0.000025368267,0.9983931,0.000010417661,0.00043367446,0.000028460301,0.000034987475,0.00008365897,0.000032501226,0.00002699825,0.00019961412,0.0006352112],"study_design_scores_gemma":[0.00001890513,0.0000748201,0.9981102,0.000012343687,0.00027136903,0.00014067127,0.00018368,0.00083093456,0.000025940248,0.000057533995,0.00026765605,0.0000058531523],"about_ca_topic_score_codex":0.013243844,"about_ca_topic_score_gemma":0.01761183,"teacher_disagreement_score":0.013243844,"about_ca_system_score_codex":0.00079103536,"about_ca_system_score_gemma":0.00080649427,"threshold_uncertainty_score":0.02633351},"labels":[],"label_agreement":null},{"id":"W3010095527","doi":"10.6004/jnccn.2019.7362","title":"Quantifying the Survival Benefits of Oncology Drugs With a Focus on Immunotherapy Using Restricted Mean Survival Time","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Canadian Centre for Applied Research in Cancer Control","keywords":"Medicine; Immunotherapy; Oncology; Internal medicine; Survival analysis; Cancer","score_opus":0.1235603526455778,"score_gpt":0.30638243455030495,"score_spread":0.18282208190472715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010095527","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041079454,0.9198778,0.027370036,0.0024560688,0.0007059451,0.000857918,0.0045685424,0.0001378697,0.0029463002],"genre_scores_gemma":[0.8311746,0.1383151,0.020539504,0.0027413906,0.0010645792,0.002498408,0.002647145,0.000109106724,0.0009101583],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9598155,0.0291418,0.0046405913,0.003184276,0.0028918905,0.00032585126],"domain_scores_gemma":[0.880977,0.10243062,0.011729293,0.0030877632,0.0015020403,0.00027328386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05261803,0.0024926732,0.00707246,0.0053285672,0.00028091713,0.0026630447,0.0013905201,0.0014231753,0.0026015467],"category_scores_gemma":[0.078385174,0.0007731373,0.03276865,0.004517772,0.0013261422,0.0026484684,0.0013848909,0.0029099984,0.00022739434],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008393594,0.00011687496,0.02542373,0.099325344,0.7575565,0.00010529832,0.00014383544,0.021997068,0.00090092595,0.0039299014,0.0017092054,0.08039775],"study_design_scores_gemma":[0.003457992,0.0029501512,0.03383818,0.016634371,0.8969863,0.00050719007,0.00013900905,0.008285792,0.0020811216,0.018547004,0.016402269,0.00017063152],"about_ca_topic_score_codex":0.001983607,"about_ca_topic_score_gemma":0.0023546864,"teacher_disagreement_score":0.05261803,"about_ca_system_score_codex":0.0021845524,"about_ca_system_score_gemma":0.0017634413,"threshold_uncertainty_score":0.27827406},"labels":[],"label_agreement":null},{"id":"W3011832439","doi":"10.6004/jnccn.2019.7502","title":"CLO20-051: LYMPHA: Eliminating the Burden of Lymphedema in Cancer Patients Requiring Nodal Dissections. A Pilot Study","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Lymphedema; NODAL; Cancer; Surgery; Oncology; General surgery; Internal medicine; Breast cancer","score_opus":0.09105522967383024,"score_gpt":0.35077567840027735,"score_spread":0.2597204487264471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011832439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701214,0.0003747296,0.00013531095,0.00029949332,0.000053216125,0.00078948366,0.00038212302,0.000029168457,0.0009241687],"genre_scores_gemma":[0.9932508,0.00092424947,0.0008017156,0.0006478,0.00023438947,0.0012979546,0.0011033181,0.000023895029,0.0017158166],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99939084,0.00029794863,0.000019921357,0.00006724183,0.000050203373,0.00017389054],"domain_scores_gemma":[0.9989542,0.00026348943,0.00010037564,0.000069401445,0.00006083094,0.0005517272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001750516,0.0009676713,0.00098461,0.00038899557,0.00060007523,0.0007901814,0.00071349676,0.000986487,0.0066602887],"category_scores_gemma":[0.0013861081,0.00035548743,0.0010586381,0.00036541247,0.0010059319,0.000774916,0.0005409257,0.0017982775,0.00078867236],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48554987,0.35888103,0.01732469,0.0006109988,0.0007588449,0.00043971336,0.00037396437,0.00092393736,0.04015903,0.00034332645,0.0038281663,0.0908065],"study_design_scores_gemma":[0.077974774,0.89821273,0.0197848,0.00001653854,0.00028037935,0.00012846121,0.00013248592,0.00042601748,0.001753895,0.00006347923,0.0012094427,0.000016902459],"about_ca_topic_score_codex":0.0036282437,"about_ca_topic_score_gemma":0.0053056683,"teacher_disagreement_score":0.0066602887,"about_ca_system_score_codex":0.00077210396,"about_ca_system_score_gemma":0.0022121302,"threshold_uncertainty_score":0.022280872},"labels":[],"label_agreement":null},{"id":"W3012039566","doi":"10.6004/jnccn.2019.7402","title":"CLO20-047: Impact of Treating Physician on Late Treatment Related Morbidity – a Secondary Analysis of a Phase III Randomized Controlled Study in Localized Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Prostate cancer; Randomized controlled trial; Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.04619140862045137,"score_gpt":0.32973219559117256,"score_spread":0.2835407869707212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012039566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9492727,0.012734752,0.0018973993,0.0032790154,0.0013110221,0.014524265,0.009538326,0.0003378606,0.007104721],"genre_scores_gemma":[0.960682,0.006284268,0.0034926988,0.0043700417,0.0014742434,0.008850723,0.0069908686,0.000102535625,0.007752539],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9974107,0.0019353756,0.00010526238,0.00017704064,0.00017028122,0.00020140698],"domain_scores_gemma":[0.99650854,0.0014052625,0.0009231814,0.00017771561,0.00036451037,0.00062087964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004162349,0.0013561718,0.0024491863,0.000583445,0.00041461247,0.0010468015,0.001196954,0.002001195,0.010068676],"category_scores_gemma":[0.004690051,0.00043639657,0.0042116963,0.00067564455,0.00079628214,0.0006362755,0.00046601196,0.0029844474,0.0009950034],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9607592,0.0068597333,0.00088596466,0.001631479,0.0042454153,0.00006190935,0.000031287596,0.00048388267,0.002175819,0.00015080752,0.0036451211,0.019069327],"study_design_scores_gemma":[0.9350488,0.058003925,0.0029007867,0.000072083436,0.002325815,0.000021440606,0.000016716698,0.0003687286,0.00040015244,0.0000834232,0.0007404173,0.000017683955],"about_ca_topic_score_codex":0.0032795896,"about_ca_topic_score_gemma":0.006639927,"teacher_disagreement_score":0.010068676,"about_ca_system_score_codex":0.0009004458,"about_ca_system_score_gemma":0.0022319772,"threshold_uncertainty_score":0.03368312},"labels":[],"label_agreement":null},{"id":"W3022049138","doi":"10.6004/jnccn.2020.7531","title":"Letter to the Editor: Radiation for Prior DCIS is a Risk Factor for Death From Invasive Breast Cancer","year":2020,"lang":"en","type":"letter","venue":"Journal of the National Comprehensive Cancer Network","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Oncology; Risk factor; Cancer; Internal medicine","score_opus":0.030119963393945893,"score_gpt":0.2949070088732546,"score_spread":0.2647870454793087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022049138","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012846194,0.0020560117,0.00015475885,0.94217575,0.052598644,0.0000141065175,0.00017315384,0.00006100176,0.0014819739],"genre_scores_gemma":[0.01769272,0.0033527203,0.00042069604,0.7641947,0.20810115,0.000057543333,0.0001411113,0.00006269939,0.005976665],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99803215,0.0008376558,0.0002824131,0.0002718635,0.00040452264,0.00017135838],"domain_scores_gemma":[0.99070483,0.005220547,0.0005824171,0.00026751703,0.0023100274,0.00091458234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025923538,0.0007823664,0.0018175729,0.00076907926,0.0014374028,0.0018651551,0.0020253824,0.013725793,0.0045308634],"category_scores_gemma":[0.023759961,0.000587021,0.00075422454,0.00079189474,0.0010806621,0.0022556516,0.0005781526,0.014951426,0.005258495],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001059223,0.00004462246,0.0014252452,0.000090278874,0.000028036307,0.002539562,0.00007116552,0.000055006454,0.00012767765,0.00037481377,0.9884748,0.0066629834],"study_design_scores_gemma":[0.00039779913,0.000311774,0.008284685,0.00078613765,0.00021808884,0.021579385,0.00079437386,0.0023480637,0.0010827078,0.0062565943,0.95775026,0.00019015626],"about_ca_topic_score_codex":0.001450722,"about_ca_topic_score_gemma":0.0017961689,"teacher_disagreement_score":0.013725793,"about_ca_system_score_codex":0.0016163536,"about_ca_system_score_gemma":0.0016542982,"threshold_uncertainty_score":0.015157282},"labels":[],"label_agreement":null},{"id":"W3023660975","doi":"10.6004/jnccn.2019.7382","title":"Outcomes of Patients With Advanced Gastrointestinal Cancer in Relationship to Opioid Use: Findings From Eight Clinical Trials","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Logistic regression; Odds ratio; Proportional hazards model; Clinical trial; Hazard ratio; Opioid; Colorectal cancer; Oncology; Confidence interval; Cancer; Surgery","score_opus":0.13150185525282418,"score_gpt":0.40005083265567326,"score_spread":0.2685489774028491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023660975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76564354,0.21949796,0.0011553623,0.0038027663,0.00020211512,0.0012196724,0.0054719374,0.00002889487,0.0029777116],"genre_scores_gemma":[0.96196663,0.030136924,0.0014073149,0.0019440718,0.00022204613,0.0015146093,0.0026355644,0.000017465813,0.00015540513],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9648373,0.017985908,0.009666838,0.0024534378,0.0042467574,0.0008096662],"domain_scores_gemma":[0.8460813,0.0863996,0.054964863,0.003909377,0.0069353445,0.0017094098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032563236,0.00042449674,0.0019853513,0.0013347905,0.00063082995,0.0022003958,0.0008944555,0.00085876766,0.0012018844],"category_scores_gemma":[0.08850858,0.00035882383,0.0035791611,0.0041813403,0.00084283546,0.0016770541,0.0014299952,0.0015195986,0.00014530217],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032026734,0.00061730057,0.81078166,0.020895934,0.04129319,0.00023381448,0.00082754856,0.000764155,0.0009842009,0.0004983159,0.0035247153,0.08755249],"study_design_scores_gemma":[0.010170047,0.008120468,0.8947923,0.010101128,0.055600002,0.001244069,0.0011374168,0.00077038456,0.001095166,0.00128583,0.015543953,0.00013933795],"about_ca_topic_score_codex":0.001037642,"about_ca_topic_score_gemma":0.0026242489,"teacher_disagreement_score":0.032563236,"about_ca_system_score_codex":0.001236084,"about_ca_system_score_gemma":0.002359718,"threshold_uncertainty_score":0.1722129},"labels":[],"label_agreement":null},{"id":"W3033313243","doi":"10.6004/jnccn.2019.7385","title":"Functional Impairment, Symptom Burden, and Clinical Outcomes Among Hospitalized Patients With Advanced Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Massachusetts General Hospital","keywords":"Medicine; Functional impairment; Activities of daily living; Observational study; Anxiety; Depression (economics); Physical therapy; Bathing; Cancer; Internal medicine; Psychiatry","score_opus":0.03003977940645467,"score_gpt":0.3165171157196245,"score_spread":0.2864773363131698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033313243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988813,0.00038716866,0.000029103438,0.00012797455,0.0000061454502,0.000006936446,0.00031373763,0.0000016619518,0.0002460489],"genre_scores_gemma":[0.99943477,0.0001266295,0.00003069831,0.000033808483,0.000012349063,0.000007065575,0.000320025,4.8377774e-7,0.000034125027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994266,0.00015571306,0.00009293805,0.000084354266,0.00013560179,0.00010487692],"domain_scores_gemma":[0.99706084,0.00034056118,0.0017357012,0.00006361786,0.00024246013,0.00055678416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080385874,0.00021439003,0.00032098332,0.0006464195,0.00042658282,0.0006170086,0.0003186177,0.00027597128,0.0011391102],"category_scores_gemma":[0.0038676122,0.0001561593,0.0003135172,0.0011172763,0.00031035623,0.00052179565,0.0005823952,0.0007104537,0.00010328437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022354954,0.000021602358,0.99934524,0.0000067943015,0.000015888405,0.000013044728,0.000024657706,0.000017924516,0.000012143275,0.0000033573085,0.000064939995,0.0004520069],"study_design_scores_gemma":[0.0000033112094,0.00004273004,0.99966395,0.0000069906173,0.000009629192,0.00004875746,0.000074109324,0.00008828288,0.000008008578,0.000009664318,0.000043149284,0.0000014540042],"about_ca_topic_score_codex":0.008285962,"about_ca_topic_score_gemma":0.011111916,"teacher_disagreement_score":0.008285962,"about_ca_system_score_codex":0.00063826883,"about_ca_system_score_gemma":0.00058946636,"threshold_uncertainty_score":0.016475499},"labels":[],"label_agreement":null},{"id":"W3088958758","doi":"10.6004/jnccn.2020.7609","title":"Adjuvant Treatment of Early Ovarian Clear Cell Carcinoma: A Population-Based Study of Whole Abdominal Versus Pelvic Nodal Radiotherapy","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"Sanofi","keywords":"Medicine; Internal medicine; Radiation therapy; Hazard ratio; Stage (stratigraphy); Population; Oncology; Chemoradiotherapy; Surgery; Confidence interval","score_opus":0.046528856390585134,"score_gpt":0.32332312424064363,"score_spread":0.2767942678500585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088958758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989806,0.00057813706,0.00006619552,0.000047929272,0.0000075489556,0.000015981597,0.00010515584,0.0000015204098,0.00019700857],"genre_scores_gemma":[0.99964356,0.00014660618,0.000022494347,0.000033192533,0.000013867764,0.0000092437485,0.00009013008,0.0000010920259,0.00003976576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871635,0.0006412772,0.00008437363,0.00023405961,0.00020674076,0.0001172752],"domain_scores_gemma":[0.99799347,0.00073795323,0.0006607858,0.00016637194,0.00016048829,0.0002810121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018972803,0.0002133606,0.0005409533,0.0005115687,0.00036889457,0.0006969164,0.0003596168,0.0007097326,0.00087885896],"category_scores_gemma":[0.004771043,0.0002757585,0.00081149314,0.00091608067,0.00037279812,0.00048943097,0.00042959652,0.00071244396,0.0001557113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011937637,0.00019500942,0.99566513,0.000024251807,0.0003625065,0.000052909883,0.00009963992,0.0000702648,0.00019378362,0.00001674803,0.00008053411,0.0020455255],"study_design_scores_gemma":[0.0001623271,0.0012999316,0.99698883,0.000012544952,0.00031437693,0.0002497953,0.00025472697,0.00028750525,0.000055898425,0.00004204909,0.00032476676,0.0000073238216],"about_ca_topic_score_codex":0.002751152,"about_ca_topic_score_gemma":0.0028220238,"teacher_disagreement_score":0.002751152,"about_ca_system_score_codex":0.0003334749,"about_ca_system_score_gemma":0.0004301216,"threshold_uncertainty_score":0.010033846},"labels":[],"label_agreement":null},{"id":"W3092516330","doi":"10.6004/jnccn.2020.7627","title":"Treatment Outcomes in Chronic Myeloid Leukemia: Does One Size Fit All?","year":2020,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Discontinuation; Adverse effect; Myeloid leukemia; Intensive care medicine; Population; Disease; Quality of life (healthcare); Oncology; Internal medicine","score_opus":0.10120312174648217,"score_gpt":0.38201367040170936,"score_spread":0.2808105486552272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092516330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000560812,0.9987637,0.000022168057,0.0007793756,0.000109437955,0.0000021491685,0.00000759248,0.000001691354,0.00025790095],"genre_scores_gemma":[0.0010684797,0.99794275,0.00006096712,0.0006408644,0.00015732454,0.000005486658,0.000013132834,0.0000010467397,0.000109902736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994204,0.00021174077,0.000099895515,0.000054804987,0.00017135487,0.00004187474],"domain_scores_gemma":[0.998541,0.0010135823,0.0001915326,0.000022482074,0.0001829645,0.000048440925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001551638,0.0005557728,0.0021066712,0.0012532144,0.00023661136,0.0012249605,0.0011731164,0.0013756499,0.0028341706],"category_scores_gemma":[0.0034665337,0.00020642877,0.0009968987,0.0016590158,0.000517804,0.0017775606,0.00058416225,0.0018974673,0.0005561607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014107277,0.000042073334,0.00031772675,0.038243726,0.00034720945,0.0000996469,0.00008248014,0.00021740675,0.0001246807,0.0044849105,0.032635428,0.9232636],"study_design_scores_gemma":[0.00014451836,0.00030388366,0.0035984872,0.09394116,0.001504337,0.0018354874,0.000359479,0.00026697604,0.00013102197,0.009448798,0.88842404,0.000041924013],"about_ca_topic_score_codex":0.0018955807,"about_ca_topic_score_gemma":0.0037911043,"teacher_disagreement_score":0.0028341706,"about_ca_system_score_codex":0.00089721626,"about_ca_system_score_gemma":0.0017508675,"threshold_uncertainty_score":0.009481251},"labels":[],"label_agreement":null},{"id":"W3092523695","doi":"10.6004/jnccn.2020.7576","title":"Contemporary Population-Based Analysis of Bone Mineral Density Testing in Men Initiating Androgen Deprivation Therapy for Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Bone health and treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Internal medicine; Osteoporosis; Bone mineral; Odds ratio; Cohort; Population; Oncology; Cancer","score_opus":0.11882753218401561,"score_gpt":0.36403795378129095,"score_spread":0.24521042159727535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092523695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98838633,0.00127663,0.00047255115,0.0003605443,0.000016430866,0.00004963452,0.008288103,0.000028058459,0.0011217749],"genre_scores_gemma":[0.99790394,0.00013510163,0.0001296141,0.00009448116,0.0000101959395,0.000019222398,0.0015714951,0.000002548941,0.00013332482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985677,0.00030134092,0.00009495044,0.00043759606,0.00033468386,0.0002635714],"domain_scores_gemma":[0.9958313,0.00066881714,0.001542761,0.00032739504,0.001122023,0.0005075913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016924774,0.00029582565,0.00048141446,0.0012328734,0.0009361125,0.0010421943,0.0010282393,0.00067519484,0.0022524558],"category_scores_gemma":[0.0048025525,0.00027373055,0.0007898457,0.0035362474,0.0005125737,0.00043930238,0.00056402036,0.0008445659,0.00022885183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004160581,0.000011348402,0.9983506,0.000009904163,0.0000845889,0.000018028953,0.000049332175,0.00008121131,0.00004456315,0.000021964504,0.00038124897,0.0009056096],"study_design_scores_gemma":[0.000006192235,0.000021365931,0.9988494,0.000009045722,0.000035942146,0.000045212917,0.000112124806,0.0005542276,0.000014500144,0.000013668067,0.00033344448,0.0000048720403],"about_ca_topic_score_codex":0.77028,"about_ca_topic_score_gemma":0.7309222,"teacher_disagreement_score":0.77028,"about_ca_system_score_codex":0.006322939,"about_ca_system_score_gemma":0.0037753165,"threshold_uncertainty_score":0.4621457},"labels":[],"label_agreement":null},{"id":"W3092544457","doi":"10.6004/jnccn.2020.7577","title":"Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN Guidelines","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Medicine; Chromophobe cell; Nephrectomy; Clear cell; Renal cell carcinoma; Urology; Clear cell carcinoma; Internal medicine; Pathology; Kidney; Carcinoma","score_opus":0.12549440038722112,"score_gpt":0.3378301358079551,"score_spread":0.212335735420734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092544457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469817,0.0022256891,0.00022142082,0.00016387494,0.000016095199,0.000060002178,0.00093278114,0.0000072435582,0.001674698],"genre_scores_gemma":[0.9979578,0.0006031601,0.0002421798,0.00007492241,0.000016696307,0.00002545094,0.0009990494,0.000004012081,0.000076897784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805045,0.0005667237,0.0003417799,0.00029947318,0.0005866432,0.00015490498],"domain_scores_gemma":[0.9916583,0.0020492447,0.003887706,0.0006270372,0.0012178163,0.0005598005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031681964,0.0001604638,0.0002325349,0.0018114434,0.00033188684,0.00058577716,0.00042921296,0.00035717967,0.0011953248],"category_scores_gemma":[0.009724654,0.00018629788,0.0002319291,0.0020553968,0.00046370065,0.00095136603,0.0007539238,0.00032247155,0.0002662775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023739478,0.000010579453,0.99785334,0.000023515839,0.000011596408,0.00011044047,0.00007953515,0.000018575613,0.00009333294,0.000033165525,0.00019512213,0.0015470411],"study_design_scores_gemma":[0.0000036531196,0.00003348257,0.9972362,0.00004834516,0.00001673451,0.0012253708,0.0003000347,0.0001597975,0.00005893835,0.000025215228,0.0008888467,0.0000034379434],"about_ca_topic_score_codex":0.004938494,"about_ca_topic_score_gemma":0.009375001,"teacher_disagreement_score":0.004938494,"about_ca_system_score_codex":0.0005322815,"about_ca_system_score_gemma":0.0008426629,"threshold_uncertainty_score":0.016755223},"labels":[],"label_agreement":null},{"id":"W3095030832","doi":"10.6004/jnccn.2020.7586","title":"Validating a Patient-Reported Outcomes–Derived Algorithm for Classifying Symptom Complexity Levels Among Patients With Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health; University of Calgary","funders":"","keywords":"Medicine; Algorithm; Checklist; Receiver operating characteristic; Cancer; Cluster (spacecraft); Correlation; Medical record; Data mining; Computer science; Surgery; Internal medicine; Mathematics","score_opus":0.10869672492642961,"score_gpt":0.3338913846029093,"score_spread":0.22519465967647967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095030832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744513,0.00040008847,0.01458927,0.00041216277,0.00007279297,0.002462012,0.003390071,0.00020961207,0.004012646],"genre_scores_gemma":[0.9748044,0.00009296769,0.020577962,0.00012542424,0.00003409981,0.0009591248,0.0031635463,0.00001595573,0.00022659104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99251163,0.0030772474,0.0010811656,0.0006378695,0.0023870645,0.00030501146],"domain_scores_gemma":[0.9776244,0.00838609,0.0053291684,0.0011773672,0.006730311,0.00075269764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012741714,0.0006039042,0.0006066097,0.002835311,0.00059235725,0.0015640439,0.00095509924,0.00065735064,0.00086917036],"category_scores_gemma":[0.0360216,0.00021727783,0.0009678851,0.0015111709,0.0005230059,0.0007465827,0.0012725834,0.0007810862,0.00024549867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002824452,0.00015875274,0.97761667,0.000062423045,0.0001495477,0.00001710026,0.00019157931,0.001534047,0.00019625682,0.00012368582,0.0011447489,0.018522728],"study_design_scores_gemma":[0.00012168535,0.0005937726,0.9768151,0.00007280162,0.00011711052,0.00011423957,0.0003623487,0.019597469,0.0006355304,0.00027818323,0.001256932,0.000034795146],"about_ca_topic_score_codex":0.015050869,"about_ca_topic_score_gemma":0.02916639,"teacher_disagreement_score":0.015050869,"about_ca_system_score_codex":0.0019184566,"about_ca_system_score_gemma":0.0034300815,"threshold_uncertainty_score":0.067385435},"labels":[],"label_agreement":null},{"id":"W3095519987","doi":"10.6004/jnccn.2020.7580","title":"Prostate Cancer Grade and Stage Misclassification in Active Surveillance Candidates: Black Versus White Patients","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Absolute risk reduction; Prostate cancer; Logistic regression; Stage (stratigraphy); Internal medicine; Urology; Cancer; Gynecology; Confidence interval","score_opus":0.057011787398923534,"score_gpt":0.32328416312974895,"score_spread":0.2662723757308254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095519987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99944,0.00016989344,0.00007994839,0.00006917017,0.0000059755107,0.0000033082965,0.000060810857,0.0000013794031,0.00016951568],"genre_scores_gemma":[0.99975604,0.000040104907,0.000040585546,0.000030921678,0.000011708249,0.0000023346568,0.00008319508,0.0000010672317,0.000033987995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989839,0.00040846728,0.00008079715,0.00023089166,0.00018052412,0.000115459654],"domain_scores_gemma":[0.9963697,0.0009996127,0.0018602326,0.00018050526,0.00015725971,0.00043263275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027095273,0.00021958479,0.0003300901,0.0010247012,0.00036574775,0.00068526535,0.0003706828,0.00037417997,0.0011067833],"category_scores_gemma":[0.0071377046,0.0001819378,0.0005188895,0.00066202006,0.00034655645,0.0006255992,0.00058232894,0.00043414062,0.00012971924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104444305,0.000010790467,0.99888223,0.0000034193329,0.000029252558,0.000014572195,0.000069928996,0.000019116249,0.000053871307,0.000018483697,0.000028600823,0.0007654025],"study_design_scores_gemma":[0.000007277876,0.00009096101,0.99894005,0.000008644744,0.00004304626,0.00015583195,0.00020877593,0.00033981545,0.00006070901,0.00005386117,0.000087761866,0.0000033832232],"about_ca_topic_score_codex":0.003173476,"about_ca_topic_score_gemma":0.004625885,"teacher_disagreement_score":0.003173476,"about_ca_system_score_codex":0.00025026908,"about_ca_system_score_gemma":0.0002414606,"threshold_uncertainty_score":0.014329493},"labels":[],"label_agreement":null},{"id":"W3097339274","doi":"10.6004/jnccn.2020.0052","title":"Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":564,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AbbVie Canada; Genentech; Bayer HealthCare; Boston Pharmaceuticals; Agios Pharmaceuticals; SK Life Science; Arbor Pharmaceuticals; AstraZeneca; Cancer Research Institute; Novocure; National Comprehensive Cancer Network; Ipsen; Takeda Pharmaceuticals North America; Jazz Pharmaceuticals; National Institutes of Health; Regeneron Pharmaceuticals; BeiGene; Varian Medical Systems; Karyopharm Therapeutics; University of Pennsylvania; National Cancer Institute; Gilead Sciences; INOVIO Pharmaceuticals; Novartis Pharmaceuticals Corporation; National Cancer Research Institute; Bristol-Myers Squibb; Johns Hopkins University; Amgen","keywords":"Medicine; Central nervous system; Radiation therapy; Clinical Practice; Oncology; Radiation oncology; Disease; Internal medicine; Pathology; Family medicine","score_opus":0.10996868575068654,"score_gpt":0.43327070406139073,"score_spread":0.3233020183107042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097339274","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077567864,0.15507819,0.050833777,0.17262287,0.02634108,0.018698392,0.095817596,0.0063449033,0.4665064],"genre_scores_gemma":[0.041811038,0.18061645,0.20456816,0.116787955,0.007755596,0.032950297,0.22887915,0.0036995467,0.18293186],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956357,0.001346509,0.001062769,0.00016819696,0.0014906479,0.0002962508],"domain_scores_gemma":[0.98495907,0.0037157445,0.0024106652,0.00039120566,0.00751953,0.0010037454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00486866,0.0010411241,0.0010810802,0.004511512,0.0012353243,0.0025056456,0.002784458,0.0047125667,0.020756433],"category_scores_gemma":[0.03161186,0.0009310987,0.0013497467,0.0054764766,0.0013804317,0.001909287,0.0019906615,0.0059479754,0.0194097],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006227622,0.00007445481,0.0010837833,0.0012275565,0.000023125438,0.0002491752,0.00012704275,0.00089108746,0.00029202824,0.0022142043,0.91674936,0.07700594],"study_design_scores_gemma":[0.00020013351,0.00008163672,0.0065994486,0.005734512,0.00005852368,0.0011089667,0.00021787257,0.0007635548,0.00031384605,0.0047644987,0.98008746,0.0000695263],"about_ca_topic_score_codex":0.028024044,"about_ca_topic_score_gemma":0.06588514,"teacher_disagreement_score":0.028024044,"about_ca_system_score_codex":0.0035109927,"about_ca_system_score_gemma":0.013745095,"threshold_uncertainty_score":0.069437146},"labels":[],"label_agreement":null},{"id":"W3110827616","doi":"10.6004/jnccn.2020.7605","title":"Impact of Geography on Care Delivery and Survival for Noncurable Pancreatic Adenocarcinoma: A Population-Based Analysis","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Sunnybrook Health Science Centre; McGill University Health Centre; Health Sciences Centre; McGill University; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Ipsen; Ipsen Biopharmaceuticals; Cancer Care Ontario","keywords":"Medicine; Pancreatic cancer; Receipt; Adenocarcinoma; Cancer; Cancer registry; Population; Internal medicine; Hazard ratio; Proportional hazards model; Oncology; Environmental health; Confidence interval","score_opus":0.057721419217144666,"score_gpt":0.37160609218805907,"score_spread":0.3138846729709144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110827616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945813,0.00064452697,0.00021662742,0.00021177095,0.000008177609,0.000022167776,0.0036877042,0.000008900664,0.0006188491],"genre_scores_gemma":[0.9985232,0.00018656181,0.00008689005,0.000026732425,0.0000059319927,0.0000110185165,0.001072996,0.0000026248304,0.00008407083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897325,0.000189879,0.00010169192,0.00024326365,0.0002494749,0.00024241558],"domain_scores_gemma":[0.9978149,0.00025276135,0.0009270383,0.00020707739,0.00045220266,0.00034588604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094742177,0.00031821305,0.00041172226,0.0010786385,0.0007693985,0.00090468116,0.0009251891,0.0003870584,0.001282411],"category_scores_gemma":[0.003023248,0.00030821905,0.0016827086,0.0030975465,0.00056940457,0.00041226877,0.0009383694,0.00061758666,0.00011598978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003066263,0.000005122642,0.99909043,0.00001245236,0.00017173224,0.000028217826,0.00006248511,0.000080770486,0.000024062074,0.000018995952,0.00013307952,0.00034204827],"study_design_scores_gemma":[0.0000066343946,0.00001780796,0.99895203,0.0000117970785,0.00010609031,0.00004919431,0.00018146596,0.00034775326,0.000011532639,0.00002218072,0.00028966175,0.000003879386],"about_ca_topic_score_codex":0.7195007,"about_ca_topic_score_gemma":0.742646,"teacher_disagreement_score":0.7195007,"about_ca_system_score_codex":0.0049556145,"about_ca_system_score_gemma":0.005389184,"threshold_uncertainty_score":0.5643023},"labels":[],"label_agreement":null},{"id":"W3112260348","doi":"10.6004/jnccn.2020.7603","title":"Impact of Exercise on Chemotherapy Tolerance and Survival in Early-Stage Breast Cancer: A Nonrandomized Controlled Trial","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Docetaxel; Chemotherapy; Breast cancer; Mucositis; Relative risk; Regimen; Neutropenia; Cyclophosphamide; Randomized controlled trial; Surgery; Cohort; Chemotherapy regimen; Cancer; Oncology; Confidence interval","score_opus":0.030091181871559795,"score_gpt":0.32712837232886705,"score_spread":0.29703719045730725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112260348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857867,0.007208118,0.0006042741,0.0005088673,0.00042401787,0.004056781,0.00039274903,0.000044882014,0.00097372493],"genre_scores_gemma":[0.989164,0.002919875,0.0009885362,0.0004935712,0.000432698,0.004830895,0.00027869546,0.000008192166,0.0008835377],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99741554,0.0018214084,0.00019843162,0.00027487724,0.00012519509,0.00016455629],"domain_scores_gemma":[0.99701095,0.0014720482,0.0007228144,0.00024082753,0.00016954128,0.000383779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038386087,0.0010260292,0.0025742804,0.00037048795,0.00048644873,0.00083799224,0.0008559993,0.0019336363,0.004444787],"category_scores_gemma":[0.0052872743,0.00044691522,0.0024161935,0.0005148496,0.0010067918,0.0006722029,0.0004372394,0.0018982802,0.00042021595],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9816342,0.0051487805,0.0016714074,0.0009937998,0.002081509,0.000023424345,0.000025969914,0.00017231943,0.000447949,0.000041277814,0.00014928186,0.007610058],"study_design_scores_gemma":[0.91273504,0.07933625,0.0048617907,0.00013699957,0.0019291268,0.00002146294,0.00001724612,0.0003517222,0.00019143397,0.00012034159,0.0002886878,0.000009930834],"about_ca_topic_score_codex":0.00089776266,"about_ca_topic_score_gemma":0.0013434368,"teacher_disagreement_score":0.004444787,"about_ca_system_score_codex":0.0005492242,"about_ca_system_score_gemma":0.001147506,"threshold_uncertainty_score":0.020300746},"labels":[],"label_agreement":null},{"id":"W3119615054","doi":"10.6004/jnccn.2020.7613","title":"Patterns and Trends of Cancer Screening in Canada: Results From a Contemporary National Survey","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Cohort; Mammography; Breast cancer; Logistic regression; Cancer screening; Cancer; Cervical cancer; Breast cancer screening; Cohort study; Odds ratio; Family medicine; Colorectal cancer; Demography; Gynecology; Internal medicine","score_opus":0.09546180959103533,"score_gpt":0.32963157749240524,"score_spread":0.2341697679013699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119615054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93476385,0.003820771,0.0005724653,0.0019660627,0.000046353787,0.00012325356,0.05210322,0.00006460067,0.0065394673],"genre_scores_gemma":[0.98620903,0.001697304,0.00057888654,0.0003569331,0.000014759405,0.000036663827,0.010251224,0.000011425137,0.0008437346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985915,0.000076941615,0.00010495391,0.00022333395,0.0007042708,0.0002990047],"domain_scores_gemma":[0.99670666,0.00012457726,0.0005878289,0.00011329494,0.0020263055,0.0004414622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010619749,0.0003062933,0.00042166913,0.0018396588,0.0017642161,0.0011589322,0.0011666395,0.00036977485,0.0016551836],"category_scores_gemma":[0.0031310753,0.00030641333,0.0006665546,0.0070470055,0.00047803746,0.00044832585,0.00092834106,0.0006396168,0.0002451006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038680657,0.000015393043,0.9922839,0.00006118753,0.0000749523,0.000023213273,0.0003223617,0.0001123873,0.000062156076,0.00008924563,0.0023850813,0.00453152],"study_design_scores_gemma":[0.000004899904,0.00001046946,0.99736816,0.000035157627,0.00003569347,0.000029364342,0.00047752165,0.00025729215,0.000026471356,0.000023569297,0.0017239943,0.0000075185867],"about_ca_topic_score_codex":0.9964036,"about_ca_topic_score_gemma":0.996878,"teacher_disagreement_score":0.027461914,"about_ca_system_score_codex":0.027461914,"about_ca_system_score_gemma":0.03594963,"threshold_uncertainty_score":0.19925106},"labels":[],"label_agreement":null},{"id":"W3119952631","doi":"10.6004/jnccn.2020.7606","title":"Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne; Université de Sherbrooke","funders":"","keywords":"Medicine; Underweight; Overweight; Body mass index; Breast cancer; Hazard ratio; Weight change; Internal medicine; Weight loss; Obesity; Cancer; Weight gain; Randomization; Oncology; Randomized controlled trial; Confidence interval; Body weight","score_opus":0.02822923941213263,"score_gpt":0.2893308653753342,"score_spread":0.2611016259632016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119952631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893113,0.006695265,0.0003574752,0.0008518433,0.00012694395,0.0003129384,0.0009869528,0.000034552366,0.001322816],"genre_scores_gemma":[0.9934018,0.0015946373,0.00074538105,0.0007722559,0.0002959274,0.00055943447,0.0017904522,0.000016758186,0.00082335627],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9984126,0.001239258,0.000059254704,0.0001005094,0.00008324119,0.000105194216],"domain_scores_gemma":[0.9978344,0.00094705063,0.000542392,0.00023302696,0.000070265014,0.0003728355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054540993,0.0010734044,0.0019839185,0.00027911644,0.0002196074,0.0011066899,0.00062862464,0.0007571364,0.0019707107],"category_scores_gemma":[0.0036148897,0.00031657814,0.0031707906,0.00037554794,0.00057089684,0.0008636589,0.00065495685,0.0017895381,0.0002660065],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94350857,0.0022678846,0.024411475,0.0007726899,0.0076640155,0.000071387025,0.00006917853,0.0014648297,0.0010165873,0.00024392518,0.0015572307,0.01695231],"study_design_scores_gemma":[0.7401454,0.1147032,0.1164578,0.0004071657,0.017596848,0.0002956549,0.00018158939,0.0048094173,0.0008221476,0.001438712,0.003046349,0.00009566259],"about_ca_topic_score_codex":0.0003846529,"about_ca_topic_score_gemma":0.0010002409,"teacher_disagreement_score":0.0054540993,"about_ca_system_score_codex":0.00044374523,"about_ca_system_score_gemma":0.000755923,"threshold_uncertainty_score":0.028844357},"labels":[],"label_agreement":null},{"id":"W3121783725","doi":"10.6004/jnccn.2020.7618","title":"Associations of Skeletal Muscle With Symptom Burden and Clinical Outcomes in Hospitalized Patients With Advanced Cancer","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Radiodensity; Hazard ratio; Internal medicine; Cancer; Surgery; Confidence interval; Radiography","score_opus":0.04174486441706441,"score_gpt":0.38466337339758033,"score_spread":0.3429185089805159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121783725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871945,0.0004492396,0.000050115512,0.0001163029,0.0000054752413,0.000006960235,0.0003686281,0.0000026481237,0.00028121064],"genre_scores_gemma":[0.99930763,0.00012657006,0.00005725071,0.000033252112,0.000011866565,0.0000068339714,0.00041398502,7.5998867e-7,0.00004184503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960583,0.000093901035,0.000073280025,0.000069058646,0.00008715955,0.000070851085],"domain_scores_gemma":[0.9975967,0.0003157465,0.0015216848,0.0000581402,0.00021246467,0.0002951975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053217576,0.00021309489,0.0003419019,0.00046332975,0.00029216814,0.0005233138,0.00030490066,0.0002543678,0.0014504022],"category_scores_gemma":[0.0029873673,0.00014603918,0.00032602833,0.0007749404,0.00022828457,0.0003430417,0.0004860703,0.00059347705,0.00010591062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003901098,0.000014454314,0.99922526,0.000009106594,0.000024711382,0.000013107743,0.0000116334895,0.00003320102,0.000028710601,0.000004667309,0.00005461549,0.00054142094],"study_design_scores_gemma":[0.000004317371,0.00004963412,0.9995247,0.000008835821,0.000015970352,0.00006001933,0.00005314883,0.00020520065,0.00001638704,0.000011885217,0.00004827557,0.0000016576862],"about_ca_topic_score_codex":0.004663044,"about_ca_topic_score_gemma":0.008664736,"teacher_disagreement_score":0.004663044,"about_ca_system_score_codex":0.000506933,"about_ca_system_score_gemma":0.0003931644,"threshold_uncertainty_score":0.0092718005},"labels":[],"label_agreement":null},{"id":"W3126744606","doi":"10.6004/jnccn.2020.7645","title":"Barriers to Optimal End-of-Life Care for Adolescents and Young Adults With Cancer: Bereaved Caregiver Perspectives","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Institute of Nursing Research; Cambia Health Foundation; National Institutes of Health; National Palliative Care Research Center","keywords":"Medicine; Regret; Palliative care; End-of-life care; Medicaid; Distress; Family caregivers; Quality of life (healthcare); Family medicine; Qualitative research; Gerontology; Young adult; Nursing; Health care; Clinical psychology","score_opus":0.02403699953910725,"score_gpt":0.3178969813034805,"score_spread":0.2938599817643732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126744606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887061,0.002000553,0.0004334966,0.0049134116,0.0000900524,0.00003512919,0.00008381249,0.0000071640334,0.0037302414],"genre_scores_gemma":[0.99741733,0.0012381212,0.00029415108,0.0005680327,0.0000143990055,0.000025399484,0.000042234427,0.0000030320984,0.00039732823],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99793077,0.0011145772,0.0001638823,0.00009954079,0.00022677763,0.00046439978],"domain_scores_gemma":[0.9946911,0.0020543842,0.0010614985,0.000102409045,0.0007750097,0.0013155603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004299643,0.0002820502,0.000431748,0.0005364771,0.004082104,0.0023744272,0.0007360069,0.0007696361,0.001597507],"category_scores_gemma":[0.009543899,0.00026815257,0.00041577884,0.0005027585,0.001873628,0.001967917,0.0037241688,0.0015866992,0.00013197854],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011361503,0.00013389166,0.21194017,0.000586784,0.0000713051,0.0037497734,0.75176364,0.00019156079,0.0007158039,0.0028918225,0.00423391,0.023607723],"study_design_scores_gemma":[0.0000074474083,0.0000624257,0.025672203,0.00043818628,0.000028488319,0.0012990059,0.9621112,0.00011208672,0.00019239476,0.00038257558,0.009676879,0.000017106193],"about_ca_topic_score_codex":0.0103574665,"about_ca_topic_score_gemma":0.020744886,"teacher_disagreement_score":0.0103574665,"about_ca_system_score_codex":0.0022723586,"about_ca_system_score_gemma":0.005406159,"threshold_uncertainty_score":0.022738934},"labels":[],"label_agreement":null},{"id":"W3126783535","doi":"10.6004/jnccn.2020.7637","title":"Sex- and Age-Related Differences in the Distribution of Metastases in Patients With Upper Urinary Tract Urothelial Carcinoma","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Lung; Metastasis; Internal medicine; Upper urinary tract; Urology; Urinary system; Lymph node; Oncology; Cancer","score_opus":0.026734438216476173,"score_gpt":0.27663128568627277,"score_spread":0.2498968474697966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126783535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981743,0.00094338413,0.000058040692,0.000043083302,0.000006294885,0.0000036302567,0.00037237466,0.000002459918,0.00039647546],"genre_scores_gemma":[0.9995485,0.00017300517,0.000026906735,0.000013558412,0.000008009991,0.0000026330167,0.00018198224,0.000001124591,0.000044326607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996749,0.000066340916,0.00005657224,0.00007502957,0.00006403533,0.00006315671],"domain_scores_gemma":[0.9983328,0.00038668566,0.00087780703,0.00006584482,0.00014335956,0.00019345414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043480887,0.00014932948,0.00023809067,0.0007932059,0.00022524103,0.00033616734,0.00020511345,0.00027191342,0.0020989538],"category_scores_gemma":[0.0026442246,0.00012909055,0.00029006458,0.001121771,0.00018893198,0.00047892658,0.0002582055,0.00031540863,0.00022367961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041896823,0.0000057590096,0.9991906,0.00000428458,0.0000134618,0.000034598408,0.000018180339,0.000013663182,0.00006160473,0.0000069454263,0.000028372397,0.0005805465],"study_design_scores_gemma":[0.0000026607358,0.000035169094,0.9993104,0.0000046569908,0.000010760268,0.00033277253,0.00008798736,0.000065740234,0.00003188205,0.000021272726,0.00009482262,0.000001866617],"about_ca_topic_score_codex":0.0018661903,"about_ca_topic_score_gemma":0.0030367668,"teacher_disagreement_score":0.0020989538,"about_ca_system_score_codex":0.00021475316,"about_ca_system_score_gemma":0.00024297672,"threshold_uncertainty_score":0.0070216656},"labels":[],"label_agreement":null},{"id":"W3131489629","doi":"10.6004/jnccn.2020.7677","title":"Reassessing the Net Benefit of Cancer Drugs With Evolution of Evidence Using the ASCO Value Framework","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Kingston Health Sciences Centre; Canadian Centre for Applied Research in Cancer Control; Occupational Cancer Research Centre; Health Sciences Centre; Queen's University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Interim; Interim analysis; Clinical trial; Clinical endpoint; Surrogate endpoint; Internal medicine; Cancer drugs; Quality of life (healthcare); Oncology; Cancer","score_opus":0.4597360644743093,"score_gpt":0.4807494730049917,"score_spread":0.021013408530682398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131489629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42501605,0.3654977,0.07923113,0.03652172,0.0023915747,0.0045215692,0.030593703,0.0005292823,0.055697266],"genre_scores_gemma":[0.9533263,0.00800825,0.029350948,0.0028433104,0.00069639256,0.00092751795,0.004088333,0.00008572439,0.00067320344],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.885932,0.06393706,0.015001566,0.004002667,0.029208805,0.0019178012],"domain_scores_gemma":[0.61414313,0.26115018,0.07260504,0.011363061,0.037222635,0.0035159804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.16520455,0.00076782895,0.0020347561,0.017393218,0.00064894045,0.006869247,0.0013917072,0.001206018,0.002561743],"category_scores_gemma":[0.26986,0.0003733291,0.0050639417,0.010497073,0.0018001478,0.0042709084,0.0036591317,0.0020045834,0.00041980395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057415795,0.00019251645,0.502215,0.017189926,0.016816614,0.0002566131,0.001275027,0.008725144,0.0016906385,0.018649494,0.01785033,0.40939707],"study_design_scores_gemma":[0.002013364,0.009015539,0.61675143,0.031083837,0.029140828,0.0024755937,0.0021468552,0.033077862,0.006619086,0.10662882,0.1603762,0.00067057856],"about_ca_topic_score_codex":0.002334534,"about_ca_topic_score_gemma":0.0034861912,"teacher_disagreement_score":0.16520455,"about_ca_system_score_codex":0.0047487183,"about_ca_system_score_gemma":0.0061933864,"threshold_uncertainty_score":0.8736956},"labels":[],"label_agreement":null},{"id":"W3134747077","doi":"10.6004/jnccn.2020.7654","title":"Shorter Diagnosis-to-Treatment Interval in Diffuse Large B-Cell Lymphoma is Associated With Inferior Overall Survival in a Large, Population-Based Registry","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Interquartile range; Hazard ratio; Diffuse large B-cell lymphoma; Internal medicine; Proportional hazards model; Rituximab; Population; Confidence interval; Cohort; Lymphoma; Surgery","score_opus":0.028263567137291393,"score_gpt":0.3030276553712567,"score_spread":0.2747640882339653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134747077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997663,0.0003059858,0.000097686985,0.00014914092,0.0000060019083,0.000008370864,0.0012100098,0.000006559836,0.00055339094],"genre_scores_gemma":[0.9989219,0.00013125995,0.00004331628,0.000033258493,0.000006487303,0.0000051596003,0.00078016875,0.0000021625035,0.000076485376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910444,0.0001408428,0.000106803345,0.0002375867,0.00021997059,0.00019030643],"domain_scores_gemma":[0.994699,0.00048839545,0.0030299996,0.0005016777,0.00063680176,0.0006441872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011880702,0.00013989808,0.00029124564,0.00061890244,0.0005966807,0.0010060583,0.00060368434,0.00026240613,0.0016096383],"category_scores_gemma":[0.004931509,0.00017735508,0.00042646797,0.0019724981,0.0004125422,0.000357999,0.00050124974,0.00042044997,0.00015960618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034890436,0.000004552166,0.9992644,0.0000038555263,0.00001769926,0.000020657948,0.000035792757,0.000018145634,0.000028961349,0.00001150817,0.00014458195,0.00041486623],"study_design_scores_gemma":[0.000006636126,0.000013065195,0.9992956,0.0000047865783,0.000026970285,0.000081065984,0.00012112954,0.0001253084,0.000017539995,0.000012200443,0.00029331428,0.000002475807],"about_ca_topic_score_codex":0.25452098,"about_ca_topic_score_gemma":0.36994612,"teacher_disagreement_score":0.25452098,"about_ca_system_score_codex":0.0028258332,"about_ca_system_score_gemma":0.0031874522,"threshold_uncertainty_score":0.506079},"labels":[],"label_agreement":null},{"id":"W3135800774","doi":"10.6004/jnccn.2020.7656","title":"Status of Cancer Care at Network Sites of the Nation’s Academic Cancer Centers","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; Case Comprehensive Cancer Center, Case Western Reserve University","keywords":"Medicine; Workforce; Family medicine; Pharmacy; Cancer; Certification; Health care; Nursing; Political science","score_opus":0.12344401835775279,"score_gpt":0.3938842738240449,"score_spread":0.27044025546629213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135800774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990949,0.000526258,0.00019344578,0.0018489108,0.000016690792,0.000038064787,0.0017340971,0.000022945225,0.004670692],"genre_scores_gemma":[0.9981755,0.00026938145,0.00028879687,0.00022701893,0.000017474496,0.00002961437,0.00071130093,0.0000049378,0.0002759064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623245,0.0012402207,0.00032903126,0.00046133192,0.0009458029,0.0007910774],"domain_scores_gemma":[0.97522146,0.0036669932,0.010427543,0.000612469,0.0038738644,0.006197684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026768744,0.00016078005,0.00014693479,0.0013980536,0.0015218924,0.0017300368,0.0011516046,0.00043795918,0.0049989675],"category_scores_gemma":[0.015892312,0.00017499946,0.00017982128,0.0032243382,0.00064946205,0.0017092347,0.0025123907,0.0005837785,0.00031923343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036464495,0.000043516982,0.9881066,0.00003849134,0.000020794763,0.00004464001,0.00095531566,0.00013401515,0.00006221339,0.00015121869,0.0020315018,0.008375265],"study_design_scores_gemma":[0.0000077727855,0.00007076185,0.9878334,0.00007823329,0.000015923171,0.00016889369,0.0076377816,0.00034783635,0.00010231188,0.00008434266,0.0036404266,0.000012384562],"about_ca_topic_score_codex":0.10823172,"about_ca_topic_score_gemma":0.15799354,"teacher_disagreement_score":0.10823172,"about_ca_system_score_codex":0.0047029033,"about_ca_system_score_gemma":0.005591158,"threshold_uncertainty_score":0.21520346},"labels":[],"label_agreement":null},{"id":"W3164222140","doi":"10.6004/jnccn.2021.0024","title":"Open Notes Are Here: Are We Ready?","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Research Data Management Practices","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"University of California, San Francisco; American Society of Clinical Oncology; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; V Foundation for Cancer Research; Pancreatic Cancer Action Network; Lustgarten Foundation; National Cancer Institute; Conquer Cancer Foundation","keywords":"Medicine; MEDLINE","score_opus":0.2708778978010283,"score_gpt":0.43010282397491123,"score_spread":0.15922492617388295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164222140","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032367764,0.0039768387,0.0026405184,0.9481485,0.03127972,0.000066201326,0.00058945944,0.00081324374,0.012161956],"genre_scores_gemma":[0.018307256,0.024196152,0.030944608,0.7142678,0.055562012,0.00060117693,0.0033815238,0.0030533455,0.14968619],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97173697,0.010662924,0.0033922545,0.0020289843,0.008125092,0.0040536537],"domain_scores_gemma":[0.62231475,0.093010366,0.01936736,0.03705086,0.13036276,0.09789393],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.057735596,0.0012104356,0.0016951421,0.0032821936,0.008027015,0.030208161,0.0049339593,0.014309941,0.21266334],"category_scores_gemma":[0.2849748,0.0013414002,0.0020868012,0.0038426695,0.0077633522,0.05661174,0.012127211,0.030851783,0.11802228],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057914014,0.00006786433,0.0010106247,0.00014631769,0.000010105216,0.000063318264,0.0002895949,0.000029853345,0.00007926763,0.0076153884,0.92103297,0.06959679],"study_design_scores_gemma":[0.00004423444,0.000030904775,0.0008555649,0.0015872029,0.000018365965,0.00008696329,0.0034205285,0.00007555307,0.00015926592,0.014087133,0.9795505,0.000083827894],"about_ca_topic_score_codex":0.016195599,"about_ca_topic_score_gemma":0.028844442,"teacher_disagreement_score":0.99506605,"about_ca_system_score_codex":0.005528961,"about_ca_system_score_gemma":0.03736694,"threshold_uncertainty_score":0.7114297},"labels":[],"label_agreement":null},{"id":"W3165196335","doi":"10.6004/jnccn.2020.7666","title":"Risk of Cancer-Specific Death for Patients Diagnosed With Neuroendocrine Tumors: A Population-Based Analysis","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Manitoba; Health Sciences Centre; Occupational Cancer Research Centre; Manitoba Health; University of Toronto; Sunnybrook Health Science Centre","funders":"Ontario Ministry of Health and Long-Term Care; EMD Serono; Ipsen; Ipsen Biopharmaceuticals","keywords":"Medicine; Interquartile range; Cancer; Internal medicine; Population; Hazard ratio; Cause of death; Oncology; Cohort; Colorectal cancer; Proportional hazards model; Cohort study; Disease; Confidence interval; Environmental health","score_opus":0.03210202073306971,"score_gpt":0.34300445236499677,"score_spread":0.31090243163192705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165196335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741036,0.00052976375,0.0003212337,0.000049134036,0.000009528592,0.000012633354,0.0014277905,0.000010885471,0.00022867837],"genre_scores_gemma":[0.9983006,0.00015159852,0.000120756005,0.000017362672,0.000011731154,0.000012750028,0.0013202339,0.0000031360996,0.00006190955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932086,0.00014791681,0.00007685359,0.0002708876,0.00009519965,0.0000883357],"domain_scores_gemma":[0.99819595,0.000443323,0.00076697883,0.00021549044,0.00015902093,0.00021927147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014238829,0.00034995616,0.0005077326,0.0014164782,0.000298931,0.00080151437,0.0006462624,0.00056640204,0.0012857597],"category_scores_gemma":[0.0026742392,0.00040258057,0.0019628736,0.0014268421,0.00024216634,0.0006046831,0.00064867985,0.00094933924,0.00018346171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014496285,0.000016403641,0.998502,0.000010088022,0.00032152917,0.00005288806,0.000016173708,0.00024987996,0.000045291556,0.000018484665,0.000090397785,0.0005318732],"study_design_scores_gemma":[0.00002602891,0.00011327155,0.9966719,0.000008049028,0.00025201048,0.00037217783,0.0000940037,0.0021093846,0.00004040081,0.00007871174,0.00022298588,0.00001105367],"about_ca_topic_score_codex":0.0051307436,"about_ca_topic_score_gemma":0.005034649,"teacher_disagreement_score":0.0051307436,"about_ca_system_score_codex":0.00046901475,"about_ca_system_score_gemma":0.0004647408,"threshold_uncertainty_score":0.010201752},"labels":[],"label_agreement":null},{"id":"W3166972402","doi":"10.6004/jnccn.2020.7681","title":"Racial Background and Health Behaviors Among Adults With Cancer in Canada: Results of a National Survey","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Demography; Socioeconomic status; Logistic regression; Odds ratio; Cancer; Gerontology; Public health; Young adult; National Health Interview Survey; Odds; Environmental health; Population; Internal medicine","score_opus":0.0695991807844237,"score_gpt":0.3459992550002257,"score_spread":0.27640007421580204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166972402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9205466,0.0032038724,0.0003767416,0.0016255887,0.00007234056,0.00022055062,0.06574568,0.000049039747,0.008159573],"genre_scores_gemma":[0.9832349,0.0017937021,0.0005863108,0.00047048763,0.0000221638,0.00007479299,0.012435696,0.000009972159,0.0013720636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999111,0.00005538385,0.000066782675,0.000094984425,0.00044682596,0.0002249848],"domain_scores_gemma":[0.9980101,0.00005402798,0.00030459347,0.00005111667,0.0011943732,0.00038586048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008883063,0.00020283373,0.00033837697,0.0012872325,0.0016320202,0.0007397435,0.00059702684,0.00024361533,0.001285101],"category_scores_gemma":[0.0019689745,0.00019254189,0.0005533379,0.0037822688,0.00026016586,0.0002837067,0.00067018473,0.00053114985,0.00022948481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003174284,0.000017695913,0.9933276,0.000059614853,0.0000447902,0.000018441964,0.00017840751,0.000044021253,0.000057103443,0.000032239364,0.0026746292,0.0035136775],"study_design_scores_gemma":[0.000003406229,0.000007999125,0.9983041,0.000033353826,0.00002514555,0.000016718706,0.000319823,0.00008197552,0.000023295299,0.000008168735,0.0011724195,0.0000035360388],"about_ca_topic_score_codex":0.99136025,"about_ca_topic_score_gemma":0.994545,"teacher_disagreement_score":0.011387421,"about_ca_system_score_codex":0.011387421,"about_ca_system_score_gemma":0.023540642,"threshold_uncertainty_score":0.08262193},"labels":[],"label_agreement":null},{"id":"W3177118749","doi":"10.6004/jnccn.2021.7042","title":"Integration of Pediatric Hodgkin Lymphoma Treatment and Late Effects Guidelines: Seeing the Forest Beyond the Trees","year":2021,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Guideline; Survivorship curve; Intensive care medicine; Adverse effect; Population; Quality of life (healthcare); Regimen; Hodgkin lymphoma; Clinical trial; Lymphoma; Environmental health; Internal medicine; Pathology","score_opus":0.11784780182124671,"score_gpt":0.40992001889445234,"score_spread":0.29207221707320563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177118749","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011992611,0.038853753,0.06278777,0.81104726,0.007993012,0.000775967,0.001262379,0.0016144696,0.06367284],"genre_scores_gemma":[0.15651488,0.0786177,0.5132507,0.22179846,0.0072314637,0.0016493222,0.0047223154,0.0009799218,0.015235253],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9803099,0.009744715,0.0024067024,0.00058497145,0.0061847465,0.00076901336],"domain_scores_gemma":[0.9302296,0.01901289,0.00576149,0.0027912073,0.034642264,0.0075625465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025735926,0.0005639069,0.0008428347,0.001997494,0.00135905,0.0049254335,0.0030747426,0.0044948664,0.0032887128],"category_scores_gemma":[0.07293644,0.0005525866,0.0013187904,0.0016356388,0.0012335589,0.0056540826,0.0035928087,0.010902508,0.0012475894],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068134235,0.00035414845,0.012625343,0.0010874419,0.00011417468,0.00071378646,0.0017297718,0.0071389033,0.0008008825,0.03595909,0.54863447,0.3907739],"study_design_scores_gemma":[0.00005977023,0.00021302234,0.007029473,0.0065158145,0.0001378217,0.00069033395,0.001356278,0.0058037583,0.0006877436,0.03002237,0.9473794,0.00010424213],"about_ca_topic_score_codex":0.023487298,"about_ca_topic_score_gemma":0.0728653,"teacher_disagreement_score":0.025735926,"about_ca_system_score_codex":0.005294783,"about_ca_system_score_gemma":0.033774804,"threshold_uncertainty_score":0.13610625},"labels":[],"label_agreement":null},{"id":"W3187036481","doi":"10.6004/jnccn.2021.7016","title":"Do Editorialists With Industry-Related Conflicts of Interest Write Unduly Favorable Editorials for Cancer Drugs in Top Journals?","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Conflict of interest; Clinical trial; Internal medicine; Clinical Oncology; Alternative medicine; Publication; Oncology; Family medicine; Cancer; Pathology; Law","score_opus":0.4962882298497098,"score_gpt":0.5624177617003119,"score_spread":0.06612953185060205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187036481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7869459,0.066599466,0.0052972157,0.063698865,0.021479925,0.0017855332,0.0045244615,0.00045646608,0.049212173],"genre_scores_gemma":[0.94418555,0.011081374,0.007183895,0.0111901965,0.022319118,0.0006194514,0.00080824946,0.00016186824,0.0024503213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.77628905,0.0797016,0.06113627,0.009372909,0.068203054,0.0052970704],"domain_scores_gemma":[0.100548744,0.35395256,0.4635253,0.014736218,0.05398468,0.013252491],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.12495701,0.0009126885,0.0010319523,0.0124852015,0.0035591982,0.010153547,0.0016985235,0.0028371639,0.0053168405],"category_scores_gemma":[0.60918796,0.0011301016,0.0010179194,0.0098365275,0.004124108,0.0046856413,0.0028684444,0.0018483098,0.0017634672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031563742,0.00025765505,0.8041286,0.008106737,0.0014346689,0.0029086187,0.011401492,0.00030940463,0.0020804415,0.0034865697,0.06462721,0.09810227],"study_design_scores_gemma":[0.0010037237,0.001049453,0.66741383,0.015535099,0.0022124208,0.01948909,0.021256665,0.0022695744,0.004836059,0.010209263,0.2542386,0.00048625213],"about_ca_topic_score_codex":0.0009028006,"about_ca_topic_score_gemma":0.0022817866,"teacher_disagreement_score":0.9971628,"about_ca_system_score_codex":0.0026683423,"about_ca_system_score_gemma":0.0063958764,"threshold_uncertainty_score":0.66084373},"labels":[],"label_agreement":null},{"id":"W3188488521","doi":"10.6004/jnccn.2020.7796","title":"Cost-Effectiveness Analysis of Durvalumab Plus Chemotherapy in the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Xiangya Hospital, Central South University; Central South University; National Natural Science Foundation of China","keywords":"Durvalumab; Medicine; Etoposide; Oncology; Chemotherapy; Lung cancer; Cost-effectiveness analysis; Internal medicine; Cost effectiveness; Stage (stratigraphy); Cancer; Immunotherapy","score_opus":0.1077639222556304,"score_gpt":0.4199083928252948,"score_spread":0.3121444705696644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188488521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96755844,0.010916108,0.010383865,0.0021392005,0.00011637448,0.0007418538,0.0026020897,0.00010732305,0.0054346807],"genre_scores_gemma":[0.99668044,0.000804896,0.001477977,0.00014159725,0.000017274146,0.00010837335,0.0004251693,0.0000062104004,0.00033806704],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99809223,0.0014781326,0.000053265394,0.00011177535,0.00011912833,0.0001454125],"domain_scores_gemma":[0.994713,0.0043511707,0.00046483247,0.000112375696,0.00013554179,0.00022310458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044113193,0.0012079121,0.0020576154,0.0008692266,0.00019478712,0.0012628217,0.0012179507,0.00092536595,0.0033190427],"category_scores_gemma":[0.010379024,0.00068186375,0.0040519703,0.0005967885,0.00038039713,0.0009860073,0.00072367454,0.0014017626,0.00010321427],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012731911,0.0004073263,0.008721347,0.000835794,0.004567354,0.00027812985,0.000038627233,0.95111716,0.000647547,0.0027682781,0.0009462752,0.016940286],"study_design_scores_gemma":[0.0043553417,0.0049881577,0.013965213,0.00045493746,0.007959017,0.0003859719,0.00010949687,0.9601777,0.00091774476,0.005186712,0.0014204064,0.00007923765],"about_ca_topic_score_codex":0.015570275,"about_ca_topic_score_gemma":0.011185032,"teacher_disagreement_score":0.015570275,"about_ca_system_score_codex":0.005779482,"about_ca_system_score_gemma":0.0031654628,"threshold_uncertainty_score":0.04193324},"labels":[],"label_agreement":null},{"id":"W3194832450","doi":"10.6004/jnccn.2021.7070","title":"Impact of the First Generation of Children’s Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor","year":2021,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Izaak Walton Killam Health Centre; University of Alberta Hospital; Alberta Hospital Edmonton; BC Children's Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Wilms' tumor; Oncology; Internal medicine; Chemotherapy; Clinical trial; Cog; Metastasis; Radiation therapy; Cancer","score_opus":0.2680173121637455,"score_gpt":0.5386201233560011,"score_spread":0.27060281119225554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194832450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010086056,0.99511033,0.00020201768,0.0028449397,0.00064106775,0.00002731229,0.000033792563,0.000010846148,0.0010287993],"genre_scores_gemma":[0.0009595096,0.9941402,0.00072932563,0.0030939842,0.00057603477,0.000057468627,0.00005047376,0.0000069451644,0.0003859402],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99717605,0.0013583245,0.00040089688,0.00029099188,0.00063662144,0.0001372582],"domain_scores_gemma":[0.9834652,0.012758227,0.0009689544,0.00023484572,0.0020023088,0.0005704918],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0135910455,0.0010492331,0.0022474632,0.0020511963,0.00029783632,0.0023343172,0.0018723881,0.0027930108,0.0029867808],"category_scores_gemma":[0.020973247,0.00041907505,0.0011655693,0.0021268507,0.001082494,0.002747831,0.0012586915,0.0039469213,0.0009990532],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024679647,0.000054910466,0.0001965645,0.016059354,0.00018498134,0.00012318065,0.0000617908,0.00044854652,0.00040810354,0.008711737,0.04692195,0.9265821],"study_design_scores_gemma":[0.0003153849,0.00040266296,0.0010929225,0.0240468,0.00034870562,0.0005345328,0.00006242492,0.00019412019,0.00030761104,0.005088031,0.9675703,0.00003666064],"about_ca_topic_score_codex":0.0014434616,"about_ca_topic_score_gemma":0.0028342206,"teacher_disagreement_score":0.98640895,"about_ca_system_score_codex":0.0031188028,"about_ca_system_score_gemma":0.0062831314,"threshold_uncertainty_score":0.07187718},"labels":[],"label_agreement":null},{"id":"W3195154633","doi":"10.6004/jnccn.2021.7049","title":"Pancreatic Cancer Progression in a Patient With Lynch Syndrome Receiving Immunotherapy: A Cautionary Tale","year":2021,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre; Jewish General Hospital; McGill University and Génome Québec Innovation Centre; McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Cancer Research Society; McGill University","keywords":"Microsatellite instability; PMS2; Medicine; Pembrolizumab; Cancer research; Cancer; Metastasis; MSH2; Oncology; Immunotherapy; DNA mismatch repair; Pathology; Internal medicine; Colorectal cancer; Biology; Microsatellite; Allele; Genetics","score_opus":0.049536194037718785,"score_gpt":0.3671157661308216,"score_spread":0.3175795720931028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195154633","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7380514,0.067538686,0.011380615,0.15007415,0.0044188304,0.00024994434,0.0005598987,0.000943021,0.026783409],"genre_scores_gemma":[0.94469017,0.01672682,0.004691376,0.021981725,0.008461088,0.000053415923,0.00018152782,0.00010996535,0.003103973],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99935704,0.00013845431,0.0001477761,0.00016412107,0.00009696987,0.00009566151],"domain_scores_gemma":[0.99821895,0.0010410913,0.00022817902,0.00012744834,0.00013659915,0.0002475955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086449785,0.0007805839,0.0008274383,0.0011651187,0.0017364392,0.0019696287,0.0009212449,0.0051163863,0.001508338],"category_scores_gemma":[0.0047983835,0.0004738803,0.00069081463,0.0007145699,0.0012664426,0.0018744782,0.00106051,0.0034164835,0.0008010067],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009235806,0.000021723696,0.024953652,0.0001320762,0.000034800083,0.9554673,0.00064274366,0.00013229063,0.0013209673,0.00034589466,0.0053234985,0.011532638],"study_design_scores_gemma":[0.000013857548,0.00005745273,0.006196415,0.00014813262,0.000050417755,0.9839289,0.0005108341,0.00030497482,0.00045575763,0.00075476884,0.007552322,0.000026148009],"about_ca_topic_score_codex":0.0013979998,"about_ca_topic_score_gemma":0.0021263063,"teacher_disagreement_score":0.0051163863,"about_ca_system_score_codex":0.00064835686,"about_ca_system_score_gemma":0.00060113857,"threshold_uncertainty_score":0.005045831},"labels":[],"label_agreement":null},{"id":"W3196892055","doi":"10.6004/jnccn.2020.7803","title":"Phase II Trial of Symptom Screening With Targeted Early Palliative Care for Patients With Advanced Cancer","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Princess Margaret Cancer Centre; University of Toronto; Queen's University; University Health Network","funders":"Eisai; Canadian Institutes of Health Research; Regeneron Pharmaceuticals; GlaxoSmithKline; Ontario Ministry of Health and Long-Term Care; AstraZeneca","keywords":"Medicine; Palliative care; Quality of life (healthcare); Depression (economics); Mood; Cancer; Internal medicine; Patient satisfaction; Physical therapy; Surgery; Nursing; Psychiatry","score_opus":0.08735327822484144,"score_gpt":0.41545993695869005,"score_spread":0.3281066587338486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196892055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844467,0.0014315814,0.00068202877,0.0007035908,0.00021136126,0.010166964,0.0008909158,0.00007195382,0.0013950056],"genre_scores_gemma":[0.9723564,0.0011354787,0.0027952108,0.0012654315,0.0002723036,0.01870642,0.0017469667,0.000013829347,0.001708011],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990951,0.00061615906,0.00004551449,0.000091338596,0.000052388103,0.0000994972],"domain_scores_gemma":[0.9982918,0.00045431207,0.00042953106,0.000143356,0.00011420512,0.0005667769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026638347,0.0011565897,0.0013513905,0.0003606014,0.0003675489,0.0008089927,0.0006992972,0.0011469814,0.0054052235],"category_scores_gemma":[0.002561882,0.00038004917,0.001188969,0.0003696277,0.000787714,0.00068973907,0.00056212104,0.0023982204,0.0006343258],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.907157,0.045513727,0.0038884259,0.0006425838,0.00061101397,0.000063184605,0.00015026788,0.0008215453,0.0028091234,0.000178598,0.0013745278,0.036790036],"study_design_scores_gemma":[0.7841813,0.21044236,0.003687517,0.000035612436,0.00014225955,0.000042067284,0.000024635945,0.00042718276,0.00030837563,0.00009515343,0.0006055604,0.000007874534],"about_ca_topic_score_codex":0.0005480168,"about_ca_topic_score_gemma":0.0010372215,"teacher_disagreement_score":0.0054052235,"about_ca_system_score_codex":0.00061810366,"about_ca_system_score_gemma":0.0017525969,"threshold_uncertainty_score":0.018082261},"labels":[],"label_agreement":null},{"id":"W3197461520","doi":"10.6004/jnccn.2021.7015","title":"Quantifying Withdrawal of Consent, Loss to Follow-Up, Early Drug Discontinuation, and Censoring in Oncology Trials","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Censoring (clinical trials); Medicine; Discontinuation; Internal medicine; Logistic regression; Clinical trial; Confidence interval; Standard error; Oncology; Statistics; Pathology","score_opus":0.572503393295862,"score_gpt":0.5838695199751416,"score_spread":0.011366126679279609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197461520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.414308,0.30775324,0.21974215,0.011130586,0.0013416468,0.017472593,0.01690008,0.00055775343,0.010793917],"genre_scores_gemma":[0.9247195,0.010173097,0.044688437,0.0027193793,0.0005404233,0.012860723,0.0036491277,0.000116433526,0.0005328296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.24423644,0.5776128,0.12601975,0.015923591,0.034096234,0.002111183],"domain_scores_gemma":[0.08127128,0.7091803,0.17493717,0.025048373,0.008437801,0.0011250718],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5771039,0.00199063,0.004458574,0.012135446,0.0015088078,0.005146027,0.003921212,0.003295234,0.0022672608],"category_scores_gemma":[0.7095598,0.0012569106,0.012678538,0.014204894,0.00405137,0.0061621605,0.0061241393,0.004758916,0.0003073748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008999233,0.00030279387,0.6282355,0.059511103,0.060845014,0.0005278528,0.006452482,0.012993688,0.000592176,0.013252505,0.004991851,0.2032958],"study_design_scores_gemma":[0.004896793,0.0068079876,0.7112058,0.04833283,0.05734051,0.0031266427,0.0027865719,0.027738135,0.0052661886,0.07666447,0.054563846,0.0012702303],"about_ca_topic_score_codex":0.0013829507,"about_ca_topic_score_gemma":0.0018955591,"teacher_disagreement_score":0.4228961,"about_ca_system_score_codex":0.0038348855,"about_ca_system_score_gemma":0.0065828674,"threshold_uncertainty_score":0.5215062},"labels":[],"label_agreement":null},{"id":"W3198724220","doi":"10.6004/jnccn.2021.7014","title":"Trajectories of Suffering in the Last Year of Life Among Patients With a Solid Metastatic Cancer","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research","funders":"Duke-NUS Medical School","keywords":"Medicine; Cancer; Confounding; Odds ratio; Cohort; Prospective cohort study; Cohort study; Pediatrics; Internal medicine","score_opus":0.09487665685362046,"score_gpt":0.386034090513386,"score_spread":0.29115743365976554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198724220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99957913,0.000050227965,0.000038081766,0.00004599692,0.0000016118767,0.0000035924918,0.00019192765,9.984203e-7,0.00008845751],"genre_scores_gemma":[0.9994399,0.00004285042,0.00005243548,0.00000897423,0.000001791472,0.0000045108527,0.0004079404,5.8315646e-7,0.00004104333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968135,0.00008339206,0.000044198845,0.00005691841,0.000048614005,0.00008549796],"domain_scores_gemma":[0.9981371,0.00019430417,0.0009780385,0.000079080004,0.00014614282,0.00046531693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065299106,0.00020980107,0.00025702408,0.00052115147,0.00060271303,0.00077035883,0.00032401053,0.00032304387,0.0012649063],"category_scores_gemma":[0.0027728954,0.00015889796,0.0006083241,0.00072722416,0.0002501562,0.0005572474,0.00086543045,0.000695774,0.00016808412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028652166,0.00001194072,0.9991935,0.0000033817232,0.000018915543,0.000026560327,0.00012150496,0.00006553607,0.000037170783,0.000009472283,0.00003783342,0.00044556815],"study_design_scores_gemma":[0.0000018839692,0.000057930672,0.999047,0.000005566706,0.000007364145,0.00010301389,0.00039524617,0.00026595374,0.000013870411,0.0000288497,0.00006986207,0.0000034410407],"about_ca_topic_score_codex":0.0081981,"about_ca_topic_score_gemma":0.012646347,"teacher_disagreement_score":0.0081981,"about_ca_system_score_codex":0.00046985626,"about_ca_system_score_gemma":0.00054172263,"threshold_uncertainty_score":0.016300797},"labels":[],"label_agreement":null},{"id":"W3201171945","doi":"10.6004/jnccn.2021.7003","title":"Associations With Definitive Outcomes and Clinical Benefit of Cancer Drugs at the Time of Marketing Approval and in the Postmarketing Period","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Postmarketing surveillance; Clinical trial; Adverse effect; Internal medicine; Oncology","score_opus":0.038686617396315556,"score_gpt":0.29488366663683363,"score_spread":0.25619704924051806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201171945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654286,0.023893358,0.001499165,0.0008917822,0.000059335038,0.00019357215,0.0037840954,0.000017035753,0.004233028],"genre_scores_gemma":[0.9965096,0.0010044123,0.0006150225,0.00014914818,0.00008061395,0.0001060454,0.0013602288,0.0000065101653,0.00016837608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98934656,0.003634006,0.0029824476,0.0012192442,0.0022445414,0.0005732473],"domain_scores_gemma":[0.839153,0.07484713,0.0761022,0.0035172254,0.0040262607,0.0023541325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018311761,0.00026558177,0.0006651655,0.0022737202,0.00029909378,0.0013085752,0.00038465072,0.00053501886,0.0029577764],"category_scores_gemma":[0.053300694,0.00011502503,0.0018712262,0.0030149193,0.00081035215,0.0018143195,0.0009990457,0.0014098093,0.0001955846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022947486,0.000069613045,0.97891355,0.00045548886,0.0008620277,0.00007990801,0.000100311816,0.00040442863,0.000366822,0.0005499568,0.00037766702,0.0155254165],"study_design_scores_gemma":[0.00008490065,0.0007379265,0.9948666,0.00015645834,0.00049723545,0.00036088264,0.0001090619,0.00028567528,0.00028976006,0.00060621934,0.001986826,0.000018257388],"about_ca_topic_score_codex":0.00039139725,"about_ca_topic_score_gemma":0.00068367046,"teacher_disagreement_score":0.018311761,"about_ca_system_score_codex":0.0007566152,"about_ca_system_score_gemma":0.0007547274,"threshold_uncertainty_score":0.096842945},"labels":[],"label_agreement":null},{"id":"W3217732564","doi":"10.6004/jnccn.2021.5109","title":"Diffuse Large B-Cell Lymphoma: Optimizing Therapy for Relapsed/Refractory Disease","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Medicine; Refractory (planetary science); Lymphoma; Diffuse large B-cell lymphoma; Oncology; Internal medicine; Disease; Intensive care medicine","score_opus":0.03837105324427232,"score_gpt":0.31363689596042993,"score_spread":0.2752658427161576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217732564","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027597344,0.59015745,0.010893978,0.336261,0.00514422,0.00020946193,0.00018967592,0.00032664379,0.029220244],"genre_scores_gemma":[0.28901502,0.5459211,0.033958126,0.09979033,0.01653959,0.0003702723,0.0004034995,0.0001744523,0.013827584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99941623,0.0002819153,0.000059652873,0.000054925513,0.000101739526,0.00008555831],"domain_scores_gemma":[0.9994429,0.00016485286,0.000085013286,0.00001690966,0.00010677464,0.00018350841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015799565,0.00035282905,0.00053713296,0.0005103805,0.00033851876,0.0010060852,0.00047610546,0.0007265273,0.0015359311],"category_scores_gemma":[0.0023403496,0.00009830223,0.00038513998,0.00028219493,0.00038941466,0.0012141898,0.0006284326,0.0024169588,0.00050783786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044266938,0.00029361073,0.004383219,0.0012697618,0.0000972282,0.0006056022,0.0003220425,0.0015380648,0.0036605045,0.006668553,0.10868493,0.87203366],"study_design_scores_gemma":[0.0005870959,0.0013496234,0.011796338,0.0043877265,0.00036748793,0.0048891595,0.00089173915,0.0034594077,0.0030005763,0.020249782,0.9489474,0.00007361947],"about_ca_topic_score_codex":0.0009278993,"about_ca_topic_score_gemma":0.0038024439,"teacher_disagreement_score":0.0015799565,"about_ca_system_score_codex":0.0014060035,"about_ca_system_score_gemma":0.0014122347,"threshold_uncertainty_score":0.010201275},"labels":[],"label_agreement":null},{"id":"W4200025323","doi":"10.6004/jnccn.2021.7066","title":"Combination Therapy of Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Phase II Randomized Double-Blind Controlled Trial","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center","keywords":"Medicine; Adverse effect; Randomized controlled trial; Internal medicine; Dexamethasone; Quality of life (healthcare); Population; Cancer; Physical therapy","score_opus":0.09430723708718246,"score_gpt":0.40363802345610855,"score_spread":0.3093307863689261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200025323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9282309,0.020808501,0.0028275307,0.0017544562,0.0023682674,0.03790587,0.002402309,0.0004330464,0.0032691036],"genre_scores_gemma":[0.9140734,0.010896901,0.006852592,0.0025754161,0.0017472117,0.058076188,0.0013878464,0.00004555586,0.0043448694],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99848205,0.0008705663,0.00012652701,0.00024261016,0.00012268614,0.00015559468],"domain_scores_gemma":[0.99841547,0.0005383358,0.0003615955,0.00014379155,0.0001384054,0.0004024308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002782139,0.001968522,0.0055134427,0.00078503025,0.0006611683,0.0012428222,0.001408855,0.002586782,0.009215712],"category_scores_gemma":[0.0029598922,0.0009615257,0.002132556,0.0009002104,0.001645719,0.0012901748,0.00060188235,0.002719164,0.001225564],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98034555,0.0077103116,0.00018046192,0.0009931626,0.0006545347,0.000022083248,0.000026236388,0.00013720783,0.0009029935,0.00005959163,0.0004150505,0.008552763],"study_design_scores_gemma":[0.98192114,0.017511388,0.00016456819,0.000021170923,0.00010272685,0.000005971112,0.000004420361,0.000073574185,0.00004050219,0.00002151078,0.00012990982,0.000003030581],"about_ca_topic_score_codex":0.00091590616,"about_ca_topic_score_gemma":0.0017988947,"teacher_disagreement_score":0.009215712,"about_ca_system_score_codex":0.00076302397,"about_ca_system_score_gemma":0.0019461939,"threshold_uncertainty_score":0.030829608},"labels":[],"label_agreement":null},{"id":"W4200032080","doi":"10.6004/jnccn.2021.7093","title":"Sustainability of Tobacco Treatment Programs in the Cancer Center Cessation Initiative","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, University of North Carolina at Chapel Hill; National Cancer Institute; School of Medicine, University of Maryland; Robert H. Lurie Comprehensive Cancer Center; Norris Cotton Cancer Center; University of North Carolina at Chapel Hill; National Institute on Drug Abuse; Dartmouth College; York University; UVA Cancer Center; Memorial Sloan-Kettering Cancer Center; University of South Carolina; Comprehensive Cancer Center, City of Hope; Hollings Cancer Center, Medical University of South Carolina; Feinberg School of Medicine; School of Medicine and Public Health, University of Wisconsin-Madison; Washington University in St. Louis; Stanford Cancer Institute; University of Wisconsin-Madison; Northwestern University; Beckman Research Institute, City of Hope","keywords":"Medicine; Smoking cessation; Center (category theory); Sustainability; Tobacco use; Environmental health; Oncology","score_opus":0.5908350087493385,"score_gpt":0.6198646113209496,"score_spread":0.029029602571611135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200032080","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28577337,0.0045173327,0.01254227,0.39032906,0.0008962579,0.003924933,0.00066951377,0.0004644954,0.30088273],"genre_scores_gemma":[0.945686,0.0019595693,0.018511772,0.02058768,0.00021954392,0.0018684187,0.0005464685,0.0000843028,0.010536409],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9715522,0.016705666,0.0007577319,0.000838438,0.005637449,0.004508562],"domain_scores_gemma":[0.9773415,0.00820058,0.0018189941,0.0011349912,0.0028212788,0.008682707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.044397675,0.000245289,0.00027198496,0.0013509986,0.0069094477,0.0098268725,0.0025461658,0.0025584786,0.0039437846],"category_scores_gemma":[0.038841818,0.0003310996,0.00068640005,0.002129222,0.0045786104,0.0043061785,0.015963437,0.004297033,0.00023922567],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021504983,0.0027108514,0.10367923,0.0010244803,0.00018526189,0.00041033488,0.022543963,0.0049920543,0.0012074718,0.24471475,0.10645359,0.511863],"study_design_scores_gemma":[0.0004781073,0.0024962092,0.12927794,0.003097546,0.00029148496,0.00025302081,0.0519403,0.0070170844,0.005056936,0.081217155,0.71862525,0.0002488985],"about_ca_topic_score_codex":0.03534864,"about_ca_topic_score_gemma":0.066961624,"teacher_disagreement_score":0.044397675,"about_ca_system_score_codex":0.019424332,"about_ca_system_score_gemma":0.12941252,"threshold_uncertainty_score":0.2348001},"labels":[],"label_agreement":null},{"id":"W4200423910","doi":"10.6004/jnccn.2021.7094","title":"Implementation Science to Improve Tobacco Cessation Services in Oncology Care","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Agency for Healthcare Research and Quality; National Institute of General Medical Sciences; National Institute on Drug Abuse; National Center for Advancing Translational Sciences; Partenariat Canadien Contre Le Cancer","keywords":"Medicine; Context (archaeology); Psychological intervention; Smoking cessation; Tobacco use; Tobacco control; Family medicine; Nursing; Environmental health; Public health","score_opus":0.3224241705783949,"score_gpt":0.6467473961898564,"score_spread":0.32432322561146154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200423910","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0069588027,0.016631382,0.030320197,0.8959967,0.0042590224,0.0031995398,0.00019353634,0.00023655966,0.042204272],"genre_scores_gemma":[0.44858453,0.051442128,0.20219366,0.26603553,0.005104714,0.016743485,0.00078822026,0.0003141813,0.008793556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.7838328,0.1845928,0.00611881,0.0035986102,0.015779579,0.006077345],"domain_scores_gemma":[0.6517289,0.28292346,0.009894839,0.014814018,0.024486456,0.01615228],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.23332052,0.0011883763,0.0014925139,0.004157908,0.006572844,0.014804661,0.0053194864,0.008676146,0.013787647],"category_scores_gemma":[0.39163306,0.00087686855,0.0028778352,0.0042004962,0.011245377,0.011348615,0.016695542,0.018324181,0.0011860302],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017149208,0.0030471627,0.010192333,0.011805232,0.0007161785,0.00015896586,0.012365215,0.004085736,0.00035008244,0.39428976,0.107392065,0.4554258],"study_design_scores_gemma":[0.001013293,0.0021072116,0.014260079,0.051243003,0.00058619294,0.0001837946,0.0259956,0.0070484,0.0020125522,0.55492574,0.3404358,0.00018845126],"about_ca_topic_score_codex":0.0135801,"about_ca_topic_score_gemma":0.014676619,"teacher_disagreement_score":0.23332052,"about_ca_system_score_codex":0.025749588,"about_ca_system_score_gemma":0.19180022,"threshold_uncertainty_score":0.9454523},"labels":[],"label_agreement":null},{"id":"W4200560749","doi":"10.6004/jnccn.2021.7092","title":"Telehealth Delivery of Tobacco Cessation Treatment in Cancer Care: An Ongoing Innovation Accelerated by the COVID-19 Pandemic","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Partenariat Canadien Contre Le Cancer; Agency for Healthcare Research and Quality; University of Louisville","keywords":"Telehealth; Medicine; Pandemic; Phone; Telemedicine; Smoking cessation; Health care; Family medicine; Ambulatory care; Medical emergency; Nursing; Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.24013154498539743,"score_gpt":0.46350132809787736,"score_spread":0.22336978311247993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200560749","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10612474,0.12264979,0.012475157,0.6794419,0.004539909,0.0005898582,0.00062706124,0.0003397546,0.07321182],"genre_scores_gemma":[0.6781477,0.18276356,0.032775793,0.087129205,0.008288017,0.0008249813,0.00067671685,0.00018125476,0.009212776],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99664056,0.0017871488,0.00017538453,0.00017726568,0.0008247383,0.00039489227],"domain_scores_gemma":[0.99173087,0.004469588,0.0007972577,0.00036930622,0.0011928589,0.0014401297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067529297,0.00016601663,0.0002517435,0.00069455366,0.0009724601,0.0032548513,0.0008269067,0.0009757822,0.006623545],"category_scores_gemma":[0.012921129,0.00013124451,0.0004371787,0.0012492846,0.0013746244,0.0028905896,0.0027095773,0.0025105153,0.00042965158],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116233176,0.00041365382,0.015505358,0.0015389168,0.000045236025,0.00015049052,0.0013685275,0.00072867435,0.0008056645,0.029899817,0.050981253,0.8984462],"study_design_scores_gemma":[0.00020544125,0.0019715326,0.08261402,0.0088549275,0.00014222982,0.00095754187,0.008836314,0.002599263,0.0020414044,0.022258325,0.86939716,0.000121740224],"about_ca_topic_score_codex":0.008934104,"about_ca_topic_score_gemma":0.02260992,"teacher_disagreement_score":0.008934104,"about_ca_system_score_codex":0.0042179385,"about_ca_system_score_gemma":0.0063823215,"threshold_uncertainty_score":0.035713315},"labels":[],"label_agreement":null},{"id":"W4200614899","doi":"10.6004/jnccn.2021.7090","title":"Involving Family and Social Support Systems in Tobacco Cessation Treatment for Patients With Cancer","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Family Support in Illness","field":"Social Sciences","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; School of Medicine and Public Health, University of Wisconsin-Madison; University of North Carolina at Chapel Hill; Agency for Healthcare Research and Quality; Norris Cotton Cancer Center; Partenariat Canadien Contre Le Cancer; Memorial Sloan-Kettering Cancer Center; University of South Carolina; Dartmouth College; University of Arizona; Massachusetts General Hospital; Virginia Commonwealth University; University of Wisconsin-Madison","keywords":"Social support; Medicine; Smoking cessation; Psychological intervention; Family medicine; Tobacco control; Family support; Cancer; Support group; Nursing; Public health; Psychiatry; Psychotherapist; Psychology; Physical therapy","score_opus":0.059081919316286216,"score_gpt":0.331173806866866,"score_spread":0.2720918875505798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200614899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7794033,0.0143523365,0.0025476452,0.14811061,0.0010089535,0.00074354466,0.00015824837,0.00007169566,0.053603694],"genre_scores_gemma":[0.98922765,0.003884432,0.0018006307,0.0031430554,0.00020249371,0.00026138118,0.000042663607,0.0000050336425,0.0014327008],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99550384,0.003511404,0.00011534165,0.00010646027,0.00029745855,0.00046545544],"domain_scores_gemma":[0.9951133,0.0013778771,0.00050608715,0.00012966225,0.00035691573,0.0025161265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049026716,0.00016737147,0.00017030786,0.0004837557,0.0042357002,0.0018124277,0.0007751258,0.0007870027,0.0030262433],"category_scores_gemma":[0.012185061,0.00010724531,0.00034292368,0.00033037126,0.00087489653,0.0011415727,0.0033385998,0.0014394021,0.00018594986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018037783,0.0016399446,0.17360638,0.00065837294,0.0001497364,0.00087759324,0.055865318,0.00060697,0.00060541375,0.002614249,0.033837866,0.7293578],"study_design_scores_gemma":[0.0004998222,0.0044155875,0.40264073,0.0048862374,0.0003775959,0.0022743419,0.22802448,0.0023115356,0.0011765448,0.0132555235,0.33997217,0.00016555437],"about_ca_topic_score_codex":0.0055039264,"about_ca_topic_score_gemma":0.023454838,"teacher_disagreement_score":0.0055039264,"about_ca_system_score_codex":0.0017029162,"about_ca_system_score_gemma":0.010882133,"threshold_uncertainty_score":0.02592814},"labels":[],"label_agreement":null},{"id":"W4210617548","doi":"10.6004/jnccn.2021.7114","title":"Incident Cancer Detection During the COVID-19 Pandemic","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Manitoba; Princess Margaret Cancer Centre; Women's College Hospital; Cancer Care Ontario; Institute of Health Services and Policy Research; Queen's University; University of Toronto; Associated Medical Services; Ontario Institute for Cancer Research; North Pacific Marine Science Organization; Manitoba Health","funders":"","keywords":"Medicine; Incidence (geometry); Cancer; Pandemic; Population; Cervical cancer; Rate ratio; Lung cancer; Cohort; Demography; Coronavirus disease 2019 (COVID-19); Internal medicine; Environmental health; Disease","score_opus":0.13858145724569573,"score_gpt":0.4264038682847975,"score_spread":0.2878224110391018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210617548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982323,0.00097561436,0.0005719621,0.001253772,0.000077303965,0.00009482723,0.010592689,0.000054227807,0.004056625],"genre_scores_gemma":[0.99508506,0.00041903948,0.00019377418,0.00026138805,0.00003247012,0.00003571679,0.0036216269,0.0000054539855,0.00034538217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989225,0.00018701862,0.00008191092,0.00023216405,0.00026615075,0.00031015265],"domain_scores_gemma":[0.9978173,0.00021605511,0.0010771997,0.00010078705,0.0005079027,0.00028069897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090410217,0.00022440868,0.00024055454,0.0007101552,0.00059518125,0.00083870516,0.00075459544,0.00048835005,0.0015794623],"category_scores_gemma":[0.0047770604,0.00026053,0.0004223784,0.0009922175,0.0003606734,0.000555106,0.0010189658,0.0007967155,0.00019963621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006877096,0.00001605195,0.99217105,0.000048156202,0.000036110385,0.00007886592,0.0003002478,0.0003057241,0.00011521727,0.00006890417,0.002562185,0.004228614],"study_design_scores_gemma":[0.000006018766,0.00004026635,0.9965258,0.00007839488,0.000020782323,0.00014479131,0.00069499307,0.00086043216,0.0000869074,0.000051441504,0.0014790068,0.00001123597],"about_ca_topic_score_codex":0.4403097,"about_ca_topic_score_gemma":0.48672736,"teacher_disagreement_score":0.4403097,"about_ca_system_score_codex":0.0041303476,"about_ca_system_score_gemma":0.0033504728,"threshold_uncertainty_score":0.87549365},"labels":[],"label_agreement":null},{"id":"W4210627757","doi":"10.6004/jnccn.2022.0009","title":"NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"Astellas Pharma; Seagen","keywords":"Medicine; Myelodysplastic syndromes; Multidisciplinary approach; Intensive care medicine; Malignancy; MEDLINE; Clinical Practice; Family medicine; Internal medicine","score_opus":0.0733164020931557,"score_gpt":0.35871192283820913,"score_spread":0.2853955207450534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210627757","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046254834,0.18693526,0.02721761,0.29425177,0.035922114,0.007943672,0.07492326,0.005798392,0.36238247],"genre_scores_gemma":[0.02430107,0.17435971,0.13489674,0.21655504,0.015105659,0.014174241,0.21083915,0.0041222647,0.2056461],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.992063,0.0024865302,0.0017625061,0.00028657928,0.0029449533,0.0004563737],"domain_scores_gemma":[0.97664726,0.005715798,0.0030610352,0.00072266377,0.012426549,0.0014266679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059305714,0.0011023633,0.0016229955,0.0044457386,0.0012293672,0.0032927196,0.003236517,0.0060412707,0.026260508],"category_scores_gemma":[0.041887943,0.0011238283,0.0017198618,0.0046220575,0.0012396596,0.0019423398,0.002409767,0.00675316,0.018517058],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006477652,0.0000430251,0.0005207435,0.0005834531,0.000024121062,0.00018639749,0.000067848385,0.00025748598,0.00016869603,0.002405121,0.9442933,0.05138505],"study_design_scores_gemma":[0.00025377545,0.000041880005,0.0021624807,0.003487279,0.00005606879,0.00096073496,0.00006880458,0.00033569615,0.00023960826,0.0032666002,0.98908114,0.000045859964],"about_ca_topic_score_codex":0.029787155,"about_ca_topic_score_gemma":0.057940345,"teacher_disagreement_score":0.029787155,"about_ca_system_score_codex":0.002923212,"about_ca_system_score_gemma":0.015255046,"threshold_uncertainty_score":0.087850094},"labels":[],"label_agreement":null},{"id":"W4210725270","doi":"10.6004/jnccn.2021.7118","title":"Preoperative and Postoperative Approaches to Gastroesophageal Cancer: What is All the Fuss About","year":2022,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Perioperative; Disease; Cancer; Radiation therapy; Intensive care medicine; Chemotherapy; Biomarker; General surgery; Surgery; Internal medicine","score_opus":0.25093225683797515,"score_gpt":0.41021314871403736,"score_spread":0.1592808918760622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210725270","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044983168,0.99874,0.000041877734,0.0006980325,0.00020537457,0.0000026510613,0.000008200439,0.0000024048072,0.00025651607],"genre_scores_gemma":[0.0003182966,0.9989636,0.00007734734,0.0003037645,0.00022637198,0.0000030657259,0.000009683213,7.290701e-7,0.000097094795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99959177,0.00010914289,0.000094198214,0.00005757035,0.00012254016,0.000024812229],"domain_scores_gemma":[0.9985257,0.000977743,0.00016746174,0.00003200153,0.00023703369,0.000060107108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011827254,0.0005966836,0.0014449258,0.0018672406,0.00030368887,0.001288885,0.00073404034,0.0012412977,0.0030047772],"category_scores_gemma":[0.0025838127,0.00023248036,0.00084431446,0.0019050627,0.0005772656,0.0021068107,0.0006164508,0.0019703216,0.0010874957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083668754,0.00003708532,0.00018725361,0.030449595,0.00013919489,0.00007610807,0.00007119305,0.00012983363,0.00022587634,0.0014668865,0.019253498,0.94787985],"study_design_scores_gemma":[0.00005537814,0.00023567976,0.0020995894,0.053558882,0.00064027414,0.0017990726,0.00028308554,0.0001305392,0.00024865245,0.0036502513,0.9372558,0.000042693937],"about_ca_topic_score_codex":0.0015449366,"about_ca_topic_score_gemma":0.0032815058,"teacher_disagreement_score":0.0030047772,"about_ca_system_score_codex":0.0005076654,"about_ca_system_score_gemma":0.0015209529,"threshold_uncertainty_score":0.010052025},"labels":[],"label_agreement":null},{"id":"W4210729420","doi":"10.6004/jnccn.2021.7113","title":"Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute","keywords":"Medicine; Adverse effect; Cancer; Common Terminology Criteria for Adverse Events; Internal medicine; Cohort; Prospective cohort study; Observational study; Cohort study; Clinical trial","score_opus":0.04286418073360021,"score_gpt":0.3641078119557966,"score_spread":0.3212436312221964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210729420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984931,0.00035210175,0.00008927551,0.000049778002,0.000010622299,0.000050504204,0.00045365075,0.0000047692656,0.00049618486],"genre_scores_gemma":[0.9989548,0.00018550816,0.00014209765,0.00008639346,0.000023731958,0.000040890725,0.00043585358,0.0000012300868,0.0001295944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989561,0.00038867566,0.00015476588,0.00014881644,0.00023608094,0.00011553551],"domain_scores_gemma":[0.9935963,0.0011974095,0.0039976966,0.00019336454,0.0004814083,0.00053389766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012234126,0.00017776819,0.0005626555,0.00040609724,0.00039297985,0.00045735447,0.00017969204,0.0003988964,0.0011162327],"category_scores_gemma":[0.004433704,0.00013056136,0.00070463656,0.00063742354,0.00018153299,0.0003147961,0.0002627649,0.0006116841,0.00016369399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005387031,0.00007765405,0.99636406,0.000023524784,0.00005967523,0.00013638199,0.00007855307,0.000058347803,0.00023327171,0.0000044240896,0.00014857676,0.0022769214],"study_design_scores_gemma":[0.000043337113,0.0017064816,0.9963361,0.000016857286,0.00006437542,0.00077853596,0.00018112527,0.00016475987,0.00024325398,0.000009489807,0.0004462211,0.000009391445],"about_ca_topic_score_codex":0.0016772824,"about_ca_topic_score_gemma":0.001909515,"teacher_disagreement_score":0.0016772824,"about_ca_system_score_codex":0.0004299138,"about_ca_system_score_gemma":0.00033084338,"threshold_uncertainty_score":0.006470144},"labels":[],"label_agreement":null},{"id":"W4221042784","doi":"10.6004/jnccn.2021.7278","title":"HSR22-173: Treatment Patterns, Healthcare Resource Use and Costs Among Patients With EGFR-Mutated Non-Small Cell Lung Cancer Following Discontinuation of Osimertinib and Platinum-Based Chemotherapy","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Osimertinib; Medicine; Discontinuation; Lung cancer; Chemotherapy; Oncology; Internal medicine; Intensive care medicine; Cancer; Adenocarcinoma","score_opus":0.0178787720146668,"score_gpt":0.3003399990160326,"score_spread":0.2824612270013658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221042784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876859,0.0007126905,0.00002978759,0.00065530895,0.000033997385,0.00003288387,0.00987471,0.000006322294,0.0009682603],"genre_scores_gemma":[0.9877771,0.0006466552,0.00008593019,0.00036681347,0.000073507625,0.000054272194,0.010127557,0.0000062297327,0.0008619139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966383,0.00006747183,0.000045454923,0.00004876359,0.000091214184,0.00008337763],"domain_scores_gemma":[0.9988512,0.000121459045,0.00054119347,0.000026178881,0.00017726472,0.0002826311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044697532,0.00023663096,0.00034238075,0.0006910632,0.00033252247,0.000536485,0.0004332906,0.0006107477,0.0019256283],"category_scores_gemma":[0.0013564426,0.00017093096,0.00077327364,0.001809926,0.000102633625,0.00038869533,0.00032139578,0.00055951386,0.0003567908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034967167,0.00008119276,0.99343055,0.000028532237,0.00014622604,0.0001329827,0.00003615288,0.00009318861,0.00012085821,0.000013476877,0.0030686122,0.00249852],"study_design_scores_gemma":[0.00002485907,0.00005863899,0.9992311,0.0000123569,0.00003262793,0.00009939863,0.00007491663,0.00012615221,0.000021262784,0.0000067317283,0.00030782734,0.0000042216366],"about_ca_topic_score_codex":0.03896101,"about_ca_topic_score_gemma":0.07141378,"teacher_disagreement_score":0.03896101,"about_ca_system_score_codex":0.00091496366,"about_ca_system_score_gemma":0.0012305487,"threshold_uncertainty_score":0.077468455},"labels":[],"label_agreement":null},{"id":"W4221104422","doi":"10.6004/jnccn.2021.7268","title":"CLO22-052: A Tale of Two Schedules: A Study of the Efficacy and Toxicity Outcomes of Extended Durvalumab Dosing in Patients with Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Durvalumab; Dosing; Toxicity; Oncology; Stage (stratigraphy); Internal medicine; Lung cancer; non-small cell lung cancer (NSCLC); Cancer; Immunotherapy","score_opus":0.020011767071446553,"score_gpt":0.30492830326985554,"score_spread":0.284916536198409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221104422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619293,0.0013027214,0.00017352036,0.0003851669,0.00008367737,0.00039906806,0.00054937345,0.000025510717,0.00088805956],"genre_scores_gemma":[0.9922145,0.0017725723,0.0006985665,0.0009996459,0.0002039014,0.00051717664,0.0011391491,0.000025743971,0.002428615],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99946946,0.00027188272,0.000022844533,0.00007079165,0.00007747001,0.00008754951],"domain_scores_gemma":[0.99929416,0.00013988692,0.00012116496,0.000053061525,0.00004044426,0.00035122855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018414494,0.0008592813,0.0014973298,0.00032735264,0.00034306297,0.00087321247,0.00067241245,0.0009235483,0.0023890792],"category_scores_gemma":[0.0009990818,0.00037448166,0.0012442832,0.00035052947,0.0005365653,0.0008268979,0.00033421325,0.0025653422,0.0003725661],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6975866,0.06409843,0.018749926,0.00063139957,0.0034908594,0.00034405602,0.00051016343,0.0021586225,0.037867956,0.00046411235,0.006640414,0.16745748],"study_design_scores_gemma":[0.32294086,0.63914156,0.025904676,0.000038546095,0.001465133,0.0002800668,0.000107270265,0.0013891994,0.003462553,0.0001153677,0.005075557,0.00007921087],"about_ca_topic_score_codex":0.0017888534,"about_ca_topic_score_gemma":0.005499658,"teacher_disagreement_score":0.0023890792,"about_ca_system_score_codex":0.00089253776,"about_ca_system_score_gemma":0.0012765378,"threshold_uncertainty_score":0.009738684},"labels":[],"label_agreement":null},{"id":"W4255357567","doi":"10.6004/jnccn.2007.0060","title":"Point: Active Surveillance for Favorable Risk Prostate Cancer","year":2007,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Disease; Comorbidity; Cancer; Intervention (counseling); Prostate; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.4769247467430893,"score_gpt":0.5108862904012774,"score_spread":0.0339615436581881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255357567","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023556757,0.9903198,0.0003741453,0.0042304783,0.00079212006,0.000039838673,0.000051941985,0.000013438867,0.003942611],"genre_scores_gemma":[0.0036969811,0.9901433,0.00051720795,0.0024634216,0.0012162585,0.000040748084,0.00009862189,0.000003366125,0.0018201111],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992261,0.00029585452,0.00008717964,0.00006882902,0.00029621902,0.000025813073],"domain_scores_gemma":[0.9976981,0.001390438,0.00034596134,0.000046837748,0.0004303699,0.000088124994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015555226,0.00054527796,0.0013351985,0.0018038137,0.00022020833,0.00090096204,0.00078587065,0.001714303,0.008283721],"category_scores_gemma":[0.0052587665,0.00016151146,0.0009001974,0.001812695,0.0006526405,0.0012230066,0.00052729895,0.0022633786,0.0032649918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121034274,0.000046481127,0.00069276994,0.019139018,0.00021355663,0.0002026214,0.00003955297,0.00024208806,0.00023385836,0.007229869,0.100907564,0.87093145],"study_design_scores_gemma":[0.00024154395,0.00024742322,0.010073571,0.058242224,0.00043644273,0.004797916,0.00016753566,0.00023582531,0.0004783341,0.013488367,0.91155016,0.0000405863],"about_ca_topic_score_codex":0.0012830634,"about_ca_topic_score_gemma":0.0024642327,"teacher_disagreement_score":0.008283721,"about_ca_system_score_codex":0.0006647412,"about_ca_system_score_gemma":0.0013563966,"threshold_uncertainty_score":0.027711868},"labels":[],"label_agreement":null},{"id":"W4281858263","doi":"10.6004/jnccn.2022.5020","title":"The Future of Telemedicine in Oncology","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Telemedicine; Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); Socioeconomic status; Telehealth; Health care; Family medicine; Medical emergency; Nursing; Internal medicine; Economic growth; Environmental health; Population","score_opus":0.06411557709359854,"score_gpt":0.4187124715446378,"score_spread":0.35459689445103926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281858263","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034776016,0.2369912,0.0011441907,0.6833211,0.008087062,0.000017611235,0.00016752297,0.000109588516,0.066684105],"genre_scores_gemma":[0.22196913,0.56371343,0.0055781496,0.15252788,0.029535664,0.000094831565,0.00028023723,0.00010051797,0.02620024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99792045,0.0010607878,0.00010626981,0.00012332592,0.0005074546,0.00028176222],"domain_scores_gemma":[0.98742515,0.0063300934,0.00080021936,0.00038708368,0.0019416607,0.0031158167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043578963,0.000256421,0.0002688125,0.001381843,0.0013747653,0.0048359823,0.00063746615,0.0041459817,0.028106658],"category_scores_gemma":[0.009364499,0.00013620636,0.00042043554,0.00106228,0.0023714732,0.0054815356,0.0027291726,0.004310292,0.002677901],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008614288,0.00018703341,0.003983465,0.0015319643,0.000023687577,0.00031156768,0.000870952,0.0005132404,0.0004679786,0.106446266,0.34678012,0.5387976],"study_design_scores_gemma":[0.00001645327,0.00012244577,0.0043890686,0.0041634436,0.000014527994,0.0006638549,0.0018219753,0.0003503795,0.00020284754,0.030512799,0.95771366,0.000028541846],"about_ca_topic_score_codex":0.002731975,"about_ca_topic_score_gemma":0.0052041323,"teacher_disagreement_score":0.028106658,"about_ca_system_score_codex":0.0035821132,"about_ca_system_score_gemma":0.0057483087,"threshold_uncertainty_score":0.09402615},"labels":[],"label_agreement":null},{"id":"W4283014330","doi":"10.6004/jnccn.2022.7014","title":"Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based Study","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Chemoimmunotherapy; Hazard ratio; Interquartile range; Proportional hazards model; Population; Diffuse large B-cell lymphoma; Internal medicine; Comorbidity; Retrospective cohort study; Lymphoma; Rituximab; Confidence interval","score_opus":0.030460634555253694,"score_gpt":0.2936127694747425,"score_spread":0.2631521349194888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283014330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993088,0.00012542425,0.00003378524,0.000028479993,0.0000027361411,0.000011424436,0.00031563544,0.0000012291247,0.0001724457],"genre_scores_gemma":[0.9995369,0.000057969246,0.000024137813,0.000023565894,0.000004329884,0.000006238543,0.00030065005,5.7257773e-7,0.00004570699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995728,0.00005413446,0.000034668927,0.000105593834,0.00011330023,0.000119414435],"domain_scores_gemma":[0.99905914,0.00006724433,0.00041231903,0.00007265065,0.00014260721,0.00024614812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006473233,0.0002842937,0.0003542708,0.0006092361,0.00075317227,0.0007264844,0.000563515,0.00034066685,0.0006928652],"category_scores_gemma":[0.0014888353,0.00026860932,0.0004700914,0.00103134,0.00044051243,0.00047434057,0.0005535566,0.00050852017,0.00012692389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027140097,0.000013201935,0.99951327,0.0000030735123,0.000019708965,0.000030125984,0.000062076215,0.0000111727,0.000036122336,0.000005003464,0.000042041334,0.00023710955],"study_design_scores_gemma":[0.0000055134333,0.000035717152,0.9995377,0.0000037255552,0.000012026125,0.00008481961,0.00013729086,0.00005998686,0.0000072081816,0.0000063914563,0.00010762445,0.0000020686418],"about_ca_topic_score_codex":0.15946694,"about_ca_topic_score_gemma":0.21010637,"teacher_disagreement_score":0.15946694,"about_ca_system_score_codex":0.0017789587,"about_ca_system_score_gemma":0.0015495686,"threshold_uncertainty_score":0.31707746},"labels":[],"label_agreement":null},{"id":"W4283032396","doi":"10.6004/jnccn.2021.7107","title":"Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Jewish General Hospital; Mount Sinai Hospital; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; STK11; Germline mutation; KRAS; Pancreatic cancer; Asymptomatic; Adenocarcinoma; Cancer; Internal medicine; Oncology; Surgical oncology; Gastroenterology; Colorectal cancer; Mutation; Gene","score_opus":0.07576385808459944,"score_gpt":0.37832339655324315,"score_spread":0.3025595384686437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283032396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799566,0.011563437,0.0004981482,0.0044897073,0.0001455751,0.000014234471,0.00020656109,0.000048306523,0.0030774768],"genre_scores_gemma":[0.9958781,0.0023701661,0.00046436547,0.0008267436,0.00016303877,0.000011126207,0.00019628063,0.000005700759,0.000084555984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993087,0.00021355797,0.00009837444,0.00013989564,0.00013565473,0.000103736784],"domain_scores_gemma":[0.9949232,0.0015070185,0.0022270496,0.00022071564,0.00039334584,0.0007287809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012171268,0.00017220894,0.00047616145,0.00048691747,0.00042607522,0.0005806266,0.00027500157,0.0010239815,0.00073177594],"category_scores_gemma":[0.008123932,0.00013446013,0.00029694295,0.0007116897,0.00043381445,0.00090613356,0.0002740175,0.00062013854,0.00011629456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004938341,0.00007449114,0.93269473,0.00012220396,0.00007904428,0.0010059958,0.00021847214,0.00013844355,0.0009510517,0.000114849594,0.0016502059,0.062456638],"study_design_scores_gemma":[0.000049881903,0.0006601768,0.9843454,0.0003022735,0.0001934183,0.009126198,0.0006737134,0.00047969015,0.0004618611,0.00041168294,0.0032764666,0.000019402436],"about_ca_topic_score_codex":0.002572857,"about_ca_topic_score_gemma":0.0051784427,"teacher_disagreement_score":0.002572857,"about_ca_system_score_codex":0.00040702333,"about_ca_system_score_gemma":0.0007683533,"threshold_uncertainty_score":0.0064368844},"labels":[],"label_agreement":null},{"id":"W4285099105","doi":"10.6004/jnccn.2022.7007","title":"Online Pharmacy Accessibility of Imatinib, An Oral Chemotherapy Medication","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Imatinib; Medical prescription; Pharmacist; Advertising; Quarter (Canadian coin); Certification; Family medicine; Internet privacy; Business; Internal medicine; Pharmacology","score_opus":0.18536691750635576,"score_gpt":0.4807106139900732,"score_spread":0.29534369648371744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285099105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692504,0.0018903004,0.00037645618,0.00081812905,0.000020070778,0.00010808272,0.0037525003,0.00010248605,0.023681624],"genre_scores_gemma":[0.9935086,0.0015482667,0.00083054404,0.0003258769,0.00008439269,0.000035749625,0.0017493704,0.000020680076,0.0018965564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899095,0.0003037908,0.00015364317,0.00010914305,0.00036373455,0.00007878083],"domain_scores_gemma":[0.9898448,0.0032236844,0.0053538415,0.00026310052,0.0008421783,0.0004723825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064080843,0.00015743251,0.00021120661,0.002206828,0.00041140863,0.0012817523,0.00032752028,0.00038938643,0.010924908],"category_scores_gemma":[0.007733752,0.00010898865,0.0002685978,0.0016858517,0.00021839193,0.0013591652,0.0006414852,0.00037987783,0.002154117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005016402,0.00035721264,0.86111087,0.0008048978,0.0000804208,0.001080831,0.00079376646,0.00014146618,0.0012271149,0.00026103645,0.0065866676,0.12705408],"study_design_scores_gemma":[0.000037393806,0.00037232167,0.9748571,0.0003540039,0.00015666339,0.004202832,0.0011996859,0.00086660555,0.0014973372,0.00024448044,0.016183995,0.000027639519],"about_ca_topic_score_codex":0.00199493,"about_ca_topic_score_gemma":0.0026685365,"teacher_disagreement_score":0.010924908,"about_ca_system_score_codex":0.00037418088,"about_ca_system_score_gemma":0.00051703193,"threshold_uncertainty_score":0.036547422},"labels":[],"label_agreement":null},{"id":"W4290958807","doi":"10.6004/jnccn.2022.7033","title":"Association of Polypharmacy and Potentially Inappropriate Medications With Frailty Among Older Adults With Blood Cancers","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Dana-Farber/Harvard Cancer Center; National Institute on Aging; National Cancer Institute; National Institutes of Health; Brigham and Women's Hospital; U.S. Department of Veterans Affairs","keywords":"Medicine; Polypharmacy; Odds ratio; Anticholinergic; Odds; Comorbidity; Beers Criteria; Geriatric oncology; Internal medicine; Geriatrics; Cross-sectional study; Cancer; Logistic regression; Psychiatry","score_opus":0.04049587474737516,"score_gpt":0.33943084726148176,"score_spread":0.2989349725141066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290958807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979395,0.0007144409,0.00009562992,0.00019045832,0.0000099345125,0.000010588695,0.0004923872,0.000003869888,0.00054307055],"genre_scores_gemma":[0.9993469,0.00018123015,0.000081405764,0.00004849177,0.000017073424,0.0000055088594,0.00025053156,7.7435834e-7,0.00006814835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927026,0.00014996815,0.00014759411,0.00013311478,0.00019504696,0.0001040818],"domain_scores_gemma":[0.9946016,0.00066697213,0.0034828759,0.00022592196,0.00053861045,0.00048406457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010879237,0.0002394411,0.0003043236,0.00091728417,0.00040340444,0.000620813,0.0003536634,0.00039350954,0.0014095529],"category_scores_gemma":[0.006163349,0.00021497914,0.0006595722,0.00094564655,0.00020770202,0.0005906026,0.000744191,0.0009067342,0.00013861644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001850681,0.000010830388,0.9989863,0.0000066206603,0.000030326903,0.0000128840165,0.000014939894,0.00001707428,0.000016029466,0.000005306771,0.000051676725,0.00082953915],"study_design_scores_gemma":[0.0000015816811,0.000026220741,0.9996081,0.000009324548,0.000019024435,0.00009170722,0.000030485793,0.00012522202,0.000011601312,0.000013940413,0.00006127771,0.0000015531118],"about_ca_topic_score_codex":0.009283947,"about_ca_topic_score_gemma":0.016252581,"teacher_disagreement_score":0.009283947,"about_ca_system_score_codex":0.0004469917,"about_ca_system_score_gemma":0.0004273205,"threshold_uncertainty_score":0.018459857},"labels":[],"label_agreement":null},{"id":"W4290959419","doi":"10.6004/jnccn.2022.7029","title":"Regional Variations in Clinical Trial Outcomes in Oncology","year":2022,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hazard ratio; Subgroup analysis; Random effects model; Internal medicine; High income countries; Clinical endpoint; Cohort; Clinical trial; Demography; Oncology; Confidence interval; Meta-analysis; Developing country","score_opus":0.5530678697641415,"score_gpt":0.5571093237104976,"score_spread":0.004041453946356133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290959419","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23652199,0.5236362,0.16903503,0.025681417,0.002491085,0.0063583064,0.0147532215,0.00085524016,0.020667432],"genre_scores_gemma":[0.95077664,0.012529095,0.025888097,0.004284484,0.0008722423,0.0029694457,0.0020372067,0.00027758733,0.00036516238],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.49616346,0.3361643,0.10048273,0.03683978,0.027629282,0.0027204137],"domain_scores_gemma":[0.1904874,0.5893124,0.16388243,0.036587797,0.01863407,0.0010959445],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.35511717,0.00094343047,0.0037516016,0.008633381,0.0010042479,0.005680068,0.0031610527,0.0019107151,0.003895659],"category_scores_gemma":[0.6083646,0.0011320097,0.008453322,0.013514955,0.004368579,0.0050947475,0.0055291364,0.00250822,0.00047064156],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047432277,0.00014228169,0.5886936,0.05639078,0.10404738,0.0006662833,0.0062837643,0.012040916,0.0012782916,0.026354795,0.011351207,0.18800747],"study_design_scores_gemma":[0.0023866352,0.0017433318,0.69738233,0.039950572,0.06508415,0.0027802186,0.0036964223,0.010628739,0.003169612,0.10758344,0.06510831,0.00048618772],"about_ca_topic_score_codex":0.003828057,"about_ca_topic_score_gemma":0.004049331,"teacher_disagreement_score":0.35511717,"about_ca_system_score_codex":0.004684883,"about_ca_system_score_gemma":0.0043966845,"threshold_uncertainty_score":0.79525536},"labels":[],"label_agreement":null},{"id":"W4294982915","doi":"10.6004/jnccn.2022.7028","title":"Prevalence of Breast Cancer Survivors Among Canadian Women","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Toronto Rehabilitation Institute; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Survivorship curve; Cancer; Demography; Gerontology; Internal medicine","score_opus":0.021276924556063274,"score_gpt":0.27881312476170383,"score_spread":0.25753620020564055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294982915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9008433,0.004608452,0.00038983786,0.001603728,0.000059052094,0.0001972477,0.07026561,0.00010537549,0.021927347],"genre_scores_gemma":[0.9815088,0.003186717,0.00067019527,0.00022250679,0.000017719387,0.00007929329,0.012359261,0.000011419404,0.0019441111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992267,0.000027426864,0.000042635245,0.00008986476,0.0004503276,0.00016296803],"domain_scores_gemma":[0.9988482,0.000045774752,0.00020976254,0.000021379727,0.00070255116,0.0001723353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005232537,0.0003875934,0.0002692973,0.0034457275,0.0019002217,0.0008291352,0.0010113723,0.0003290705,0.003648444],"category_scores_gemma":[0.0018106265,0.00024849531,0.00060939434,0.004443059,0.00032707126,0.00030024655,0.0005836892,0.00035189255,0.00039510522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038088114,0.000011237554,0.9844753,0.00016205992,0.000060605555,0.00010896169,0.00053904107,0.00014184392,0.00018751276,0.0001569261,0.0055432897,0.008574998],"study_design_scores_gemma":[0.0000043981795,0.000014008827,0.9940766,0.00009786824,0.00004705825,0.00023526477,0.00075749896,0.0002580091,0.00006385162,0.000035280038,0.0043945895,0.000015648482],"about_ca_topic_score_codex":0.99229866,"about_ca_topic_score_gemma":0.99285346,"teacher_disagreement_score":0.018842053,"about_ca_system_score_codex":0.018842053,"about_ca_system_score_gemma":0.021688422,"threshold_uncertainty_score":0.13670933},"labels":[],"label_agreement":null},{"id":"W4294982963","doi":"10.6004/jnccn.2022.7038","title":"Healthcare Cost Trajectories in the Last 2 Years of Life Among Patients With a Solid Metastatic Cancer: A Prospective Cohort Study","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research","funders":"","keywords":"Medicine; Health care; Cohort; Cancer; Trajectory; Life expectancy; Cohort study; Cost effectiveness; Demography; Gerontology; Environmental health; Internal medicine; Population; Risk analysis (engineering)","score_opus":0.0341766775942928,"score_gpt":0.2792527583144628,"score_spread":0.24507608072016998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294982963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992879,0.000046361238,0.000059870385,0.000023885394,0.0000021877236,0.000011527794,0.0004903639,0.0000014748064,0.00007650246],"genre_scores_gemma":[0.99865,0.000067547866,0.000122063895,0.000023487706,0.000004248119,0.000021734886,0.0010347526,0.0000018779675,0.00007429861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999553,0.00010059236,0.00006136673,0.00012667335,0.000068404006,0.00008991588],"domain_scores_gemma":[0.998645,0.00016463958,0.0005632567,0.00016924649,0.0001870148,0.000270819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009421607,0.00035474446,0.00041204583,0.0007791823,0.00079064805,0.0009758045,0.00046152316,0.00054408,0.0010728483],"category_scores_gemma":[0.0022833701,0.00037661058,0.0010953393,0.0014672882,0.00023360734,0.0009253871,0.0007158417,0.00096900656,0.0002608986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007687968,0.000034404275,0.999258,0.0000032473574,0.000041094096,0.000041918076,0.000079234225,0.00003913217,0.000038912563,0.000010725589,0.0000558877,0.0003205832],"study_design_scores_gemma":[0.000013475677,0.0001893621,0.99842036,0.000008558558,0.000040487084,0.00024875323,0.00036841878,0.00049670745,0.000023255434,0.00003150207,0.00015051875,0.0000086189575],"about_ca_topic_score_codex":0.016181018,"about_ca_topic_score_gemma":0.015915299,"teacher_disagreement_score":0.016181018,"about_ca_system_score_codex":0.0005689383,"about_ca_system_score_gemma":0.0006580433,"threshold_uncertainty_score":0.032173693},"labels":[],"label_agreement":null},{"id":"W4294983054","doi":"10.6004/jnccn.2022.7041","title":"FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"National Institute on Minority Health and Health Disparities; National Cancer Institute","keywords":"Medicine; Neoadjuvant therapy; Internal medicine; Adenocarcinoma; Oncology; Nat; Multivariate analysis; Pancreatic ductal adenocarcinoma; Univariate analysis; Odds ratio; Complete response; Gastroenterology; Pancreatic cancer; Cancer; Chemotherapy","score_opus":0.04880449726578326,"score_gpt":0.35505449688932406,"score_spread":0.3062499996235408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294983054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99959356,0.00016819795,0.000059611306,0.000019169454,0.0000018721812,0.000002161128,0.00002724061,0.0000019461702,0.0001261827],"genre_scores_gemma":[0.99976474,0.00004363884,0.000076347605,0.0000073949213,0.0000046615082,0.0000023052428,0.00006890856,7.001754e-7,0.000031360138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986887,0.000055207514,0.000020482532,0.000017465703,0.000019051986,0.000018825358],"domain_scores_gemma":[0.99890625,0.00052694784,0.00026436753,0.000027308726,0.0000741014,0.000201074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056824216,0.00016273657,0.00016671048,0.0003536413,0.00010155727,0.00027888635,0.00012143391,0.00020114279,0.0009199129],"category_scores_gemma":[0.001858703,0.000101701764,0.00015409307,0.00020213677,0.00016963869,0.00019041423,0.00015965612,0.00022373271,0.00022757956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031833147,0.000020198702,0.9968298,0.0000062337567,0.0000093449835,0.000095035,0.000016927583,0.0001241583,0.00058679667,0.0000037898055,0.000036033565,0.00195333],"study_design_scores_gemma":[0.000020029476,0.00044371973,0.99591005,0.000008217495,0.000029730092,0.0014015593,0.000098142016,0.0012601655,0.0005604398,0.000024659359,0.0002396866,0.0000034828922],"about_ca_topic_score_codex":0.00030646884,"about_ca_topic_score_gemma":0.000658458,"teacher_disagreement_score":0.0009199129,"about_ca_system_score_codex":0.00014555386,"about_ca_system_score_gemma":0.000092500486,"threshold_uncertainty_score":0.0030773878},"labels":[],"label_agreement":null},{"id":"W4308772617","doi":"10.6004/jnccn.2022.7052","title":"Association Between Frailty and Time Alive and At Home After Cancer Surgery Among Older Adults: A Population-Based Analysis","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Frailty in Older Adults","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Manitoba Health; Health Sciences Centre; University of Toronto; University of Manitoba; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Ipsen; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research","keywords":"Medicine; Interquartile range; Hazard ratio; Proportional hazards model; Cancer; Perioperative; Surgery; Population; Retrospective cohort study; Breast cancer; Cohort; Cohort study; Internal medicine; Confidence interval","score_opus":0.019034249641618747,"score_gpt":0.2800684600469516,"score_spread":0.2610342104053328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308772617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983897,0.00023832051,0.00007153769,0.000034467175,0.0000034797765,0.000009538712,0.0011214847,0.0000029923349,0.00012849135],"genre_scores_gemma":[0.99891937,0.00009649686,0.000046046327,0.000015869158,0.000005158156,0.0000078481435,0.0008635354,0.000001040011,0.00004480824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993606,0.00011671367,0.00007686235,0.00016816804,0.00013997708,0.00013768818],"domain_scores_gemma":[0.99795145,0.00028833005,0.00086684164,0.00024368089,0.00028346953,0.00036612697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012927146,0.00033952622,0.0004962826,0.00094292767,0.00050827593,0.0007547713,0.0006336047,0.00045368297,0.0008484263],"category_scores_gemma":[0.0025093239,0.00028851896,0.0013252092,0.0016447353,0.00032298538,0.00035098073,0.0006650742,0.00061489874,0.000092624236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062869374,0.000010285503,0.9993217,0.000006136672,0.00013417275,0.000019471157,0.000031122923,0.000036740974,0.000029344574,0.0000059505046,0.000064934626,0.00027737388],"study_design_scores_gemma":[0.000007808095,0.000031468,0.99944586,0.0000052082964,0.00006847146,0.000036220797,0.00006279605,0.0002348956,0.000006790904,0.000008655897,0.00008888829,0.0000029590576],"about_ca_topic_score_codex":0.16759203,"about_ca_topic_score_gemma":0.203654,"teacher_disagreement_score":0.16759203,"about_ca_system_score_codex":0.0014126982,"about_ca_system_score_gemma":0.0014017532,"threshold_uncertainty_score":0.33323312},"labels":[],"label_agreement":null},{"id":"W4308937667","doi":"10.6004/jnccn.2022.7075","title":"Incident Cancer Detection During Multiple Waves of COVID-19: The Tsunami After the Earthquake","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; Cancer Care Ontario; Queen's University; Institute of Health Services and Policy Research; Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Clearance; Pandemic; Incidence (geometry); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Cancer; Population; Seismology; Virology; Internal medicine; Environmental health; Geology; Optics","score_opus":0.06427195668621836,"score_gpt":0.37535593275086876,"score_spread":0.3110839760646504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308937667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97128165,0.0016129919,0.0010525052,0.001357294,0.00013967311,0.00018137984,0.019133205,0.000026116642,0.0052152476],"genre_scores_gemma":[0.9865422,0.000989815,0.00060939166,0.0006285221,0.00015679986,0.00016647826,0.009703685,0.000026921218,0.0011762109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997486,0.00036354872,0.00023604825,0.00033216598,0.0006676534,0.00091459445],"domain_scores_gemma":[0.9944253,0.00066585303,0.0019864333,0.00041077603,0.001832891,0.00067862263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020492813,0.00037780948,0.00062351127,0.0010402323,0.0012874104,0.0015956097,0.0011796036,0.0005813052,0.0020627112],"category_scores_gemma":[0.009617302,0.00033679302,0.0009973248,0.0031545612,0.00053847866,0.0010220532,0.0018251741,0.0011752958,0.00027300208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020742472,0.00002852521,0.99128014,0.00012142729,0.00020210868,0.000053881336,0.0004952759,0.00025086547,0.00006605275,0.00013624538,0.002430732,0.0047272877],"study_design_scores_gemma":[0.000015644557,0.000062853,0.99488467,0.00011074231,0.00016164393,0.000045327397,0.0007380427,0.0002768596,0.000088837,0.000067222434,0.0035294346,0.000018763303],"about_ca_topic_score_codex":0.6595332,"about_ca_topic_score_gemma":0.8044346,"teacher_disagreement_score":0.6595332,"about_ca_system_score_codex":0.0063963314,"about_ca_system_score_gemma":0.00871957,"threshold_uncertainty_score":0.68494374},"labels":[],"label_agreement":null},{"id":"W4320892900","doi":"10.6004/jnccn.2022.7087","title":"Patient-Reported Symptom Complexity and Acute Care Utilization Among Patients With Cancer: A Population-Based Study Using a Novel Symptom Complexity Algorithm and Observational Data","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Emergency department; Observational study; Logistic regression; Odds; Retrospective cohort study; Ambulatory; Odds ratio; Population; Health care; Cohort; Diagnosis code; Emergency medicine; Cancer; Algorithm; Internal medicine; Psychiatry","score_opus":0.19698948836998023,"score_gpt":0.37252836190708705,"score_spread":0.17553887353710682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320892900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988611,0.000053416243,0.000096640506,0.000031053118,0.0000037678353,0.000047391553,0.0007812533,0.0000030210656,0.00012234332],"genre_scores_gemma":[0.99815637,0.0000524979,0.00026915592,0.000040511022,0.00000851422,0.00005489385,0.0013597137,0.0000021371998,0.000056108063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980026,0.0005492595,0.00019642212,0.00043823704,0.000547447,0.00026603497],"domain_scores_gemma":[0.9940165,0.00090890133,0.0028541991,0.00053052267,0.0009464048,0.000743338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002548263,0.0004954273,0.00046199458,0.0015055628,0.0010855285,0.0015679828,0.0010481826,0.00068805576,0.0007714296],"category_scores_gemma":[0.0063226996,0.0005211463,0.0009932176,0.0032449856,0.00084403943,0.0007253886,0.0011243568,0.0011078137,0.00015583071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065051034,0.00003785065,0.999498,0.000003859205,0.000042457876,0.000008769863,0.000043050924,0.000032776257,0.000021231945,0.000005588916,0.00005359399,0.00018779426],"study_design_scores_gemma":[0.00003586306,0.00012674366,0.99848,0.0000074836726,0.00004551589,0.000063882355,0.00026022087,0.0008130716,0.00002578428,0.000012836583,0.00011961801,0.000008973172],"about_ca_topic_score_codex":0.34077296,"about_ca_topic_score_gemma":0.37329733,"teacher_disagreement_score":0.34077296,"about_ca_system_score_codex":0.0046027554,"about_ca_system_score_gemma":0.0045100776,"threshold_uncertainty_score":0.67757887},"labels":[],"label_agreement":null},{"id":"W4320893540","doi":"10.6004/jnccn.2022.7083","title":"Androgen Deprivation Therapy and Risk of Cardiovascular Disease in Patients With Prostate Cancer Based on Existence of Cardiovascular Risk","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Internal medicine; Hazard ratio; Interquartile range; Proportional hazards model; Vitamin K antagonist; Oncology; Cancer; Confidence interval","score_opus":0.035489812507363626,"score_gpt":0.28799455768787524,"score_spread":0.25250474518051164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320893540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995002,0.0019682313,0.00012797842,0.00016338013,0.00001200512,0.000026047102,0.0014882529,0.000004679792,0.0012074535],"genre_scores_gemma":[0.9989668,0.00027939386,0.00008587208,0.000045768527,0.000009749015,0.000006974679,0.0005220721,7.2802203e-7,0.000082608516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995372,0.00010129254,0.000046448313,0.000084648746,0.00016880262,0.000061493534],"domain_scores_gemma":[0.9987752,0.00016999946,0.00061886286,0.00004140089,0.00015026599,0.0002442859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004885391,0.00014546768,0.00021016024,0.00068583345,0.00034043015,0.00041556844,0.0002699374,0.00020797212,0.0014428227],"category_scores_gemma":[0.0013411542,0.00009485129,0.00042518525,0.0010567755,0.00022057879,0.00015117363,0.00022987639,0.0004979764,0.00010924533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007511608,0.000012443962,0.9987709,0.000014892564,0.00006895689,0.000014356034,0.000012567148,0.000039168634,0.000058480942,0.000013729096,0.00008916182,0.00083013216],"study_design_scores_gemma":[0.000007608471,0.00003043818,0.9995061,0.000007897085,0.000024326799,0.00007757599,0.000024254061,0.00012169468,0.000017624803,0.00001568987,0.00016434182,0.0000023458874],"about_ca_topic_score_codex":0.053139042,"about_ca_topic_score_gemma":0.1045167,"teacher_disagreement_score":0.053139042,"about_ca_system_score_codex":0.0011404874,"about_ca_system_score_gemma":0.0011113987,"threshold_uncertainty_score":0.105659425},"labels":[],"label_agreement":null},{"id":"W4320914516","doi":"10.6004/jnccn.2022.7089","title":"Small Cell Lung Cancer in Light/Never Smokers – A Role for Molecular Testing?","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Lung cancer; Chemotherapy; Oncology; Disease; Cancer; Internal medicine; Incidence (geometry); Cancer research","score_opus":0.06197872644611645,"score_gpt":0.37007329462359173,"score_spread":0.30809456817747527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320914516","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27158904,0.39892057,0.00786377,0.270151,0.00436903,0.00014971494,0.00018564206,0.0002836504,0.046487562],"genre_scores_gemma":[0.81187314,0.13059472,0.014431377,0.028292226,0.010882903,0.00007162513,0.00015945775,0.00007277089,0.0036217042],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993787,0.000255473,0.0000779144,0.000057178062,0.00016165918,0.000069058886],"domain_scores_gemma":[0.9963245,0.0020748375,0.0003630693,0.00015872066,0.00061418914,0.000464656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031508596,0.00027887465,0.0005989907,0.0008813932,0.0003493478,0.0012610664,0.000907085,0.0017832369,0.0022158497],"category_scores_gemma":[0.0070411526,0.00018074473,0.00034947856,0.000382976,0.001101301,0.0025515044,0.00046150817,0.0017897246,0.0005562094],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006779532,0.00037187373,0.2924549,0.00074368576,0.00012702854,0.01984784,0.00043400153,0.00056965766,0.0060316147,0.004418435,0.015988931,0.658334],"study_design_scores_gemma":[0.00040691879,0.002906713,0.38551146,0.012037303,0.0007314535,0.29775983,0.01008597,0.0072840415,0.0042791218,0.052368943,0.2263862,0.00024201573],"about_ca_topic_score_codex":0.0017277055,"about_ca_topic_score_gemma":0.0045142453,"teacher_disagreement_score":0.0031508596,"about_ca_system_score_codex":0.00043096853,"about_ca_system_score_gemma":0.0009779278,"threshold_uncertainty_score":0.016663551},"labels":[],"label_agreement":null},{"id":"W4320932490","doi":"10.6004/jnccn.2022.7096","title":"Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice","year":2023,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Profiling (computer programming); Endometrial cancer; Categorization; Clinical trial; Adjuvant; Disease; Oncology; Bioinformatics; Computational biology; Internal medicine; Cancer; Computer science; Artificial intelligence","score_opus":0.25901739956103037,"score_gpt":0.5116208674045226,"score_spread":0.25260346784349225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320932490","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015653523,0.99798465,0.000119394805,0.00070925493,0.00014181175,0.000008870024,0.000043904427,0.0000069394387,0.0008285931],"genre_scores_gemma":[0.0014592897,0.9973815,0.0002618474,0.00046522394,0.00011953177,0.000010839318,0.0000667629,0.000001683976,0.00023334943],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996463,0.00010020389,0.000058296493,0.000053433156,0.00011017007,0.000031578733],"domain_scores_gemma":[0.9991302,0.0004399991,0.00010011349,0.000022090935,0.00026674432,0.00004075249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014432961,0.0005720927,0.00095881417,0.0025554372,0.00021273173,0.001293591,0.00086434337,0.0006563106,0.0029015737],"category_scores_gemma":[0.0030346974,0.0002923395,0.0006926331,0.0023315472,0.00041492895,0.0010487171,0.0008956826,0.001385984,0.0010974063],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060940445,0.000020775251,0.00045888624,0.015055939,0.00017460754,0.00007075968,0.000063926534,0.0002950604,0.00039878214,0.002729637,0.022925083,0.9577457],"study_design_scores_gemma":[0.000032770593,0.00012767126,0.0042326944,0.028444024,0.00046525637,0.00082897657,0.00013137884,0.0003401889,0.00043463588,0.0031964162,0.96173394,0.000032106913],"about_ca_topic_score_codex":0.0038499448,"about_ca_topic_score_gemma":0.006089516,"teacher_disagreement_score":0.0038499448,"about_ca_system_score_codex":0.0014151387,"about_ca_system_score_gemma":0.002080943,"threshold_uncertainty_score":0.010267556},"labels":[],"label_agreement":null},{"id":"W4323823168","doi":"10.6004/jnccn.2022.7095","title":"Feasibility and Effectiveness of Self-Management Education and Coaching on Patient Activation for Managing Cancer Treatment Toxicities","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal Victoria Regional Health Centre; Institute of Aging; University of Victoria; Princess Margaret Cancer Centre; Women's College Hospital; McMaster University; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Coaching; Cancer; Intensive care medicine; Patient education; Nursing; Internal medicine; Psychotherapist","score_opus":0.04298865649454445,"score_gpt":0.3445372463943131,"score_spread":0.3015485898997686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323823168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679774,0.00010977674,0.00015839435,0.000096191405,0.000014594998,0.0017755744,0.000038953414,0.000012416904,0.0009963779],"genre_scores_gemma":[0.9959198,0.00015333013,0.0010948844,0.00005943687,0.000027128128,0.0023948129,0.000054322183,0.0000022859024,0.00029390925],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99747795,0.0015672629,0.00016937435,0.00019286497,0.00033144752,0.00026116066],"domain_scores_gemma":[0.99656504,0.0017983182,0.00070048886,0.00017463524,0.00017098495,0.00059064873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037343663,0.00039839133,0.00041679156,0.000331852,0.00037398667,0.0004724086,0.00063002034,0.0006536585,0.0046657557],"category_scores_gemma":[0.0069622956,0.00020889343,0.0007835672,0.00025843186,0.0005859539,0.00043865168,0.0006636135,0.0007148304,0.0002465105],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20010847,0.23005126,0.040524613,0.0019079109,0.0006043605,0.00008828462,0.0018853486,0.0017146824,0.0048626307,0.00027761195,0.0009103883,0.51706445],"study_design_scores_gemma":[0.11541922,0.6630128,0.21182638,0.00033385126,0.00066470087,0.00007422755,0.0005203071,0.002815518,0.0033659148,0.00016684883,0.001769568,0.000030587817],"about_ca_topic_score_codex":0.003217455,"about_ca_topic_score_gemma":0.0047683767,"teacher_disagreement_score":0.0046657557,"about_ca_system_score_codex":0.0011529329,"about_ca_system_score_gemma":0.002240688,"threshold_uncertainty_score":0.019749463},"labels":[],"label_agreement":null},{"id":"W4323823189","doi":"10.6004/jnccn.2022.7097","title":"Evaluating Germline Testing Panels in Southern African Males With Advanced Prostate Cancer","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"DOD Prostate Cancer Research Program; South African Medical Research Council; Medical Research Council; University of Sydney; Cancer Association of South Africa; National Health and Medical Research Council; Johns Hopkins University","keywords":"Prostate cancer; CHEK2; Germline; Medicine; Genetic testing; Cancer; Family history; Oncology; PALB2; Germline mutation; Disease; Internal medicine; Genetics; Gene; Mutation; Biology","score_opus":0.12616336662457778,"score_gpt":0.38977934067146486,"score_spread":0.2636159740468871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323823189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99915206,0.00024603607,0.0002131772,0.000048032452,0.0000022935553,0.0000062475942,0.000097850985,0.000007783684,0.00022658317],"genre_scores_gemma":[0.9991449,0.00012957212,0.00050701614,0.00002907566,0.000003817834,0.0000034431407,0.00012877544,0.0000032613773,0.000050183357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996959,0.000080278645,0.000018856885,0.00007270534,0.00007147174,0.000060762708],"domain_scores_gemma":[0.99949884,0.00022813126,0.00015095304,0.000020555402,0.000046420533,0.00005500418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006141227,0.00042431068,0.00019622642,0.0010740049,0.0005619842,0.00040927573,0.00019928666,0.00032821577,0.0015221577],"category_scores_gemma":[0.0019726136,0.00014762013,0.0002426695,0.00087237585,0.00035595556,0.00019464121,0.0005119084,0.00023394704,0.00018576006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020687612,0.000022937644,0.9816281,0.000047183537,0.00004419091,0.0015837544,0.00059132423,0.0006685524,0.005346744,0.00010507995,0.00017084193,0.009584446],"study_design_scores_gemma":[0.000020532321,0.00031181457,0.97611266,0.000085841144,0.00015249706,0.007912652,0.0016280679,0.0055395076,0.005456531,0.000556322,0.0022073472,0.000016253467],"about_ca_topic_score_codex":0.004167633,"about_ca_topic_score_gemma":0.006190464,"teacher_disagreement_score":0.004167633,"about_ca_system_score_codex":0.00027492843,"about_ca_system_score_gemma":0.00034299723,"threshold_uncertainty_score":0.008286774},"labels":[],"label_agreement":null},{"id":"W4362469831","doi":"10.6004/jnccn.2022.7199","title":"CLO23-056: Risk of Second Malignancy Among Non-Metastatic Seminoma Patients Treated With Radiation Therapy and Chemotherapy in Manitoba","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Malignancy; Radiation therapy; Chemotherapy; Seminoma; Oncology; Internal medicine; Cancer","score_opus":0.025859424793628853,"score_gpt":0.2705497157981843,"score_spread":0.24469029100455547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362469831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98758346,0.0016235854,0.000046694684,0.00076186936,0.00005289329,0.000031727817,0.0077248495,0.000016601034,0.0021582777],"genre_scores_gemma":[0.98894674,0.0019942757,0.00019462068,0.0003022101,0.000043194148,0.000030159094,0.005108899,0.000012296158,0.003367739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998418,0.000024431145,0.000009939751,0.000027360124,0.000050582552,0.000045926634],"domain_scores_gemma":[0.9992932,0.000039806106,0.00017081344,0.000013615531,0.00016835246,0.00031424707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025609066,0.00035375866,0.000317098,0.0010591995,0.00085351855,0.0006082037,0.00076249446,0.0005256562,0.0032270334],"category_scores_gemma":[0.0006956454,0.00027943464,0.0005124755,0.0017739909,0.00018617995,0.0001310238,0.00049727916,0.00058280915,0.00039786135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020401631,0.00003095413,0.9952421,0.000023427654,0.000083943036,0.00021929103,0.000072865965,0.00007381177,0.00033872432,0.000016925009,0.0019479219,0.0017461135],"study_design_scores_gemma":[0.000027916205,0.00006615789,0.9986002,0.000032481872,0.00006190989,0.00016721328,0.00021077733,0.00012826546,0.00007305564,0.000008580017,0.00061827747,0.000005158362],"about_ca_topic_score_codex":0.7133766,"about_ca_topic_score_gemma":0.8385077,"teacher_disagreement_score":0.28662342,"about_ca_system_score_codex":0.0027785841,"about_ca_system_score_gemma":0.0049786614,"threshold_uncertainty_score":0.5766228},"labels":[],"label_agreement":null},{"id":"W4362471859","doi":"10.6004/jnccn.2022.7118","title":"QIM23-129: Impact of the COVID Pandemic on Oncology Education, Mentorship, and Networking—A National Survey","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Mentorship; Coronavirus disease 2019 (COVID-19); Pandemic; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus Infections; Oncology; Internal medicine; Family medicine; Virology; Medical education","score_opus":0.11052315370529352,"score_gpt":0.48096082175558696,"score_spread":0.37043766805029343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362471859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97272295,0.00034664533,0.00014889563,0.0044304766,0.00010721769,0.00023929354,0.015478387,0.000023309794,0.0065027876],"genre_scores_gemma":[0.9823214,0.0005464217,0.0003715777,0.0043650954,0.0000803848,0.00060318736,0.007856412,0.000030513247,0.0038250422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798846,0.00034302037,0.0002007707,0.00018189047,0.0005487641,0.00073705637],"domain_scores_gemma":[0.9920731,0.0005475185,0.0022638985,0.00030090378,0.0013126772,0.0035017563],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0023836768,0.00022962884,0.0002891253,0.0009816843,0.0013363423,0.0010285181,0.0013077684,0.0015952802,0.0041362853],"category_scores_gemma":[0.0058325045,0.00036884556,0.0005525956,0.0015434104,0.00045964273,0.0011732973,0.0028837891,0.0026203154,0.0011727761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029302753,0.00022278853,0.9882206,0.000036011184,0.000025202127,0.000031270833,0.0005667646,0.00003920181,0.000084107545,0.00005943898,0.0066447803,0.0040405346],"study_design_scores_gemma":[0.0000037737834,0.000036903406,0.99557436,0.000024897687,0.000005252843,0.00003039392,0.0019898936,0.000057163925,0.000024058914,0.00001123246,0.002237739,0.000004299783],"about_ca_topic_score_codex":0.12014912,"about_ca_topic_score_gemma":0.20953734,"teacher_disagreement_score":0.99761635,"about_ca_system_score_codex":0.0020634278,"about_ca_system_score_gemma":0.005656019,"threshold_uncertainty_score":0.23889959},"labels":[],"label_agreement":null},{"id":"W4362473019","doi":"10.6004/jnccn.2022.7109","title":"CLO23-025: Comparison of Outcomes Using NCCN Classification in Two Concurrent Phase III Trials in Intermediate and High Risk Prostate Cancer: Long-Term Data","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Hospitalier de l’Université de Montréal; Hôpital Maisonneuve-Rosemont; Nova Scotia Cancer Centre; Centre hospitalier universitaire de Québec; McGill University Health Centre; Centre Intégré de Santé et de Services Sociaux du Bas-Saint-Laurent; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Prostate cancer; Term (time); Oncology; Cancer; Internal medicine; Clinical trial; Prostate","score_opus":0.32030928530987374,"score_gpt":0.5348290192169047,"score_spread":0.214519733907031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362473019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8460899,0.08490621,0.00437836,0.0057568373,0.0025090708,0.011966375,0.03258539,0.000360441,0.01144755],"genre_scores_gemma":[0.94558907,0.008923346,0.004036747,0.0027598194,0.0010185189,0.008263847,0.024483629,0.000141464,0.0047835098],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9869533,0.008902079,0.0011214333,0.0008916583,0.0016340188,0.0004974964],"domain_scores_gemma":[0.9751091,0.00964131,0.008168911,0.001879483,0.0023812263,0.0028199586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019756742,0.0015746796,0.003746828,0.0008725002,0.0006039338,0.002662962,0.0015612518,0.0022577655,0.0037728692],"category_scores_gemma":[0.031586412,0.00052213174,0.006648733,0.0016681626,0.00086275337,0.0020232669,0.0010950571,0.00309895,0.00058100384],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8977372,0.0013969977,0.010411439,0.0030579683,0.02174385,0.00005213557,0.00012734956,0.0013699976,0.0014915754,0.0003976364,0.0097481385,0.052465666],"study_design_scores_gemma":[0.732822,0.13432804,0.08676133,0.00130366,0.02581161,0.00022844375,0.00016232103,0.002781799,0.0017203144,0.0008029499,0.012958571,0.0003190533],"about_ca_topic_score_codex":0.004602021,"about_ca_topic_score_gemma":0.01111732,"teacher_disagreement_score":0.019756742,"about_ca_system_score_codex":0.0025268653,"about_ca_system_score_gemma":0.0036935494,"threshold_uncertainty_score":0.104484916},"labels":[],"label_agreement":null},{"id":"W4375853356","doi":"10.6004/jnccn.2022.7256","title":"Applying Quality Indicators to Examine Quality of Care During Active Surveillance in Low-Risk Prostate Cancer: A Population-Based Study","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University Health Network; University of Toronto; Toronto General Hospital; Toronto Public Health; Institute of Health Services and Policy Research","funders":"Government of Ontario","keywords":"Medicine; Prostate cancer; Population; Cohort; Cancer registry; Retrospective cohort study; Cancer; Cohort study; Emergency medicine; Internal medicine; Environmental health","score_opus":0.04607041986331676,"score_gpt":0.3821461362965448,"score_spread":0.33607571643322803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375853356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969597,0.0005135455,0.00076689984,0.00018103671,0.000008273171,0.00031297168,0.00074977573,0.000006456377,0.00050128094],"genre_scores_gemma":[0.9984022,0.00018103982,0.00058892043,0.00006216915,0.000008572737,0.00024353186,0.00047786633,0.000002150188,0.00003360648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98773926,0.0054576155,0.0017269818,0.0010940247,0.0031046877,0.00087742024],"domain_scores_gemma":[0.9675261,0.007823959,0.015362224,0.001249417,0.0062735123,0.0017648856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02102169,0.00041252293,0.00061644433,0.0045054173,0.00089837663,0.0016396929,0.0014795723,0.00079153077,0.0006230394],"category_scores_gemma":[0.037285633,0.00041548526,0.0015332936,0.0062214746,0.0010290096,0.0015778233,0.0020604264,0.0010502657,0.00011303943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028789795,0.000040555504,0.99835026,0.000042966232,0.000080162936,0.000006531632,0.00033414448,0.000039899947,0.000018740453,0.00001714134,0.00006926259,0.00097148796],"study_design_scores_gemma":[0.000013992795,0.00018374326,0.9982122,0.00004928048,0.00006112547,0.000029711473,0.0007835078,0.00039093435,0.000038935843,0.000034208068,0.00019245518,0.0000100069155],"about_ca_topic_score_codex":0.05160525,"about_ca_topic_score_gemma":0.048361618,"teacher_disagreement_score":0.05160525,"about_ca_system_score_codex":0.0056141587,"about_ca_system_score_gemma":0.0045686634,"threshold_uncertainty_score":0.11117464},"labels":[],"label_agreement":null},{"id":"W4383874089","doi":"10.6004/jnccn.2023.7023","title":"Social Determinants of Health and Racial Disparities in Cardiac Events in Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Mace; Health equity; Social determinants of health; Gerontology; Demography; Cancer; Internal medicine; Public health; Myocardial infarction; Percutaneous coronary intervention; Pathology","score_opus":0.07557736132578949,"score_gpt":0.42169939000989776,"score_spread":0.34612202868410824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383874089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700016,0.0007054066,0.00016902188,0.00037827977,0.000009418719,0.000012719,0.00059385167,0.000004597537,0.0011265094],"genre_scores_gemma":[0.99937767,0.00015364416,0.00008024788,0.000041594787,0.000015580918,0.000007057763,0.00026199088,9.287643e-7,0.00006125523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938214,0.00026577772,0.000046894216,0.00009837603,0.000098965094,0.000107725165],"domain_scores_gemma":[0.99727565,0.0007961774,0.0013174831,0.00016671336,0.00019446967,0.00024949617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012798187,0.00012936695,0.00017094368,0.00075272244,0.00031972775,0.00041322547,0.00024480655,0.00022984942,0.0018356853],"category_scores_gemma":[0.004189463,0.0000854465,0.00037204206,0.0009793806,0.00026890452,0.00023373123,0.0005883999,0.00043755982,0.00012382834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021738319,0.000018299006,0.99805546,0.00000770565,0.000042434054,0.000008896893,0.000026460237,0.00007073958,0.000020506406,0.000052734395,0.000090069654,0.0015850418],"study_design_scores_gemma":[0.0000022498516,0.00002271613,0.9990897,0.000011654408,0.000027889166,0.00003823181,0.00006661365,0.0003408697,0.000023326014,0.00016023002,0.00021515151,0.000001494766],"about_ca_topic_score_codex":0.006731669,"about_ca_topic_score_gemma":0.010202913,"teacher_disagreement_score":0.006731669,"about_ca_system_score_codex":0.0003818441,"about_ca_system_score_gemma":0.0005028532,"threshold_uncertainty_score":0.013384938},"labels":[],"label_agreement":null},{"id":"W4387568217","doi":"10.6004/jnccn.2023.7046","title":"Machine Learning–Based Early Warning Systems for Acute Care Utilization During Systemic Therapy for Cancer","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Vector Institute; Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"Ipsen; Eisai; Incyte; Princess Margaret Cancer Foundation; Pfizer; University of Toronto; Exelixis; Eli Lilly and Company","keywords":"Medicine; Cohort; Acute care; Emergency department; Emergency medicine; Regimen; Retrospective cohort study; Population; Cancer; Intensive care medicine; Health care; Internal medicine","score_opus":0.13972691780023644,"score_gpt":0.40064150056042064,"score_spread":0.2609145827601842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387568217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87849194,0.0011863598,0.110823445,0.0019317293,0.00021297357,0.00038277524,0.0026630624,0.0022929595,0.0020147567],"genre_scores_gemma":[0.9791935,0.00013702619,0.018999912,0.0002003373,0.000078537654,0.000088390385,0.0011075527,0.00001508799,0.00017954831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986077,0.00058623566,0.00015970126,0.00029400404,0.00025485823,0.00009750897],"domain_scores_gemma":[0.988063,0.0064862114,0.0029604014,0.0005717714,0.0015236544,0.00039498994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004023909,0.00062832603,0.0007408465,0.0012795421,0.00029414525,0.00085416366,0.0007336935,0.0005088091,0.00089713756],"category_scores_gemma":[0.016633969,0.00024188435,0.00068562955,0.00056805264,0.00019460464,0.0007592848,0.00070519955,0.0008938718,0.00024118011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010301356,0.00080708734,0.6270178,0.00022747213,0.00042670066,0.00014329613,0.00018059596,0.18292126,0.002764331,0.0006914882,0.005770802,0.17801906],"study_design_scores_gemma":[0.00008922602,0.0008214734,0.080568135,0.00007204138,0.00017056886,0.00014312555,0.00005319207,0.91259956,0.0026377202,0.0014895942,0.001305369,0.000050031413],"about_ca_topic_score_codex":0.003656221,"about_ca_topic_score_gemma":0.003923299,"teacher_disagreement_score":0.004023909,"about_ca_system_score_codex":0.0008943144,"about_ca_system_score_gemma":0.0010320959,"threshold_uncertainty_score":0.021280706},"labels":[],"label_agreement":null},{"id":"W4388450013","doi":"10.6004/jnccn.2023.7092","title":"Authors’ Reply to the Letter to the Editor by Nguyen et al","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine","score_opus":0.04729631797960049,"score_gpt":0.35786615185020604,"score_spread":0.31056983387060555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388450013","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029298328,0.0015403,0.00007302179,0.8858006,0.11142882,0.0000075159373,0.00005344763,0.000030557258,0.000772757],"genre_scores_gemma":[0.0028997166,0.0012860242,0.00009832936,0.8764825,0.11672469,0.000022382132,0.00002854556,0.000027544938,0.0024303154],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99526465,0.0011877317,0.00082092296,0.00064743863,0.0014000847,0.000679198],"domain_scores_gemma":[0.9803854,0.008919374,0.0018584937,0.0005669596,0.0061473935,0.0021223146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004376696,0.00090662757,0.001938909,0.001069324,0.002575401,0.00416797,0.002596549,0.03748512,0.007281294],"category_scores_gemma":[0.04508146,0.00096716516,0.001278484,0.0007622307,0.00268513,0.0036120622,0.0018438332,0.032450154,0.008078413],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039388993,0.000011916534,0.00029112492,0.00006254521,0.00001767198,0.0007962412,0.00009790516,0.000027779848,0.00007269541,0.00044551626,0.9959227,0.0022145482],"study_design_scores_gemma":[0.00014214501,0.00007643296,0.0013394332,0.0004529507,0.00007799422,0.003302205,0.00080192357,0.0002867197,0.0005000676,0.002643949,0.9902469,0.000129348],"about_ca_topic_score_codex":0.00257341,"about_ca_topic_score_gemma":0.0027658253,"teacher_disagreement_score":0.03748512,"about_ca_system_score_codex":0.0026943244,"about_ca_system_score_gemma":0.0047059734,"threshold_uncertainty_score":0.024358392},"labels":[],"label_agreement":null},{"id":"W4388450064","doi":"10.6004/jnccn.2023.7089","title":"Letter to the Editor: Disaggregating Asian Prostate Cancer Cohorts Can Help Us Improve Care for All Patients With Prostate Cancer","year":2023,"lang":"en","type":"letter","venue":"Journal of the National Comprehensive Cancer Network","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Cancer; Prostate; Oncology; Internal medicine; Family medicine","score_opus":0.021454705010819797,"score_gpt":0.255855868657141,"score_spread":0.2344011636463212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388450064","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028302314,0.0005225819,0.000064143336,0.9610472,0.036447804,0.000012596387,0.00010317926,0.000020547639,0.0014990247],"genre_scores_gemma":[0.0024025976,0.0006518464,0.000140725,0.9356587,0.054170102,0.000038901555,0.000040847448,0.000030616964,0.0068656816],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996763,0.0010449841,0.0004720223,0.00041242983,0.0008636903,0.0004439126],"domain_scores_gemma":[0.98510253,0.008101651,0.0009512439,0.00040093344,0.0032815442,0.0021621613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056108953,0.0008324499,0.0017484016,0.0007704062,0.0033836865,0.0038571144,0.0019508712,0.039216183,0.00714808],"category_scores_gemma":[0.034041923,0.00094598543,0.0012571405,0.00087349495,0.0017554475,0.0027926685,0.0012326345,0.033766456,0.007587241],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032704058,0.000019637984,0.0003817007,0.000028193035,0.000010449915,0.00030019216,0.00004747538,0.000040579816,0.00003965404,0.0004860387,0.9954615,0.0031517649],"study_design_scores_gemma":[0.0001573334,0.000073387644,0.0025194709,0.00043958536,0.000060373484,0.00083386916,0.00048792607,0.00078224787,0.000252167,0.004846626,0.98946404,0.000082835766],"about_ca_topic_score_codex":0.008347651,"about_ca_topic_score_gemma":0.014130475,"teacher_disagreement_score":0.039216183,"about_ca_system_score_codex":0.0035763683,"about_ca_system_score_gemma":0.0068625067,"threshold_uncertainty_score":0.029673636},"labels":[],"label_agreement":null},{"id":"W4390033373","doi":"10.6004/jnccn.2023.7069","title":"Development and Validation of a Nomogram for Predicting Postoperative Early Relapse and Survival in Hepatocellular Carcinoma","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"Jiangxi Provincial Department of Science and Technology; National Natural Science Foundation of China","keywords":"Nomogram; Medicine; Hepatocellular carcinoma; Concordance; Hepatectomy; Internal medicine; Cohort; Retrospective cohort study; Oncology; Surgery; Resection","score_opus":0.09559302608642728,"score_gpt":0.3015228849217186,"score_spread":0.2059298588352913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390033373","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.957305,0.0006602056,0.040359512,0.00023712327,0.000053880707,0.00014567075,0.0004588615,0.00015829777,0.00062142836],"genre_scores_gemma":[0.9858436,0.00011913256,0.013348934,0.000020096622,0.000024785979,0.00006963635,0.0005030955,0.000011853366,0.000058825866],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99797946,0.001298875,0.00012683486,0.00016758638,0.00032163959,0.00010557261],"domain_scores_gemma":[0.990811,0.0054400875,0.0012372929,0.00073827297,0.0014102528,0.00036308603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008346448,0.0008291344,0.0007850664,0.002139285,0.0004331269,0.0011796807,0.0006801128,0.00056240347,0.0004413154],"category_scores_gemma":[0.018878747,0.0002304777,0.00078244385,0.00090931496,0.0004355133,0.0006736931,0.0008103746,0.00071250374,0.0002353112],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005674922,0.0001869737,0.9145403,0.000049188315,0.00023079013,0.00010260567,0.00008313699,0.030792804,0.00082813465,0.00015184424,0.0009203168,0.051546346],"study_design_scores_gemma":[0.00015834492,0.00096978416,0.32297686,0.00008409707,0.00045237987,0.00074993016,0.00024019195,0.668954,0.0025960072,0.0009334118,0.0018245779,0.00006041662],"about_ca_topic_score_codex":0.002073854,"about_ca_topic_score_gemma":0.0020404574,"teacher_disagreement_score":0.008346448,"about_ca_system_score_codex":0.00063743786,"about_ca_system_score_gemma":0.001083501,"threshold_uncertainty_score":0.044140816},"labels":[],"label_agreement":null},{"id":"W4393991649","doi":"10.6004/jnccn.2023.7280","title":"BPI24-011: Impact of Obesity on Sentinel Lymph Node Mapping in Patients With Endometrial Intraepithelial Neoplasia Undergoing Robotic Surgery","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Lymph node; Robotic surgery; General surgery; Sentinel lymph node; Sentinel node; Oncology; Internal medicine; Cancer; Breast cancer","score_opus":0.036651504712202534,"score_gpt":0.30249376782122034,"score_spread":0.2658422631090178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393991649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.877887,0.019321084,0.00032189704,0.03114655,0.0050488673,0.0005242394,0.049213666,0.00010002785,0.016436651],"genre_scores_gemma":[0.9315091,0.010957451,0.0013050211,0.006338067,0.0035319256,0.0008406101,0.036539555,0.00008641281,0.008891984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999426,0.000205242,0.000036829606,0.000071112954,0.0001715643,0.00008923306],"domain_scores_gemma":[0.99774003,0.0005291856,0.00060490734,0.000046043264,0.00035480945,0.0007250686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013674782,0.000385295,0.0005771063,0.0006574666,0.00051874085,0.001126524,0.0005872583,0.0008508376,0.0060070283],"category_scores_gemma":[0.004895876,0.00020638568,0.0011205582,0.0009368204,0.00016774981,0.0004302949,0.00078717415,0.0014640725,0.00091430306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021210708,0.0014568637,0.72942823,0.0012209304,0.0019894906,0.0004922013,0.000148543,0.0010795228,0.0013820012,0.00029441854,0.13438544,0.10691174],"study_design_scores_gemma":[0.0017270827,0.0020194973,0.983489,0.00037410724,0.00087672076,0.00020867608,0.00017766035,0.0007580901,0.00023510172,0.00015475904,0.009928666,0.000050728217],"about_ca_topic_score_codex":0.011039712,"about_ca_topic_score_gemma":0.020173099,"teacher_disagreement_score":0.011039712,"about_ca_system_score_codex":0.0009533505,"about_ca_system_score_gemma":0.0024449364,"threshold_uncertainty_score":0.0219509},"labels":[],"label_agreement":null},{"id":"W4394859738","doi":"10.6004/jnccn.2023.7097","title":"The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Center for Advancing Translational Sciences; Interpace Diagnostics; National Cancer Institute; Amazon Web Services; FibroGen; AstraZeneca Canada; Teva Pharmaceutical Industries; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Cohort; Odds ratio; Pancreatic cancer; Internal medicine; Cohort study; Endoscopic ultrasound; Cancer; Oncology; Surgery","score_opus":0.025498185788854745,"score_gpt":0.36077265637153755,"score_spread":0.3352744705826828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394859738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91910046,0.003952592,0.0044387374,0.003965448,0.00043784137,0.0021869473,0.055477843,0.00017003827,0.010270151],"genre_scores_gemma":[0.894656,0.0036360414,0.013862398,0.0031113878,0.00069704547,0.0049815904,0.074456386,0.00013913959,0.004459908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778867,0.00091480213,0.00015840642,0.000613114,0.00037975088,0.00014522362],"domain_scores_gemma":[0.9905813,0.001378623,0.0030957551,0.0014606809,0.0016154593,0.0018681778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068900688,0.0005940475,0.0007713609,0.0010830726,0.0012505202,0.0015463039,0.001039818,0.00094041554,0.0016995749],"category_scores_gemma":[0.0063614543,0.0005981486,0.0006796327,0.002217376,0.00063436304,0.00097363413,0.0027120034,0.0015504941,0.0005054349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021251857,0.00029759543,0.9732748,0.00028606894,0.00045792843,0.00014557647,0.00020218772,0.00014700886,0.0008154135,0.00049331365,0.010304126,0.011450673],"study_design_scores_gemma":[0.0011797809,0.0007315185,0.9841233,0.00023441821,0.00050522573,0.0004187318,0.0002700714,0.00032530635,0.0004142742,0.0004075931,0.011362312,0.000027471147],"about_ca_topic_score_codex":0.0063403035,"about_ca_topic_score_gemma":0.014392633,"teacher_disagreement_score":0.0068900688,"about_ca_system_score_codex":0.00088183006,"about_ca_system_score_gemma":0.0023404541,"threshold_uncertainty_score":0.036438644},"labels":[],"label_agreement":null},{"id":"W4399215381","doi":"10.6004/jnccn.2024.5019","title":"Updates in Clinical Management of Pancreatic Cancer","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nautilus Biosciences (Canada)","funders":"","keywords":"Medicine; Pancreatic cancer; Radiation therapy; Oncology; Chemotherapy; Intensive care medicine; Internal medicine; Cancer","score_opus":0.10393018519792709,"score_gpt":0.4601177103225228,"score_spread":0.3561875251245957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399215381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002917882,0.56908154,0.007339487,0.27009112,0.066108085,0.00029710948,0.0016461477,0.001325596,0.081193045],"genre_scores_gemma":[0.019682065,0.7233026,0.029467234,0.09630041,0.09589002,0.0005181892,0.005396531,0.00040345304,0.029039506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971361,0.00095317344,0.00065986504,0.00017048843,0.00092238956,0.00015793262],"domain_scores_gemma":[0.9842482,0.0049696984,0.0016245756,0.00040664888,0.0073094256,0.0014414906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004587216,0.0008169097,0.0012905452,0.002706393,0.0006364775,0.0022698508,0.0017683291,0.0028504329,0.0111619355],"category_scores_gemma":[0.022356275,0.00035782927,0.0010727037,0.0022033134,0.000608654,0.0029976976,0.0015636664,0.00522017,0.0065608267],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008513221,0.00005821874,0.00078636385,0.0014827829,0.000038248858,0.0002145003,0.000089866015,0.00037550094,0.00025121978,0.0017075144,0.49186477,0.50304574],"study_design_scores_gemma":[0.000025298385,0.000049896087,0.0009407278,0.002624847,0.000048106936,0.00049361767,0.000066997716,0.000111085,0.00009685883,0.001008197,0.9945193,0.000015106399],"about_ca_topic_score_codex":0.0029654189,"about_ca_topic_score_gemma":0.007464058,"teacher_disagreement_score":0.0111619355,"about_ca_system_score_codex":0.0019901064,"about_ca_system_score_gemma":0.003057286,"threshold_uncertainty_score":0.037340343},"labels":[],"label_agreement":null},{"id":"W4399369708","doi":"10.6004/jnccn.2024.7011","title":"Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active Treatment","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Proportional hazards model; Internal medicine; Nephrectomy; Clear cell renal cell carcinoma; Surgery; Oncology; Kidney; Confidence interval","score_opus":0.07271995487144732,"score_gpt":0.30501299002645355,"score_spread":0.2322930351550062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399369708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99944156,0.00017619591,0.000041547886,0.00006825654,0.000003606235,0.0000042546085,0.000089599765,0.0000012199787,0.0001736811],"genre_scores_gemma":[0.99965966,0.00006290005,0.000029826548,0.000032172557,0.000011667997,0.0000027965243,0.00017983302,4.3632667e-7,0.00002077496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971586,0.000066659464,0.00001988186,0.000078409634,0.00006708267,0.000051988263],"domain_scores_gemma":[0.9986677,0.00018298475,0.000792739,0.000045072924,0.00010088305,0.000210625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051014725,0.00014335921,0.00028045123,0.00042543176,0.00041000848,0.00075009343,0.0003219825,0.00035265202,0.0012005708],"category_scores_gemma":[0.0023343717,0.00010137846,0.00028418176,0.0007816428,0.0003652298,0.0004450712,0.00042753198,0.0004900047,0.00008023302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011707975,0.0000416885,0.99789846,0.000008580393,0.000032259846,0.000044392928,0.00004856953,0.00007626572,0.00011711158,0.000025544232,0.00008995918,0.0015001028],"study_design_scores_gemma":[0.000022728469,0.00018499634,0.9983205,0.0000090285685,0.000032064385,0.00033321136,0.00020686901,0.0004683116,0.00005522031,0.00009210211,0.00027088344,0.000004187805],"about_ca_topic_score_codex":0.0045238575,"about_ca_topic_score_gemma":0.009149798,"teacher_disagreement_score":0.0045238575,"about_ca_system_score_codex":0.0005913182,"about_ca_system_score_gemma":0.00064488326,"threshold_uncertainty_score":0.008994997},"labels":[],"label_agreement":null},{"id":"W4399521570","doi":"10.6004/jnccn.2024.7042","title":"Optimizing Ovarian Cancer Treatment and Prevention Through Parallel Germline and Somatic Genetic Testing","year":2024,"lang":"en","type":"letter","venue":"Journal of the National Comprehensive Cancer Network","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Michael Smith Health Research BC","keywords":"Ovarian cancer; Medicine; Olaparib; Genetic testing; PARP inhibitor; Oncology; Germline; Cancer; BRCA mutation; Internal medicine; Germline mutation; Breast cancer; PALB2; Gynecology; Mutation; Genetics; Gene; Biology","score_opus":0.06058403225475431,"score_gpt":0.3355404807866882,"score_spread":0.2749564485319339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399521570","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3058939,0.21988043,0.16014275,0.10364316,0.0032186967,0.0059903627,0.004794831,0.0051830714,0.19125278],"genre_scores_gemma":[0.7442364,0.084376864,0.12664923,0.022198861,0.0032233102,0.0014601235,0.0026457557,0.00038757297,0.014821939],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989526,0.0003814854,0.000058146587,0.000119506054,0.00037559896,0.00011268098],"domain_scores_gemma":[0.99847835,0.00051685114,0.00028716994,0.00010482679,0.00035218702,0.00026059346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019354178,0.000380525,0.00056534813,0.0011355792,0.0003608731,0.0009275798,0.00055630517,0.00062933884,0.009331442],"category_scores_gemma":[0.006030123,0.00017542481,0.00069222064,0.00063421245,0.00027691934,0.00087056315,0.0011756412,0.0009117702,0.0015547889],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041991583,0.0011639232,0.026112735,0.0006431422,0.00023652964,0.00040254314,0.00011362817,0.004702978,0.003532992,0.0021641653,0.03025584,0.9302516],"study_design_scores_gemma":[0.0022872803,0.008500348,0.29113498,0.0062728585,0.001614253,0.00934979,0.0013927527,0.03018083,0.017091803,0.04492668,0.5870454,0.00020300971],"about_ca_topic_score_codex":0.0040843072,"about_ca_topic_score_gemma":0.0070404825,"teacher_disagreement_score":0.009331442,"about_ca_system_score_codex":0.00089980086,"about_ca_system_score_gemma":0.0020006343,"threshold_uncertainty_score":0.03121674},"labels":[],"label_agreement":null},{"id":"W4400060993","doi":"10.6004/jnccn.2024.7003","title":"Changes in New Patient Consultations During the COVID-19 Pandemic at a Canadian Comprehensive Cancer Center","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Saskatchewan; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Cancer; Center (category theory); Health care; Family medicine; Healthcare system; Medical emergency; Virology; Disease; Internal medicine; Infectious disease (medical specialty); Economic growth","score_opus":0.1308255174835729,"score_gpt":0.4122198450496803,"score_spread":0.2813943275661074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400060993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865176,0.00072265416,0.00021337651,0.0026711763,0.000041346033,0.00011501681,0.004867836,0.000034112643,0.0048167505],"genre_scores_gemma":[0.9968585,0.0004162943,0.00032564657,0.0005383954,0.000023411252,0.000037482852,0.0012765543,0.000008520204,0.00051509816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963736,0.0003818856,0.00022183945,0.00038862514,0.001433084,0.0012010017],"domain_scores_gemma":[0.9914398,0.0007992242,0.003153712,0.00016719387,0.0023761229,0.0020639044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001426745,0.0002465681,0.0002848029,0.0012882309,0.0024181367,0.0012713094,0.0014642015,0.000569847,0.0026636843],"category_scores_gemma":[0.008853876,0.00030119988,0.00043813747,0.0026375456,0.0007040395,0.00066102017,0.001414189,0.0012280786,0.00016418421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093872004,0.000042615313,0.9851863,0.00008780135,0.000047390713,0.0002921413,0.0018849574,0.00031749162,0.00029327802,0.00013576585,0.00441825,0.0072002253],"study_design_scores_gemma":[0.0000038098954,0.000032856336,0.99423015,0.000055703415,0.000011022742,0.00013028474,0.003264445,0.00043153335,0.000084680294,0.0000207981,0.0017184783,0.000016237324],"about_ca_topic_score_codex":0.94058865,"about_ca_topic_score_gemma":0.9709373,"teacher_disagreement_score":0.059411347,"about_ca_system_score_codex":0.034241904,"about_ca_system_score_gemma":0.030195115,"threshold_uncertainty_score":0.24844354},"labels":[],"label_agreement":null},{"id":"W4401640830","doi":"10.6004/jnccn.2024.7051","title":"Current and Emerging Biomarkers: Impact on Risk Stratification for Neuroblastoma","year":2024,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Oncology; Telomerase; Anaplastic lymphoma kinase; Liquid biopsy; Biomarker; Internal medicine; Neuroblastoma; Disease; Immunotherapy; Bioinformatics; Cancer research; Cancer; Gene; Biology; Lung cancer","score_opus":0.10500773361077949,"score_gpt":0.4606522043830703,"score_spread":0.35564447077229083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401640830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07174787,0.7722158,0.043242067,0.086080424,0.004872222,0.00022040059,0.0030468889,0.00073352124,0.01784086],"genre_scores_gemma":[0.5184185,0.34396458,0.097641245,0.015092445,0.011053345,0.0003026412,0.006316481,0.00020302371,0.0070077423],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978719,0.0009777106,0.00023505502,0.00032204136,0.000517015,0.00007629489],"domain_scores_gemma":[0.9916049,0.0038478293,0.0010568465,0.0003758515,0.0025424561,0.0005719846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008685542,0.0010515798,0.0011901706,0.0019482269,0.0003366518,0.0028534024,0.0010710205,0.0013875589,0.0031832114],"category_scores_gemma":[0.018933894,0.0002839502,0.0008389334,0.0015532854,0.000523154,0.0025050747,0.00093880226,0.0020857141,0.0012624298],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008338119,0.00011229717,0.17052658,0.0009949943,0.00042006854,0.00032970365,0.00010436927,0.003506778,0.002175597,0.00765066,0.025836937,0.7875082],"study_design_scores_gemma":[0.0004922782,0.0027465704,0.29973072,0.007773504,0.00363951,0.004626696,0.0013336249,0.07047638,0.0066935564,0.09589336,0.5061762,0.00041749096],"about_ca_topic_score_codex":0.0024613815,"about_ca_topic_score_gemma":0.0032977925,"teacher_disagreement_score":0.008685542,"about_ca_system_score_codex":0.0010012229,"about_ca_system_score_gemma":0.0014343719,"threshold_uncertainty_score":0.04593408},"labels":[],"label_agreement":null},{"id":"W4403461604","doi":"10.6004/jnccn.2024.7028","title":"Sympathetic Blockade for Pain Associated With Nonaxial Bone Lesions in Patients With Cancer: An Uncontrolled Cohort","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cohort; Retrospective cohort study; Blockade; Cancer; Visual analogue scale; Cancer pain; Multimodal therapy; Anesthesia; Internal medicine; Surgery","score_opus":0.023184458604149603,"score_gpt":0.3193258889044194,"score_spread":0.2961414303002698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403461604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999316,0.00022484585,0.00011389428,0.000013330133,0.000004423081,0.000038998114,0.00010859446,0.000001777573,0.00017809463],"genre_scores_gemma":[0.9990396,0.000260055,0.00014954469,0.000044844583,0.0000233954,0.000044978384,0.00031738626,0.0000023416635,0.00011794158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956864,0.00007845179,0.000042723765,0.00012288571,0.000118011245,0.00006931895],"domain_scores_gemma":[0.99933916,0.000119250995,0.00026352785,0.00008537273,0.00006889519,0.00012377823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005385238,0.0002799421,0.00047214684,0.0004931984,0.0007607935,0.00059325,0.00032596555,0.00033563303,0.0011944944],"category_scores_gemma":[0.0010385627,0.00026069276,0.0005403555,0.00050701736,0.00051551644,0.000398211,0.00039838642,0.0005679019,0.00023549593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048066906,0.00034978773,0.9954668,0.000014841542,0.000059518436,0.000579726,0.00011242719,0.000020078345,0.0007415477,0.000020120266,0.00008827617,0.0020662025],"study_design_scores_gemma":[0.00017001305,0.0030351826,0.99036014,0.000016563761,0.00011967996,0.0046879053,0.00052203116,0.00024490381,0.0002535215,0.000040243012,0.0005339584,0.000015803547],"about_ca_topic_score_codex":0.0026052487,"about_ca_topic_score_gemma":0.0035657657,"teacher_disagreement_score":0.0026052487,"about_ca_system_score_codex":0.0003240402,"about_ca_system_score_gemma":0.00061866886,"threshold_uncertainty_score":0.00518018},"labels":[],"label_agreement":null},{"id":"W4404401635","doi":"10.6004/jnccn.2024.7061","title":"Proportion of Gleason Score ≥8 Prostate Cancer on Biopsy and Tumor Aggressiveness in Matched Cohorts of East Asian and Non-East Asian Men","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; Sunnybrook Health Science Centre; Health Sciences Centre; Mount Sinai Hospital; Princess Margaret Cancer Centre; McGill University; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Hazard ratio; Cohort; Internal medicine; Proportional hazards model; Prostate-specific antigen; East Asia; Biopsy; Prostate biopsy; Propensity score matching; Logistic regression; Cancer; Demography; Oncology; China; Confidence interval","score_opus":0.024680822971680474,"score_gpt":0.30589881450825684,"score_spread":0.2812179915365764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404401635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995364,0.000072612056,0.000024941002,0.000008690579,0.0000020044317,0.00000378353,0.0002185917,0.0000015514017,0.00013147817],"genre_scores_gemma":[0.9995958,0.000037931324,0.000019069248,0.000010889833,0.000003814883,0.0000045284964,0.00025328112,9.693264e-7,0.000073666626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996313,0.00006996422,0.0000385893,0.00013383586,0.000058212063,0.000068132525],"domain_scores_gemma":[0.99887305,0.00015629493,0.0004869782,0.00014582524,0.00009937402,0.00023836995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007701482,0.00028239624,0.00028612072,0.00079979503,0.0003239608,0.0005937896,0.00034730506,0.000370766,0.0013948295],"category_scores_gemma":[0.0014839804,0.00030907505,0.0004874648,0.0008129857,0.00033537426,0.0004165241,0.00048234302,0.00034195682,0.00024857375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012666144,0.000011561601,0.99934465,0.0000033935721,0.00004205794,0.00003548805,0.0000497204,0.000017926624,0.000086497435,0.000007918288,0.00002907709,0.0002450979],"study_design_scores_gemma":[0.00000784529,0.000076038916,0.99933845,0.000002089831,0.000034766734,0.00016918078,0.00014125166,0.00011694896,0.00003434488,0.000012491448,0.00006419248,0.0000023435866],"about_ca_topic_score_codex":0.0070453673,"about_ca_topic_score_gemma":0.0061091413,"teacher_disagreement_score":0.0070453673,"about_ca_system_score_codex":0.00028580744,"about_ca_system_score_gemma":0.00031938686,"threshold_uncertainty_score":0.014008701},"labels":[],"label_agreement":null},{"id":"W4404759855","doi":"10.6004/jnccn.2024.7053","title":"Comparative Safety and Effectiveness of Bevacizumab Biosimilars to Originator for the Treatment of Metastatic Colorectal Cancer","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Canadian Centre for Applied Research in Cancer Control; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","funders":"","keywords":"Bevacizumab; Medicine; Biosimilar; Internal medicine; Hazard ratio; Propensity score matching; Oncology; Proportional hazards model; Colorectal cancer; Irinotecan; Retrospective cohort study; Cancer; Chemotherapy; Confidence interval","score_opus":0.057561800520168335,"score_gpt":0.3925016962626685,"score_spread":0.33493989574250016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404759855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479127,0.00370451,0.00013732452,0.00010716017,0.000016366574,0.00009573429,0.0002494987,0.0000042727997,0.0008939405],"genre_scores_gemma":[0.9987453,0.00071325176,0.000116481955,0.00005025992,0.000020137672,0.000020092131,0.00024267181,0.0000014747593,0.000090230045],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9971154,0.001368971,0.0002309207,0.00023117432,0.0008937959,0.00015977191],"domain_scores_gemma":[0.9928128,0.0018769264,0.0035839556,0.00036607785,0.00094606774,0.0004141715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037749526,0.00022642336,0.00064033316,0.0004498254,0.00020790886,0.00083229755,0.00034660072,0.00036268102,0.0011341225],"category_scores_gemma":[0.012467876,0.00014350981,0.0010043278,0.00054608047,0.0006076234,0.00036772364,0.00027820517,0.00052746636,0.00009197626],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4036856,0.0033205266,0.34517032,0.0020953377,0.010652924,0.0003906858,0.0008974173,0.0031272261,0.010627771,0.0006873091,0.0017641452,0.21758063],"study_design_scores_gemma":[0.033566225,0.14833812,0.79265493,0.00035238106,0.007486198,0.0009618314,0.00041722832,0.00433864,0.004184535,0.0005136851,0.00710229,0.00008398517],"about_ca_topic_score_codex":0.014595679,"about_ca_topic_score_gemma":0.022300377,"teacher_disagreement_score":0.014595679,"about_ca_system_score_codex":0.0043029166,"about_ca_system_score_gemma":0.0024625678,"threshold_uncertainty_score":0.031220019},"labels":[],"label_agreement":null},{"id":"W4405847696","doi":"10.6004/jnccn.2024.7063","title":"Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children’s Oncology Group Bone Tumor Committee Consensus Statement","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Sarcoma; Osteosarcoma; Biopsy; Tissue bank; Ewing's sarcoma; Oncology; Internal medicine; Surgery; Pathology","score_opus":0.036203384515802135,"score_gpt":0.32985686990325114,"score_spread":0.293653485387449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405847696","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025303012,0.137387,0.12145024,0.59914714,0.022451274,0.009565143,0.0049339063,0.0017099098,0.07805245],"genre_scores_gemma":[0.12992167,0.15275396,0.5104793,0.14734638,0.010618268,0.009740307,0.014391176,0.0015951791,0.02315383],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96119803,0.013589233,0.008366903,0.0025671585,0.01226179,0.002016768],"domain_scores_gemma":[0.8616119,0.031208532,0.009712431,0.005516482,0.08170082,0.01024977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08893826,0.0009737325,0.0014775554,0.0044349525,0.0024593498,0.0037286403,0.0059466283,0.0050534685,0.0024314355],"category_scores_gemma":[0.07658494,0.0011507685,0.0017376597,0.0033208004,0.002898507,0.0028436033,0.00384989,0.009299995,0.0023415089],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020515194,0.00017577874,0.0186271,0.0029790197,0.00016240684,0.00074008293,0.0015841797,0.0018693047,0.00521822,0.009079592,0.54530066,0.41405845],"study_design_scores_gemma":[0.000079212245,0.0001669169,0.025561884,0.00903122,0.0001934319,0.0022550088,0.0016565024,0.0014107205,0.0041425694,0.0046671294,0.9507049,0.00013053142],"about_ca_topic_score_codex":0.027547518,"about_ca_topic_score_gemma":0.048697803,"teacher_disagreement_score":0.08893826,"about_ca_system_score_codex":0.0062666116,"about_ca_system_score_gemma":0.0434153,"threshold_uncertainty_score":0.4703561},"labels":[],"label_agreement":null},{"id":"W4406143906","doi":"10.6004/jnccn.2024.7071","title":"Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Preliminary Placebo-Controlled, Randomized, Double-Blind Trial","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Nursing Research","keywords":"Medicine; Placebo; Dexamethasone; Randomized controlled trial; Internal medicine; Quality of life (healthcare); Cancer-related fatigue; Physical therapy; Cancer; Nursing","score_opus":0.0640043063864643,"score_gpt":0.381203838341808,"score_spread":0.31719953195534367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406143906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9547329,0.017355101,0.0016232646,0.0018117704,0.0016673994,0.018199686,0.0017842259,0.00028296863,0.0025426478],"genre_scores_gemma":[0.95607066,0.008661889,0.0038933938,0.0020544007,0.0015485884,0.023142684,0.0011338919,0.000034684614,0.0034598226],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99850947,0.0009257853,0.00012969028,0.00018530384,0.000092557646,0.00015703004],"domain_scores_gemma":[0.998095,0.0007910506,0.00035342193,0.0001479676,0.00014207014,0.00047054913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027778535,0.0017765716,0.003989706,0.00058803934,0.0007158127,0.0012176035,0.0012309983,0.0028433695,0.007969717],"category_scores_gemma":[0.003036859,0.0008654283,0.0023119575,0.00075594673,0.0015681568,0.0012676476,0.00053345965,0.0031484475,0.0012306707],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9810937,0.007034945,0.00019463128,0.0007674701,0.00045720718,0.000024546573,0.00003621778,0.000104424915,0.0013964172,0.00004636661,0.00030503393,0.008539029],"study_design_scores_gemma":[0.9743367,0.024970371,0.00024668244,0.000019776637,0.00010444514,0.0000065880363,0.000005970703,0.000058855545,0.000077112905,0.000022273014,0.0001476751,0.0000035940448],"about_ca_topic_score_codex":0.0009993374,"about_ca_topic_score_gemma":0.002327139,"teacher_disagreement_score":0.007969717,"about_ca_system_score_codex":0.0006761998,"about_ca_system_score_gemma":0.002120516,"threshold_uncertainty_score":0.026661336},"labels":[],"label_agreement":null},{"id":"W4407360625","doi":"10.6004/jnccn.2024.7083","title":"Association Between Nonfatal Self-Injury and Survival Following a Cancer Diagnosis: A Comparative Population-Based Cohort Study","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Suicide and Self-Harm Studies","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Women's College Hospital; Queen's University; Health Sciences Centre; University of Toronto; University of Calgary; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Hazard ratio; Cancer; Retrospective cohort study; Cohort; Cohort study; Proportional hazards model; Oncology; Internal medicine; Confidence interval","score_opus":0.049944626875707596,"score_gpt":0.3922401091567441,"score_spread":0.3422954822810365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407360625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985863,0.00016901718,0.000086240616,0.00004767476,0.000010022932,0.000023933404,0.0008462275,0.0000031558593,0.00022743641],"genre_scores_gemma":[0.9986582,0.00013574702,0.00008368015,0.000053002575,0.000017166016,0.000025436566,0.0009264624,0.0000021310716,0.000098269906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885964,0.00024011741,0.00012023545,0.00038005048,0.00020275313,0.00019711007],"domain_scores_gemma":[0.9977314,0.00034199093,0.00079464715,0.00043878827,0.0002942833,0.00039894672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019293323,0.0003336854,0.000441356,0.0011343753,0.00075426983,0.0009829941,0.0007588501,0.0007938849,0.0018480936],"category_scores_gemma":[0.0036869661,0.00046812385,0.0010841474,0.0016747,0.00037457718,0.00065354985,0.00082101335,0.0009096746,0.00025896906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019512564,0.00009313154,0.9985728,0.00001134199,0.00024751635,0.00006721339,0.00007794348,0.000028846845,0.00009935552,0.000022592581,0.00012507825,0.00045901714],"study_design_scores_gemma":[0.0000354251,0.00020146929,0.9989085,0.000009524876,0.00013392261,0.00016656517,0.00017330445,0.00016117803,0.000021312208,0.000021623415,0.00016064983,0.0000065614513],"about_ca_topic_score_codex":0.023083393,"about_ca_topic_score_gemma":0.024364313,"teacher_disagreement_score":0.023083393,"about_ca_system_score_codex":0.00079684186,"about_ca_system_score_gemma":0.0008616844,"threshold_uncertainty_score":0.04589808},"labels":[],"label_agreement":null},{"id":"W4407743712","doi":"10.6004/jnccn.2024.7082","title":"Longitudinal Patient-Reported Outcomes in Older Adults With Aggressive Lymphomas Receiving Chemoimmunotherapy","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemoimmunotherapy; Hospital Anxiety and Depression Scale; Quality of life (healthcare); Anxiety; Depression (economics); Geriatric Depression Scale; Population; Clinical trial; Internal medicine; Physical therapy; Lymphoma; Rituximab; Psychiatry","score_opus":0.017783172372039358,"score_gpt":0.30242581169189714,"score_spread":0.2846426393198578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407743712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998965,0.00022779469,0.00006187666,0.000047776146,0.0000048019774,0.000017587734,0.00047993017,0.0000021851758,0.0001929798],"genre_scores_gemma":[0.9986773,0.00012423204,0.00009623492,0.000052105315,0.000011622531,0.000039919873,0.0009121782,9.2097685e-7,0.00008546823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925727,0.0002547102,0.00011129248,0.00011456648,0.00011437718,0.00014786086],"domain_scores_gemma":[0.99714476,0.00031020894,0.0015417963,0.00012303749,0.000411877,0.00046824157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002254715,0.0002384762,0.00036937336,0.0007738762,0.0005660615,0.00070474605,0.00026631865,0.0003848398,0.00080858846],"category_scores_gemma":[0.0038208885,0.0001743607,0.0005319957,0.0010498496,0.00016682925,0.00064586126,0.00069112383,0.0007077806,0.00019766674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113855145,0.000062738596,0.9985544,0.0000066482626,0.00003280814,0.000025005433,0.00010023458,0.000022769444,0.000037832302,0.000004697683,0.00006673899,0.00097217463],"study_design_scores_gemma":[0.000013385257,0.0003650565,0.99893516,0.000011654705,0.000034299905,0.00009784234,0.00019926135,0.0001061127,0.000033307442,0.000015488837,0.00018470167,0.0000038177755],"about_ca_topic_score_codex":0.0046239467,"about_ca_topic_score_gemma":0.005949989,"teacher_disagreement_score":0.0046239467,"about_ca_system_score_codex":0.00039459745,"about_ca_system_score_gemma":0.0004281248,"threshold_uncertainty_score":0.011924207},"labels":[],"label_agreement":null},{"id":"W4408929030","doi":"10.6004/jnccn.2024.7259","title":"HSR25-164: Mapping Patient Reported Side-Effect Incidence to Degradation of Health-Related Quality of Life Dimensions in Lymphoma and Chronic Lymphocytic Leukemia – A Study From the Lymphoma Coalition’s 2024 Global Patient Survey on Lymphomas &amp; CLL","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Lymphoma; Incidence (geometry); Quality of life (healthcare); Internal medicine; Leukemia; Health related quality of life; Oncology; Nursing","score_opus":0.08067527100508136,"score_gpt":0.3747189196011525,"score_spread":0.2940436485960711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408929030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9618557,0.00089109165,0.00044760286,0.00031848374,0.00004775236,0.0003399072,0.034021474,0.000037067734,0.0020409618],"genre_scores_gemma":[0.96341205,0.00037714603,0.00064818637,0.0003067992,0.000055809334,0.00058805675,0.03330749,0.00001786022,0.00128665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968996,0.0015319956,0.00037595833,0.00036037707,0.00060522207,0.00022676119],"domain_scores_gemma":[0.9904475,0.0013955197,0.0055858917,0.00067069096,0.00094272976,0.00095771224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042302352,0.0006576311,0.0007114096,0.0022359681,0.00040333578,0.0008155284,0.0010403736,0.00088033365,0.0020712614],"category_scores_gemma":[0.0073917364,0.00036581123,0.0023109193,0.0038653074,0.00037724912,0.00063813536,0.0015955071,0.00087591365,0.00087985606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007792931,0.000109925204,0.9924346,0.000085433334,0.000682519,0.000041328076,0.00008037469,0.00021954608,0.00011181174,0.000036368045,0.0021481984,0.0032706189],"study_design_scores_gemma":[0.00004983597,0.00015865805,0.9987496,0.000013382975,0.000098234384,0.000033219858,0.000051905343,0.00010170009,0.000030334988,0.00001102338,0.00069374073,0.0000083355135],"about_ca_topic_score_codex":0.019716276,"about_ca_topic_score_gemma":0.022060238,"teacher_disagreement_score":0.019716276,"about_ca_system_score_codex":0.0010908112,"about_ca_system_score_gemma":0.0008611726,"threshold_uncertainty_score":0.03920299},"labels":[],"label_agreement":null},{"id":"W4408929182","doi":"10.6004/jnccn.2024.7279","title":"HSR25-165: The Effectiveness of Implementing a Community-Based Lung Clinic in Rural Community Cancer Center","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Public Health and Nutrition","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority","funders":"","keywords":"Medicine; Center (category theory); Lung cancer; Cancer; Rural community; Community health center; Family medicine; Oncology; Intensive care medicine; Internal medicine; Demography","score_opus":0.06144985360058012,"score_gpt":0.4246007846720235,"score_spread":0.36315093107144336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408929182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956898,0.00022075472,0.00008923372,0.0010927895,0.000077087454,0.000638465,0.00010937921,0.00006635626,0.0020161918],"genre_scores_gemma":[0.99721825,0.00013956185,0.0009185638,0.0007600596,0.000054674,0.000280021,0.00013945262,0.000007468935,0.00048198202],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99385804,0.0040037944,0.0002261131,0.00057391834,0.00059587444,0.00074233196],"domain_scores_gemma":[0.9876057,0.0030034485,0.0013726924,0.00032951246,0.0006748666,0.0070139095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006178003,0.00056554755,0.0006394452,0.00069154846,0.0024847954,0.001394225,0.002336565,0.0017143536,0.005803327],"category_scores_gemma":[0.013607235,0.00048703913,0.0010390353,0.0005491313,0.0010746974,0.0009074239,0.00205029,0.0016446986,0.0003713568],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06166663,0.18101707,0.23627058,0.0016217357,0.0015024873,0.00079381326,0.0057635903,0.0058305594,0.0044292496,0.00079847587,0.013840893,0.48646492],"study_design_scores_gemma":[0.02621118,0.16727145,0.7731728,0.0007493925,0.0013601184,0.0002751714,0.014306885,0.007901127,0.002037292,0.00035798803,0.00615468,0.00020191287],"about_ca_topic_score_codex":0.05284972,"about_ca_topic_score_gemma":0.103373475,"teacher_disagreement_score":0.05284972,"about_ca_system_score_codex":0.0053449594,"about_ca_system_score_gemma":0.01959273,"threshold_uncertainty_score":0.10508418},"labels":[],"label_agreement":null},{"id":"W4408929714","doi":"10.6004/jnccn.2024.7262","title":"HSR25-180: Real-World (rw) Characteristics, Treatment (tx) Patterns and Clinical Outcomes in Patients (pts) With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Received Chemoradiotherapy (CRT)","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Chemoradiotherapy; Stage (stratigraphy); Oncology; Internal medicine; Lung cancer; Cancer","score_opus":0.046397441055767874,"score_gpt":0.39264714849384935,"score_spread":0.3462497074380815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408929714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99129593,0.0002655148,0.000045200344,0.00030977093,0.000028271816,0.000045175046,0.0072874078,0.0000062690724,0.0007164857],"genre_scores_gemma":[0.9911157,0.00012456901,0.00012812977,0.00016569307,0.000043780285,0.000054947144,0.007706694,0.000004194092,0.0006563446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968266,0.0001098569,0.000036371763,0.000056670524,0.000051415733,0.00006305688],"domain_scores_gemma":[0.9985532,0.00013120963,0.000732077,0.00006810929,0.00012673868,0.0003885619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007315584,0.0002194659,0.00023849326,0.0005775507,0.00028306068,0.0004546352,0.0003743332,0.0004112355,0.0024544834],"category_scores_gemma":[0.001504402,0.00014743471,0.00053507264,0.0011626829,0.00019177714,0.00042066444,0.00046769236,0.00041977593,0.0005525276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001230017,0.00013404145,0.9918516,0.000036576912,0.00019278457,0.00004221926,0.000066776214,0.00010442922,0.00016678942,0.00003500517,0.0030908738,0.0030488917],"study_design_scores_gemma":[0.00008988833,0.0003117083,0.9984275,0.000011805522,0.000060984632,0.00005097853,0.000107145446,0.00010126377,0.00004799474,0.00001571158,0.000768885,0.000006221322],"about_ca_topic_score_codex":0.007459136,"about_ca_topic_score_gemma":0.013739698,"teacher_disagreement_score":0.007459136,"about_ca_system_score_codex":0.000516401,"about_ca_system_score_gemma":0.0007525861,"threshold_uncertainty_score":0.014831424},"labels":[],"label_agreement":null},{"id":"W4408940018","doi":"10.6004/jnccn.2024.7105","title":"BIO25-022: Why Don’t They Want to Wear Sunscreen? Quantifying Anti-Sunscreen Messaging on TikTok","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Olfactory and Sensory Function Studies","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; Université de Sherbrooke; McGill University","funders":"","keywords":"Medicine; Sun protection factor; Sunscreening Agents; Dermatology; Internal medicine; Skin cancer","score_opus":0.22941395461455974,"score_gpt":0.3637065073801082,"score_spread":0.13429255276554844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408940018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884277,0.00047393327,0.00064627203,0.00024242925,0.00011067498,0.000054365508,0.0016335517,0.000034788984,0.008376456],"genre_scores_gemma":[0.98568857,0.00042752657,0.0014556899,0.0006773216,0.000029072164,0.00009022044,0.0012886144,0.000046036217,0.010297099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978167,0.000032777178,0.000009520618,0.000051157913,0.00007697794,0.000047835958],"domain_scores_gemma":[0.99970216,0.00006366223,0.000059059526,0.000015610209,0.00010398289,0.000055442528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032499927,0.00022303156,0.00016511708,0.00024326207,0.00041340376,0.00071623956,0.0002234575,0.00052819104,0.007002721],"category_scores_gemma":[0.0010198803,0.00011140062,0.00023551096,0.00023205098,0.00017873221,0.00029075955,0.000245095,0.0005167979,0.0013275784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007886694,0.0016124042,0.47766313,0.0010674506,0.00055121165,0.0005483873,0.002701057,0.00035630076,0.3731277,0.00079720217,0.012192546,0.12149588],"study_design_scores_gemma":[0.00008250671,0.0017829271,0.92303634,0.00016213111,0.0005150802,0.0005316146,0.0040913024,0.0008217052,0.055924866,0.0004917634,0.01250905,0.000050691393],"about_ca_topic_score_codex":0.0048742127,"about_ca_topic_score_gemma":0.0088507645,"teacher_disagreement_score":0.007002721,"about_ca_system_score_codex":0.000263864,"about_ca_system_score_gemma":0.000330745,"threshold_uncertainty_score":0.023426414},"labels":[],"label_agreement":null},{"id":"W4408942933","doi":"10.6004/jnccn.2024.7252","title":"TIP25-243: Randomized Study Evaluating Optimal Dose, Efficacy and Safety of E7386 + Lenvatinib Versus Treatment of Physicians' Choice in Advance/Recurrent Endometrial Carcinoma Previously Treated With Anti-PD-(L)1 Immunotherapy","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Lenvatinib; Medicine; Immunotherapy; Oncology; Endometrial cancer; Internal medicine; Randomized controlled trial; Carcinoma; Cancer","score_opus":0.049249119791007004,"score_gpt":0.3769303939944209,"score_spread":0.3276812742034139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408942933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852828,0.004549204,0.00050414604,0.0009976096,0.0006821811,0.0026068643,0.0021231596,0.00011403228,0.003139895],"genre_scores_gemma":[0.9884702,0.0014535845,0.00092831027,0.0018942686,0.00044284054,0.0018172642,0.0015987997,0.000020803924,0.003373952],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990521,0.0005860861,0.000040765393,0.00012754521,0.00006860276,0.00012493784],"domain_scores_gemma":[0.9988689,0.000350128,0.0002909837,0.00007167448,0.00004761713,0.00037061755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002099716,0.0011429834,0.0020991256,0.000362793,0.0003261527,0.0009950205,0.00081956724,0.0017266119,0.0060941414],"category_scores_gemma":[0.002107318,0.00053546013,0.0023461895,0.00039867056,0.0008687108,0.00067171425,0.00038610134,0.0026181145,0.0006883764],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9859446,0.0023176195,0.0006994024,0.00023174945,0.0012700524,0.000040659892,0.000013218488,0.00035785162,0.0008826199,0.000084198335,0.0010590898,0.0070988303],"study_design_scores_gemma":[0.9576568,0.037648626,0.0022046918,0.000028055852,0.0010005082,0.000023791423,0.000012781217,0.0004634382,0.00024847896,0.00009654595,0.00060000876,0.000016176029],"about_ca_topic_score_codex":0.001700066,"about_ca_topic_score_gemma":0.003696439,"teacher_disagreement_score":0.0060941414,"about_ca_system_score_codex":0.001011695,"about_ca_system_score_gemma":0.0012596336,"threshold_uncertainty_score":0.020386875},"labels":[],"label_agreement":null},{"id":"W4411211637","doi":"10.6004/jnccn.2025.7020","title":"Telehealth Geriatric Assessment and Supportive Care Intervention (GAIN-S) Program: A Randomized Clinical Trial","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Frailty in Older Adults","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Telehealth; Randomized controlled trial; Intervention (counseling); Clinical trial; Physical therapy; MEDLINE; Telemedicine; Nursing; Health care; Internal medicine","score_opus":0.0582286536802449,"score_gpt":0.46480747684059,"score_spread":0.4065788231603451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411211637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769677,0.0047892374,0.0006149924,0.0010532339,0.0005878914,0.013458751,0.000706429,0.000104216466,0.0017176411],"genre_scores_gemma":[0.9659641,0.00321099,0.0023945796,0.0013169779,0.000734094,0.023774536,0.0008031323,0.000007949329,0.0017935982],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990434,0.00053593505,0.00008444168,0.00013764529,0.000076391756,0.00012217302],"domain_scores_gemma":[0.99896204,0.00029197853,0.00028296537,0.00006540402,0.00007767334,0.00031998407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019767853,0.0012125341,0.0022802535,0.00050214544,0.00042919966,0.0006870169,0.00086635695,0.0018061926,0.007578733],"category_scores_gemma":[0.00240322,0.00040042016,0.0019099859,0.00050377357,0.00090839446,0.0007227121,0.0006469286,0.0014003809,0.0006742503],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95515853,0.018247446,0.00096314336,0.0015447144,0.0011294734,0.000034630906,0.000048745645,0.00030994744,0.0006371127,0.00010967123,0.0005613657,0.021255225],"study_design_scores_gemma":[0.9485886,0.048639666,0.0016433516,0.00008518757,0.00041717535,0.000011530885,0.00001724831,0.00021283908,0.00008232037,0.00006420478,0.00023282155,0.0000050525878],"about_ca_topic_score_codex":0.0013201036,"about_ca_topic_score_gemma":0.002405488,"teacher_disagreement_score":0.007578733,"about_ca_system_score_codex":0.0007918695,"about_ca_system_score_gemma":0.0015787084,"threshold_uncertainty_score":0.025353372},"labels":[],"label_agreement":null},{"id":"W4411715496","doi":"10.6004/jnccn.2025.7029","title":"Association of Polypharmacy and Potentially Inappropriate Medications With Outcomes in Older Adults With DLBCL: A Population Study","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; University Health Network; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Polypharmacy; Hazard ratio; Internal medicine; Population; Comorbidity; Proportional hazards model; Emergency medicine; Confidence interval; Environmental health","score_opus":0.015517056097077942,"score_gpt":0.3569374022833494,"score_spread":0.3414203461862715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411715496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986224,0.00036210893,0.0001023781,0.000057200323,0.0000067862024,0.000024013878,0.0005203234,0.0000031640889,0.00030148216],"genre_scores_gemma":[0.99915814,0.0001689958,0.00007282309,0.00007909909,0.000019532243,0.0000225239,0.0003989347,0.0000012086929,0.00007870953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920803,0.00020722061,0.00011381174,0.00021197193,0.0001485284,0.00011053094],"domain_scores_gemma":[0.99864167,0.0001337698,0.0007079612,0.00012678617,0.00017367801,0.00021606416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089939806,0.00033941196,0.0004359903,0.00089699443,0.00048564322,0.0008737152,0.00035195865,0.00052201154,0.0008180353],"category_scores_gemma":[0.0022908584,0.00034839215,0.00079605833,0.0014053334,0.00027013975,0.00071035855,0.0006535181,0.0008296007,0.00020338935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006601075,0.000054363525,0.9988901,0.000008265469,0.0001061653,0.00003854951,0.000045106353,0.000013352882,0.00005415081,0.0000065766476,0.00006576356,0.0006515674],"study_design_scores_gemma":[0.0000162183,0.00015564694,0.9990289,0.000009092109,0.00008528171,0.00022343095,0.00014747462,0.00010845678,0.000017243608,0.000018694856,0.00018620524,0.0000033191127],"about_ca_topic_score_codex":0.0062182443,"about_ca_topic_score_gemma":0.008867172,"teacher_disagreement_score":0.0062182443,"about_ca_system_score_codex":0.00039389724,"about_ca_system_score_gemma":0.0003758515,"threshold_uncertainty_score":0.012364149},"labels":[],"label_agreement":null},{"id":"W4412751557","doi":"10.6004/jnccn.2025.7033","title":"Olanzapine for Anorexia in Patients With Incurable Cancer and Cachexia (OlAnCa): A Double-Blind, Placebo-Controlled, Randomized Clinical Trial","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Anorexia; Olanzapine; Cachexia; Placebo; Internal medicine; Nausea; Randomized controlled trial; Gastroenterology; Cancer; Psychiatry; Schizophrenia (object-oriented programming)","score_opus":0.09292550295862327,"score_gpt":0.4331965260629955,"score_spread":0.34027102310437224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412751557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94894433,0.014608449,0.0018822904,0.0020873367,0.0022022063,0.024104621,0.0025686047,0.0003418454,0.003260304],"genre_scores_gemma":[0.9505836,0.007959417,0.004589859,0.0018696098,0.00090335135,0.02878304,0.001165842,0.000032361717,0.004112999],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99901795,0.00050892425,0.00010855721,0.00017399683,0.000085590225,0.000104818144],"domain_scores_gemma":[0.99890816,0.00030502342,0.00030856306,0.00007061916,0.000101116195,0.00030653956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00252535,0.0017796828,0.0034463382,0.0005156123,0.0006516898,0.0011048001,0.00088661973,0.0021978805,0.008323163],"category_scores_gemma":[0.002832469,0.000726537,0.0016669553,0.00054227386,0.0011361955,0.0010168455,0.00042412625,0.0018474313,0.0009435738],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9831035,0.0041296314,0.00020164104,0.001300494,0.0005822417,0.000035052093,0.000028733884,0.000105424326,0.0016489157,0.00008680855,0.00055516505,0.008222382],"study_design_scores_gemma":[0.9826749,0.016458014,0.00022504205,0.000028915474,0.00016402616,0.000013828078,0.0000060778734,0.000109792585,0.00007781547,0.00003884321,0.00019749664,0.0000052971573],"about_ca_topic_score_codex":0.00086061854,"about_ca_topic_score_gemma":0.0022570977,"teacher_disagreement_score":0.008323163,"about_ca_system_score_codex":0.0007369414,"about_ca_system_score_gemma":0.0019943803,"threshold_uncertainty_score":0.027843773},"labels":[],"label_agreement":null},{"id":"W4414195398","doi":"10.6004/jnccn.2025.7055","title":"Association of HOXB13 G84E With Prostate Cancer Among 592,158 Men","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Advanced Research","funders":"U.S. Department of Veterans Affairs","keywords":"Prostate cancer; Cohort; Cohort study; Association (psychology); Heterozygote advantage; MEDLINE","score_opus":0.015265263297621437,"score_gpt":0.3025436563592291,"score_spread":0.28727839306160763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414195398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993457,0.00011350655,0.000060742932,0.000019596106,0.0000025339937,0.0000046003524,0.00030952008,0.0000023978562,0.00014137682],"genre_scores_gemma":[0.9995571,0.000037256188,0.000060180213,0.000013908826,0.0000041008643,0.0000064355086,0.00020371425,0.000001413792,0.000115917785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968076,0.00005833844,0.0000226255,0.0001317084,0.00006942796,0.00003711245],"domain_scores_gemma":[0.9996117,0.00007860622,0.00017665801,0.000038705308,0.000026555028,0.00006784822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004167016,0.00019312181,0.00027641078,0.00041534725,0.00040803108,0.00029225586,0.00028769163,0.0002912762,0.0019048514],"category_scores_gemma":[0.00090798433,0.00026264368,0.00026202414,0.0006477738,0.00023490479,0.00016055026,0.0003654877,0.00032703354,0.00016004173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009428177,0.00001207647,0.998473,0.000005951561,0.00004251801,0.000075583535,0.00004463156,0.000021174097,0.0005580773,0.000011729768,0.000059787108,0.000601181],"study_design_scores_gemma":[0.000012847573,0.000064862266,0.99899656,0.000004041007,0.000037137273,0.00037289152,0.00006220432,0.00013168278,0.00012152573,0.000020405261,0.00017340817,0.0000025259776],"about_ca_topic_score_codex":0.0044903285,"about_ca_topic_score_gemma":0.005528014,"teacher_disagreement_score":0.0044903285,"about_ca_system_score_codex":0.00017370009,"about_ca_system_score_gemma":0.00018353398,"threshold_uncertainty_score":0.008928359},"labels":[],"label_agreement":null},{"id":"W4414195497","doi":"10.6004/jnccn.2025.7056","title":"Perioperative Radiotherapy and Survival After Surgical Treatment of Nonmetastatic Retroperitoneal Sarcoma","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Perioperative; Context (archaeology); Sarcoma; Liposarcoma; Overall survival; Guideline; Soft tissue sarcoma","score_opus":0.031580722843369845,"score_gpt":0.3419503267951725,"score_spread":0.3103696039518027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414195497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847525,0.0008881366,0.00012933617,0.00008137511,0.000004762586,0.000002252782,0.00015361849,0.000003980454,0.00026125953],"genre_scores_gemma":[0.99946886,0.00025358488,0.000049766804,0.000015518495,0.0000064444534,0.0000022707236,0.00016196373,0.0000010196324,0.00004066236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981874,0.00005552847,0.000027893257,0.00002981241,0.000041538762,0.000026490507],"domain_scores_gemma":[0.99833125,0.00033761928,0.0010842937,0.000048754166,0.00007018445,0.0001278575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028118992,0.00006681757,0.0001163923,0.00024978776,0.00009292042,0.0001974567,0.00017653899,0.000121751385,0.0008412143],"category_scores_gemma":[0.0025691616,0.000067490226,0.00023192466,0.0003674133,0.00015024586,0.00015981743,0.00017965144,0.00026621783,0.00008363478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097815166,0.000015769008,0.9949209,0.000016562855,0.000036784662,0.00006370493,0.000021161357,0.00018298729,0.00019566588,0.000013704506,0.00007734777,0.0043576225],"study_design_scores_gemma":[0.0000058625806,0.00012299049,0.9982679,0.000013877356,0.00003488085,0.000695485,0.000054585336,0.00033808404,0.0001895346,0.00002557202,0.0002487748,0.00000252069],"about_ca_topic_score_codex":0.0011087713,"about_ca_topic_score_gemma":0.0019417865,"teacher_disagreement_score":0.0011087713,"about_ca_system_score_codex":0.00023052824,"about_ca_system_score_gemma":0.00026705905,"threshold_uncertainty_score":0.002814114},"labels":[],"label_agreement":null}]}